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Chromosome instability (CIN) is a hallmark of human cancer and causes structural (S-CIN) as 
well as whole (W-CIN) chromosome aberrations. Cancers exhibiting the CIN phenotype are 
characterized by a large genetic heterogeneity that is associated with an increased adaptability of 
cancer cells and with a poor patient’s prognosis. In order to improve cancer therapy, it is of 
particular interest to unravel the mechanisms underlying CIN. Recently, enhanced mitotic 
microtubule growth rates were identified to contribute to CIN via inducing transient mitotic spindle 
mis-orientation, thereby triggering an increase in chromosome mis-segregation. Moreover, a 
pathway containing the microtubule plus-end binding protein EB1, the guanine exchange factor 
TRIO and its Rho GTPase Rac1, as well as the F-actin regulating Arp2/3 complex was identified 
to be involved in generation of the spindle orientation defect in cells with increased microtubule 
plus-end growth rates. However, many links within this pathway were still elusive and their 
investigation was the main aim of this study.  
This study revealed that EB1 and TRIO interact at microtubule plus-ends and that this interaction 
depends on microtubule dynamics. Moreover, it could be shown that this interaction is required 
for downstream activation of Rac1 and Arp2/3 in mitotic cells, which in turn results in 
reorganization of the actin cytoskeleton. Upon hyperactivation of this pathway, such as through 
increased microtubule plus-end growth rates found in CIN cells, the connectivity and thus density 
of the actin cortex increases, thereby causing a decreased cortical tension. Since a reduced 
cortical tension is associated with defects in spindle orientation, this triggers chromosome mis-
segregation and thus CIN. Interestingly, an upregulation of TRIO did not only induce whole 
chromosome instability in an EB1 binding dependent manner via the introduced pathway, but also 
structural chromosome instability. S-CIN did not only arise through the EB1 binding dependent 
pathway but also through an EB1 binding independent hitherto unknown pathway. Moreover, 
TRIO upregulation also resulted in enhanced cell migration in an EB1 binding independent 
manner. Therefore, these findings do not only give rise to further details and links of a CIN-inducing 
pathway connecting increased microtubule plus-end growth rates and spindle mis-orientation, but 







1.1 The eukaryotic cell cycle 
Common to every living creature is their reproduction by a cycle of duplication and division, the 
so-called cell cycle. While this cycle results in the generation of a completely new organism for 
unicellular species, multiple cycles following a complex sequence are required for the 
development of multicellular species (Alberts et al., 2015). Moreover, cell duplication and division 
are continuously ongoing even in the adult multicellular organism to ensure replacement of dying 
cells. This process needs to be tightly regulated, as defects in the regulation can induce 
uncontrolled cell division, a common feature of all cancer cells (Clurman & Roberts, 1995; Collins 
et al., 1997; Hanahan & Weinberg, 2000). The fundamental process underlying the cell cycle is 
the duplication of the cell´s genetic information and its equal distribution into two daughter cells. 
These events take place at different phases of the cell cycle: duplication of chromosomes occurs 
in S phase via DNA synthesis, while segregation of chromosomes and cell division takes place 
during mitosis (Murray & Hunt, 1993). These phases are separated by two gap phases, G1 
between mitosis and S phase and G2 between S phase and mitosis, that allow time for growth and 
doubling of the cell´s organelles and protein mass. G1, S and G2 phases together are summarized 
as interphase. Subsequently to mitosis, G1 phase begins, allowing not only time for the cell to grow 
but also to take notice of the environmental conditions and whether they are suitable for another 
round of duplication and division. In case of unfavorable extracellular conditions, G1 phase is 
extended or the cell even withdraws temporarily or permanently from the active cell cycle by 
entering the resting phase G0. However, in the presence of proliferative stimuli that indicate 
favorable environmental conditions, cells pass the so-called restriction point at the end of G1 
phase, thereby entering S phase in an irreversible manner. During S phase, cells do not only 
replicate their DNA, but also perform centrosome duplication (Laskey et al., 1989). Moreover, the 
resulting sister chromatids are paired and held together by the cohesin protein complex (Skibbens, 
2009). After S phase, cells enter G2 phase, characterized by synthesis and activation of proteins 
that are required for subsequent mitosis. G2 phase also allows time for the repair of DNA double-
strand breaks that arise during DNA replication (Cuddihy & O'Connell, 2003). Following G2 phase, 
cells enter mitosis that consists of prophase, prometaphase, metaphase, anaphase and telophase 
(Murray & Hunt, 1993) (Figure 1.1). In prophase, chromosome condensation occurs. Additionally, 
the two centrosomes separate and start to migrate along the nuclear envelope in opposite 
directions (Tanenbaum & Medema, 2010). During this process, microtubule nucleation at 




prometaphase, nuclear envelope breakdown (NEBD) takes place and kinetochores are 
assembled at the centromeric region of the duplicated chromatids, thereby providing a platform 
that links the chromosomes to microtubules emanating from the mitotic spindle (Cheeseman & 
Desai, 2008). The process, in which microtubules begin to search for and attach to chromosomal 
kinetochores, takes place in late prometaphase and ends in metaphase with all sister chromatids 
being attached to microtubules from opposing poles of the mitotic spindle. Upon alignment of all 
chromosomes at the spindle equator forming the metaphase plate, a cohesin subunit is cleaved 
by the protease separase that has been activated by the anaphase-promoting complex/cyclosome 
(APC/C). This results in disassembly of the cohesin protein complex and consequently in the 
separation of sister chromatids (Nakajima et al., 2007). In anaphase A, sister chromatids are 
pulled to opposite spindle poles by kinetochore microtubule depolymerization, whereas in 
anaphase B the two spindle poles themselves move further apart by polar microtubules pushing 
against each other (Goshima & Scholey, 2010; Inoué & Ritter, 1975). During this process, the cell 
  
 
Figure 1.1: The phases of a eukaryotic cell cycle. The eukaryotic cell cycle consists of interphase 
containing the three phases G1 (first gap phase) S (DNA synthesis), and G2 (second gap phase) and mitosis. 
G0 phase is a resting phase entered by cells that withdraw from the active cell cycle. The five sub-phases 
of mitosis are prophase, prometaphase, metaphase, anaphase and telophase. In prophase, chromosome 
condensation takes place and formation of a bipolar spindle is initiated. Breakdown of the nuclear envelope 
is accomplished in prometaphase, as well as kinetochore assembly, followed by chromosome capturing by 
mitotic spindle derived microtubules. After complete chromosome alignment at the metaphase plate, sister 
chromatids become separated and pulled to opposite spindle poles during anaphase. Finally, new nuclear 
envelopes are built around the separated, decondensing chromosome masses and a cleavage furrow is 




elongates and an actomyosin ring assembles at the division plane. In telophase, separate nuclear 
envelops form around the segregated chromosomes that begin to decondense again and 
contraction of the actomyosin ring leads to the formation of a cleavage furrow (Glotzer, 2005). 
Finally, cytokinesis ends up with the complete separation of the dividing cell in two daughter cells.  
To ensure an error-free cell cycle progression, control systems govern major cell cycle events, 
such as entry into S phase, G2/M transition or metaphase-to-anaphase transition. Control of many 
cell cycle events is mediated by the oscillating activation and inactivation of members of a family 
of cyclin-dependent kinases (Cdks) (Arellano & Moreno, 1997). Cyclical activity of these Cdks is 
not archived by the protein level of Cdks, as this is constant throughout the cell cycle, but by 
binding of so-called cyclins that activate the protein kinase. In contrast to Cdk protein levels, cyclin 
levels change cyclically, thereby allowing for activation of Cdks at specific stages of the cell cycle 
(Figure 1.2). Depending on the cyclin-Cdk complex and its activity, cell cycle stage specific events 
are triggered by modulation of transcriptional, translational and DNA replication-related processes 
as well as of mitotic checkpoints. D cyclins bind to CDK4 and CDK6 during G1 phase resulting in 
the phosphorylation of retinoblastoma (Rb) protein (Harbour & Dean, 2000; Malumbres & 
Barbacid, 2005). Rb in turn releases its binding partner and transcription factor E2F that triggers 
transcription of genes important for DNA replication. Further phosphorylation of Rb induced by 
cyclin E/CDK2 complexes that form at late G1 phase finally results in S phase entry. During S 
phase, cyclin A binds to CDK2, thereby replacing cyclin E. This complex initiates and regulates 
DNA replication by triggering the assembly of the pre-replication complex, but at the same time 
preventing the assembly of additional replication complexes. Cyclin A binds to CDK1 at the 
beginning of G2 phase and supports the assembly and activation of cyclin B/CDK1 complexes at 
the end of G2 phase. This complex phosphorylates several proteins that are involved in 
chromosome condensation, nuclear envelope breakdown and spindle formation, thereby 
triggering entry into mitosis (Nigg, 2001). Degradation of cyclin B takes place during mitosis and 
the resulting inactivation of CDK1 promotes mitotic exit. As binding of cyclins only allows for partial 
activation, phosphorylation of Cdks by the Cdk-activating kinase (CAK) is required for full 
activation of the Cdk-cyclin complex (Lolli & Johnson, 2005). In addition to the cyclically changing 
cyclin levels, further mechanisms are involved in the control of Cdk activity. This includes 
inactivation of cyclin-Cdk complexes through phosphorylation by the kinases Wee1 or Myt1, 
whereas removal of these phosphates by the phosphatase Cdc25 can restore the cyclin-Cdk 
activity (Den Haese et al., 1995; Malumbres & Barbacid, 2005; D. O. Morgan, 1997). Inactivation 
of cyclin-Cdk levels is also archived by binding of Cdk inhibitor proteins (CKIs). Dysregulated 




observed in cancer cells (Deshpande et al., 2005). In healthy cells, DNA damage induced by 
environmental factors or by errors in DNA replication results in cell cycle arrest or, in case of 
severe DNA damage, in apoptosis (Zhou & Elledge, 2000). In order to stop the cell cycle from 
continuing until the DNA damage has been repaired, various protein kinases are recruited to the 
site of DNA damage. They trigger a signaling cascade ending with inhibition of the CDK1/cyclin B 
complex and thereby preventing entry into mitosis. In response to DNA damage and replication 
stress, the replication fork is slowed or stalled to allow time for DNA damage repair (Rickman & 
Smogorzewska, 2019). Upon activation of the DNA damage response (DDR) signaling, the kinase 
ATM (ataxia telangiectasia mutated) is primarily recruited to DNA double strand breaks, whereas 
the kinase ATR (ATM-Rad3-related) responds to various DNA damages, such as DNA single and 
double strand breaks (Maréchal & Zou, 2013). Following ATM/ATR binding to the DNA damage 
site, ATM and ATR recruit the kinases Chk2 and Chk1, respectively (Jackson & Bartek, 2009). 
These kinases phosphorylate cell cycle arrest-inducing target proteins, with p53 as major target. 
Activated p53 stimulates the transcription of diverse genes, including the gene coding for the 
cyclin-dependent kinase inhibitor p21. p21 in turn binds and inactivates cyclin E/CDK2 and 
 
 
Figure 1.2: Cyclin-Cdk complexes are regulators of the cell cycle. Progression through the cell cycle 
is controlled by the presence of different cyclin-Cdk complexes at specific cell cycle stages: In G1 phase, 
Cyclin D binds to CDK4 and CDK6, while cyclin E/CDK2 complexes form at the end of G1 phase triggering 
expression of genes required for DNA replication. Upon entry into S phase, cyclin A binds to CDK2 for 
initiation and regulation of DNA replication. At the beginning of G2 phase cyclin A binds to CDK1 and is 
replaced by cyclin B at the end of G2, thereby promoting entry into mitosis. Mitotic exit is induced by cyclin 





cyclin A/CDK2 complexes, thereby arresting the cell in G1. Additionally, Chk1 and Chk2 
phosphorylate and thus inactivate members of the Cdc25 protein phosphatase family. These are 
no longer able to activate cyclin B/CDK1 complexes, thus blocking entry into mitosis. Upon cell 
cycle arrest, different cell cycle dependent DNA repair mechanisms have enough time to fulfil their 
task. The major DNA repair mechanisms include base excision repair (BER), nucleotide excision 
repair (NER), mismatch repair (MMR), homologous recombination (HR), nonhomologous end 
joining (NHEJ) and microhomology-mediated end joining (MMEJ) (Chatterjee & Walker, 2017; 
Sallmyr & Tomkinson, 2018).      
While cyclin-Cdk complexes are responsible for the control of G1/S and G2/M transition, the spindle 
assembly checkpoint (SAC) controls metaphase-to-anaphase transition and ensures that this 
transition only takes place after all chromosomes have been properly attached to microtubules 
emanating from the mitotic spindle (Lara-Gonzalez et al., 2012). This prevents chromosome mis-
segregation and thereby assures genomic stability. The major effector of the SAC is the mitotic 
checkpoint complex (MCC) that consists of the proteins MAD2, BUBR1, Bub3, Cdc20 and Mad2. 
The MCC assembles at unattached kinetochores and prevents Cdc20 from activating the APC/C, 
thereby avoiding premature separation of sister chromatids. In case of correct microtubule-
kinetochore attachment, the MCC disassembles from the kinetochore. The released Cdc20 
activates the APC/C, which in turn causes ubiquitination of cyclin B and securin via its EB3 
ubiquitin ligase activity. The subsequent proteasomal degradation of securin leads to release of 
separase that cleaves the cohesin subunit of the cohesin complex, thereby promoting separation 
of sister chromatids. APC/C-mediated degradation of cyclin B inactivates Cdk1 and thus induces 
mitotic exit. Another regulator of SAC activation is kinetochore tension (Maresca & Salmon, 2010). 
Only when kinetochores from sister chromatids are properly attached to microtubules from 
opposing spindle poles, pulling forces of the mitotic spindle generate tension at the kinetochores 
that stabilizes the microtubule-kinetochore attachment. In contrast, weak tension due to incorrect 
attachments destabilizes binding of microtubules to kinetochores and allows reattachment to 
microtubules from the correct spindle pole. However, the SAC is not able to detect merotelic 
attachments, in which a single kinetochore is attached to microtubules emanating from both 
spindle poles, thereby inducing lagging chromosomes and chromosomal instability (Gregan et al., 
2011). Correction of these merotelic attachments involves Aurora B kinase that is highly 
concentrated at the inner centromere where it destabilizes microtubules rather from the incorrect 





1.2 The cellular cytoskeleton 
Inside a cell many processes take place that require changes in the cell´s shape and 
rearrangement of internal components including cell cycle dependent cell growth and division, but 
also processes such as adhesion and migration. To overcome these challenging tasks, the cell 
possesses of a dynamic filamentous system, the cytoskeleton. There are three major cytoskeletal 
filaments, namely actin filaments, microtubules and intermediate filaments (Fletcher & Mullins, 
2010; Hohmann & Dehghani, 2019). Actin filaments determine the shape and tension of the cell´s 
surface and are required for cell migration and cytokinesis. Microtubules act as platform for 
intracellular transport and are the major components of mitotic spindles, but also play a role for 
cell migration (Etienne-Manneville, 2013; Kaverina & Straube, 2011). Intermediate filaments 
organize internal structures of the cell and are involved in forming the nuclear lamina and cell-cell 
junctions (Hohmann & Dehghani, 2019). During mitosis, reorganization of the actin cytoskeleton 
is necessary to allow for correct spindle assembly and positioning and thereby proper 
chromosome segregation (Cadart et al., 2014). For this reason, not only microtubules forming the 
mitotic spindle are crucial for early mitotic processes but also a tightly regulated rearrangement of 
actin filaments. For a better understanding of the role of microtubules and actin filaments in 
mitosis, it is important to have a closer look at their assembly and regulation as well as their 
interplay and impact on the cell surface tension.   
1.2.1 Assembly and regulation of the microtubule cytoskeleton 
Microtubules are polymers of heterodimerized α- and β-tubulin subunits. These αβ-tubulin 
heterodimers are bound head to tail, thereby generating a protofilament (Alberts et al., 2015). The 
parallel assembly of 13 protofilaments leads to the formation of a hollow cylindrical structure, the 
microtubule. As major microtubule nucleator, γ-tubulin forms together with other proteins the so-
called γ-tubulin ring complex (γ-TuRC), which is usually found at the centrosomal microtubule 
organization center (MTOC) and serves as scaffold for initial microtubule assembly (Hohmann & 
Dehghani, 2019). Strong interactions between longitudinal connected αβ-tubulin heterodimers and 
between lateral connected α-α- or β-β-monomers are responsible for the microtubule stiffness and 
allow microtubule turnover only at the ends (Alberts et al., 2015). As all αβ-tubulin heterodimers 
point in the same direction within the microtubule structure, they bear one end with α-tubulin 
exposed, called the minus end, and one end with β-tubulin exposed, called the plus end, which 
has been shown to grow and shrink more rapidly. Microtubule dynamics highly depend on the 
binding and hydrolysis of GTP bound to β-tubulin, as in a GTP bound state tubulin tends to 




growth, GTP bound β-tubulin polymerizes at microtubule ends, thereby forming a so-called GTP 
cap. However, when the GTP of β-tubulin at the GTP cap hydrolyzes faster to GDP than new GTP 
bound β-tubulin is added to the microtubule end, depolymerization of tubulin subunits occurs 
leading to microtubule shrinking. This process is called a catastrophe, whereas switching to 
microtubule growth again is called a rescue (Figure 1.3). In addition to the concentration of GTP 
bound β-tubulin within the cell, microtubule dynamics are also regulated by microtubule-
associated proteins (MAPs) (Bowne-Anderson et al., 2015). They can have a stabilizing or 
destabilizing effect, that several MAPs execute by their function as polymerase or depolymerase. 
While some MAPs execute their function along the length of the microtubule, other MAPs belong 
to a group of microtubule plus-end binding proteins (+TIP). One member of this +TIP family is the 
microtubule polymerase ch-TOG/XMAP215 (colonic and hepatic tumor overexpressed gene), 
which catalyzes the polymerization of tubulin dimers at the microtubule plus-end (Brouhard et al., 
2008). The opposite effect is observed for the microtubule depolymerase MCAK (mitotic 
centromere-associated kinesin), that triggers dissociation of microtubule plus-end-located tubulin 
dimers (Hunter et al., 2003). Another important family of +TIPs are end binding proteins (EBs) 
(Hohmann & Dehghani, 2019). EB proteins bind to growing microtubule plus-ends, where they 
recruit other factors, such as ch-TOG and MCAK, that affect microtubule dynamics or they act as 
a link between microtubule plus-ends and other cellular structures (Honnappa et al., 2009; 
Tirnauer & Bierer, 2000). In this context, an EB1-mediated link between microtubule plus-ends 
and the cell cortex has been shown to be crucial for correct mitotic spindle assembly, dynamics 
and positioning as well as chromosome alignment and maintenance of chromosome stability 
(Rogers et al., 2002; Tirnauer & Bierer, 2000). This observed link was reported to be generated 
by EB1 interacting with the guanine nucleotide exchange factor (GEF) RhoGEFD2 in Drosophila 
or with APC (adenomatous polyposis coli) in order to facilitate their delivery or interaction with 
specific sites at the cell cortex (Green et al., 2005; Rogers et al., 2002; Rogers et al., 2004).  
Not only MAPs have been found to affect microtubule dynamics, but also chemical compounds, 
such as Taxol and Nocodazole. Interestingly, these two drugs cause different effects at different 
concentrations: At micromolar concentrations, Taxol stabilizes microtubules while Nocodazole 
causes microtubule depolymerization and both result in blocking mitosis (Lu et al., 2012; Yang & 
Horwitz, 2017). At concentrations within a low to mediate nanomolar range, however, both drugs 
were shown to strongly inhibit microtubule dynamics, meaning both growth and shrinkage events 
(Jordan et al., 1992; Vasquez et al., 1997). This in turn results in aberrant mitosis and aneuploidy. 
Interestingly, Taxol was shown to suppress microtubule assembly preferentially at the plus ends 




microtubule plus end growth rates in contrast to chromosomally stable cells, even subnanomolar 
concentrations of Taxol were sufficient to decrease microtubule plus end growth rates (Berger, 
2016; Ertych et al., 2014). Although Nocodazole also inhibits microtubule dynamics at low 
nanomolar concentrations (Vasquez et al., 1997), it has been shown to increase microtubule plus 
end growth rates in chromosomally stable cells when used at even lower nanomolar or at 
subnanomolar concentrations (Berger, 2016; Ertych et al., 2014; Schermuly, 2019).   
 
 
Figure 1.3: Dynamic instability of microtubules. Microtubules are assembled by polymerization of GTP 
bound αβ-tubulin heterodimers at the end of microtubules. When the addition of GTP bound tubulin at the 
microtubule end decreases, microtubule stability is reduced by ongoing GTP hydrolysis of assembled tubulin 
subunits resulting in microtubule disassembly. This process is called catastrophe, whereas a reactivation of 
microtubule growth is called rescue. Modified from Al-Bassam and Chang (2011). 
 
1.2.2 Assembly and regulation of the actin cytoskeleton 
Actin filaments are assembled by head-to-tail bound globular actin monomers (G-actin) (Alberts 
et al., 2015). Actin in its filamentous form is also called F-actin. Similar as for microtubules, the 
actin subunits all point in the same direction, thereby forming a filament with actin assembly and 
disassembly being fast at the plus-end (barded end) but slow at the minus-end (pointed end). 
Another impact on actin filament dynamics has the ATPase function of actin. Most free actin 
subunits are in an ATP bound form, that shows accelerated hydrolysis after incorporation into actin 




exists in two structures: ATP bound actin filaments that are known to allow fast actin assembly 
and disassembly, and ADP bound actin filaments showing slower actin assembly and 
disassembly. In case the concentration of free actin subunits is within a specific range, assembly 
is faster than disassembly at the plus end, but not at the minus end, thereby keeping the plus end 
in ATP bound and the minus end in ADP bound conformation. This process, in which a continuous 
filament growth occurs at the plus end with simultaneous shrinkage at the minus end, is called 
treadmilling. However, not only the concentration of free actin subunits regulates actin filament 
dynamics, but also actin binding proteins (Pollard, 2016). While binding of thymosin to free actin 
subunits prevents actin assembly, profilin binding at the minus-end-faced site of actin subunits 
accelerates filament formation at the plus-end. Further regulation of actin filament dynamics is 
done by the F-actin capping protein (CP), that binds to plus-ends, thereby preventing assembly 
and disassembly of free actin subunits (Wear et al., 2003).  
For actin filament formation, nucleation is required, which can take place by spontaneous 
assembly of actin monomers. However, small actin oligomers that form in this way are unstable 
and only few of them result in the assembly of a stable actin filament. For this reason, actin 
nucleation is mostly catalyzed by actin nucleators, such as the Arp2/3 complex, formins and 
tandem-monomer-binding nucleators (Firat-Karalar & Welch, 2011). While the Arp2/3 complex 
promotes the formation of branched actin filaments in an ATP dependent manner, nucleation 
mediated by formins and tandem-monomer-binding nucleators result in unbranched, linear actin 
filaments (Figure 1.4) (Goley & Welch, 2006). In order to generate branched actin filaments, the 
Arp2/3 complex attaches to the side of already existing actin filaments, resulting in the formation 
of a daughter filament branch that grows at an 70° angle relative to the pre-existing mother 
filament. The Arp2/3 complex consists of seven subunits, from which the two actin-relating and 
heterodimer-forming proteins Arp2 and Arp3 are not only responsible for the name of the complex, 
but also show strong structural similarity to actin monomers that enables them to act as actin 
nucleator. From the five additional subunits ARPC1-5, the subunits ARPC2 and ARPC4 form a 
heterodimer that is responsible for the main interaction with the mother filament and generate the 
link between Arp3 and the daughter filament (Rouiller et al., 2008). This link is further supported 
by ARPC3. ARPC5 also interacts with the mother filament and stabilizes Arp2 within the complex. 
Although ARPC1 has only a minor important function in binding to the mother filament, it is 
essential for Arp2/3 complex activation by binding nucleation promoting factors (NPFs) (Pan et 
al., 2004). There are many NPFs known so far with the Wiskott-Aldrich Syndrome protein (WASP) 
family being the best-characterized group. The WASP family comprises WASP, N-WASP 




WASH (WASP and SCAR homolog), WHAMM (WASP homolog associated with actin, 
membranes and microtubules) and JMY (junction mediating regulatory protein) (Firat-Karalar & 
Welch, 2011). All WASP family members contain a conserved VCA domain at their C-terminal 
regions, that contains an actin monomer binding verprolin homology sequence (V) as well as 
central (C) and acidic sequences (A), that are able to bind to the Arp2/3 subunit ARPC1 (Kelly et 
al., 2006). Sometimes the VCA domain is also termed as WCA domain, with W standing for WASP 
homology 2 domain (Derivery & Gautreau, 2010). The activity of WASP family members is 
regulated by an autoinhibitory conformation of the VCA domain that it has when it is not bound to 
an activating Rho (Ras homolog) family GTPase and in which VCA is not able to bind to the Arp2/3 
complex (Padrick & Rosen, 2010). While the Rho GTPase Rac1 activates SCAR/WAVE proteins 
by binding to their VCA domain, WASP is activated by VCA binding to Cdc42 (Goley & Welch, 
2006). Further activation of WASP family members is achieved by oligomerization of VCA 
domains, as this have been shown to result in a stronger Arp2/3 complex activation (Padrick & 
Rosen, 2010).  
In contrast to the formation of branched actin filaments, generated by Arp2/3 complex-mediated 
actin nucleation, formins promote formation of unbranched, linear actin filaments. The 15 formins 
known in mammals can be categorized into seven subtypes, namely Dia (diaphanous). DAAM 
(disheveled-associated activator of morphogenesis), delphilin, FHOD (fomin homology domain-
containing protein), FMN (formin), FRL (formin-related gene in leukocytes) and INF (inverted 
formin) (H. N. Higgs & Peterson, 2005). All formins share a C-terminally located FH1 (formin 
homology 1) and FH2 (formin homology 2) domain. Dimerization of formin FH2 domains facilitates 
actin nucleation by binding to and thereby stabilizing spontaneously formed actin dimers or trimers 
(Goley & Welch, 2006). In contrast to Arp2/3, formins protect the barbed ends from capping 
proteins as they remain associated with the growing barbed end after nucleation (Figure 1.4). 
Additionally, formins act as actin elongators by binding to profilin bound actin monomers via their 
FH1 domains, thereby bringing them close to the site of actin assembly at the barbed end (Firat-
Karalar & Welch, 2011). Most mammalian formins belong to the Dia subtype, which contains a 
Rho GTPase binding domain (GBD), a diaphanous inhibitory domain (DID) and a diaphanous 
autoregulatory domain (DAD) (Courtemanche, 2018). Without binding of a Rho GTPase to the 
GBD, the interaction of DID and DAD results in autoinhibition of the formin. However, in case of 
Rho GTPase binding to the GBD, the DID/DAD association is disrupted and the autoinhibition is 
partially relieved. This partial activation is facilitated by the GTPases RhoA, RhoB, RhoC, Rac1 
and Rac2 for the formin mDia1, whereas mDia2 requires binding of RhoA, RhoB, Rac1, Rac2 or 




requires additional factors, such as binding to specific membrane phospholipids (Ramalingam et 
al., 2010), interaction with NPFs or phosphorylation by kinases like the Rho-associated kinase 
(ROCK) (Breitsprecher & Goode, 2013). Interestingly, several formins belonging to the Dia, FMN 
and INF subtypes have been shown to interact with microtubule plus-tip proteins, such as EB1, 
APC or the cytoplasmic linker protein 170 (CLIP170), or even directly with microtubules (Bartolini 
et al., 2008; Chesarone et al., 2010). Therefore, some formins do not only regulate actin filament 
formation but also microtubule stability and dynamics. 
The group of tandem-monomer-binding actin nucleators includes Spire, cordon bleu (Cobl), 
leiomodin (Lmod), JMY and APC. All of them have tandem G-actin binding motifs that contain 
actin binding WH2 domains bringing together actin monomers to form an actin nucleus (Firat-
Karalar & Welch, 2011). As the Arp2/3 complex, tandem-monomer-binding actin nucleators 
remain bound to the pointed end during actin filament elongation.  
 
  
Figure 1.4: Actin filament assembly, nucleation and elongation factors.  Cytoplasmic actin monomers 
(G-actin) are mostly present in GTP-bound form and assemble to actin filaments with the help of actin 
nucleators such as the Arp2/3 complex and formins. The Arp2/3 complex remains at the minus end after 
nucleation and enables formation of branched filaments, whereas formins stay associated with the growing 
plus-end and generate unbranched, linear filaments. Actin dynamics are regulated by several factors: cofilin 
binds to the minus ends and accelerates actin disassembly, whereas interaction of profilin with G-actin 
accelerates plus end assembly. By binding of the F-actin capping protein to the filament end, further growth 




As mentioned above, Arp2/3 complex mediated nucleation results in the formation of unbranched 
actin filaments, while nucleation by formins and tandem-monomer-binding nucleators forms 
unbranched, linear filaments. Consequently, Arp2/3 organizes branched actin filaments into 
dendritic networks, whereas linear actin filaments nucleated by formins or tandem-monomer-
binding nucleators are organized in parallel bundles (Davidson & Wood, 2016). Another group of 
actin-binding proteins (ABPs), that act as crosslinkers, also affects actin filament organization. 
One of these crosslinkers is fimbrin that holds two actin filaments together in a parallel and very 
close manner via its directly adjacent actin binding sites, thereby generating tight actin bundles 
(Pollard, 2016). Actin filament crosslinking by fascin also results in tight actin bundles, but with 
antiparallel alignment. Another crosslinker, α-actinin, forms a homodimer that contains two actin 
binding sites separated by a spacer, thereby forming more loosely packed, parallel actin bundles. 
The crosslinker filamin, however, forms homodimers with two V-shape-oriented actin binding sites 
that connect actin filaments into a loose, web-like network, in which the filaments are oriented in 
an almost 90°C angle to one another (Figure 1.5) (Nakamura et al., 2007). Depending on the 
crosslinker, interaction of other actin binding proteins with the crosslinked actin filaments can be 
affected. Fimbrin-mediated tight parallel actin bundles exclude binding of other proteins, such as 
α-actinin and myosin II (Alberts et al., 2015). The motor protein myosin II also acts as crosslinker  
 
 
Figure 1.5: Actin filament crosslinker. The structural organization of actin filaments is dictated by 
crosslinking proteins: fimbrin contains two directly adjacent actin binding sites, thereby generating tight, 
parallel actin bundles. The two actin binding sites of α-actinin are separated by a linker, resulting in more 
loosely packed, parallel actin bundles. Due to its V-shape oriented actin binding sites, filamin connects actin 





and is essential for the generation of a contractile actin structure by enabling actin filaments to 
slide relative to one another. In contrast to fimbrin, α-actinin-mediated crosslinks result in a loose, 
parallel orientation of actin filaments that allows myosin II binding, thereby forming contractile actin 
bundles. Thick bundles of rigid, contractile actomyosin fibers are also called stress fibers. 
Depending on the type of organization, the resulting actin structure exhibits different mechanical 
properties that are required for different cellular processes, such as adhesion, migration, mitotic 
cell rounding and cytokinesis. 
1.2.3 Function and regulation of the cellular cytoskeleton in cell migration 
The ability to migrate is essential for many biological processes, such as embryonic development, 
immune surveillance and tissue repair. However, an impaired regulation of cell migration is known 
to promote progression of cancer cell invasion and metastasis (Fife et al., 2014; Yamaguchi & 
Condeelis, 2007). In general, directed cell migration comprises several steps, beginning with 
forming an actin polymerization-driven protrusion of the cell membrane in the direction of 
movement that is determined by an extracellular gradient of cytokines or chemokines. In the next 
step, adhesion of the newly generated protrusions at the leading edge takes place by forming focal 
contacts that connect the actin cytoskeleton with extracellular matrix (ECM) proteins or with the 
substratum. Actomyosin-driven contraction at the rear part of the cell generates forces that trigger 
disassembly of cell-ECM adhesions at the cell rear (Lauffenburger & Horwitz, 1996). This results 
in retraction of the trailing edge of the cell towards the direction of movement. In some cell types, 
disassembly of cell-ECM adhesions is accompanied by pericellular proteolytic degradation of ECM 
components (Friedl & Wolf, 2009).  
Actin polymerization-driven protrusions at the plasma membrane, which are generated at the 
leading edge of migrating cells, comprise lamellipodia, that are broad, sheet-like actin networks, 
and filopodia, which are thin, finger-like projections of crosslinked actin bundles extending beyond 
the lamellipodia (Yamaguchi & Condeelis, 2007). These differences in shape are based on 
different actin filament nucleators and crosslinker: While the actin network of lamellipodia depends 
on Arp2/3, tight actin bundles of filopodia are nucleated by mDia formins and mostly crosslinked 
by fimbrin or fascin. A timely and spatially coordinated assembly and disassembly of actin 
structures required for the formation of adhesion sites, lamellipodia and filopodia is crucial for cell 
migration (Lawson & Ridley, 2018; K. Martin et al., 2016). This tight regulation of actin dynamics 
depends on several members of the family of Rho GTPases. While Cdc42 promotes mDia-
mediated formation of actin filaments in filopodia, Rac1 is required to induce Arp2/3-mediated 




to activate the formin mDia (A. J. Ridley, 2015). In addition, RhoA activates ROCK, especially at 
the rear of the migrating cell. ROCK in turn triggers myosin II-dependent contraction by increasing 
the phosphorylation of the myosin light chain (MLC) on the one hand by its kinase function and on 
the other hand by inhibiting MLC phosphatase (A. J. Ridley, 2001). ROCK also activates LIM 
kinase (LIMK), which in turn inhibits the actin binding protein cofilin, that is known to disassemble 
actin filaments at their minus-ends (Yamaguchi & Condeelis, 2007). LIMK is not only activated by 
ROCK, but also by the actin-binding protein p21-activated kinase (PAK), that is again activated by 
Rac1 and Cdc42. Another effector of both Rac1 and Cdc42 is the actin binding protein IQGAP1, 
that is not only able to modulate actin dynamics by itself, but also by activating N-WASP, which 
then activates the Arp2/3 complex, and by activating formins (Watanabe et al., 2015). 
Furthermore, Rac1 was found to promote actin polymerization by stimulating phosphatidylinositol-
4-phosphate 5-kinase (PI(4)P 5-kinase), that catalyzes the generation of phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2), which in turn was shown to cause capping protein disassembly from 
barbed plus ends (Figure 1.6) (Tolias et al., 2000). 
 
Figure 1.6: Regulation of actin cytoskeleton dynamics by Rho GTPases and their effectors. RhoA 
activates ROCK, that triggers actomyosin contractility via myosin II activation. Activation of mDia by RhoA 
results in the generation of unbranched actin filaments. Cdc42 and Rac1 activate the Arp2/3 complex via 
the WASP and WAVE complexes, respectively. This leads to the formation of branched actin filaments. 
Cdc42 and Rac1 also activate IQGAP, that stimulates actin polymerization via activation of N-WASP, Arp2/3 
and formins, such as mDia. Another Cdc42 and Rac1 target is PAK, that triggers activation of LIMK, which 
in turn prevents disassembly of actin filaments via inhibition of cofilin. Actin polymerization is also triggered 
by Rac1 dependent activation of PI(4)P 5-kinase, that promotes PI(4,5)P2 formation, which in turn mediates 




This complex, interwoven signaling pathways demonstrate the importance of the family of Rho 
GTPases in regulatory processes of cell migration. In turn, the Rho GTPases participating in these 
processes are regulated by opposing actions of GTPase-activating proteins (GAPs) and guanine 
nucleotide exchange factors (GEFs), as well as by guanine nucleotide dissociation inhibitors 
(GDIs) (Lawson & Ridley, 2018). GAPs are proteins that bind to GTPases, such as Rho GTPases, 
and induce hydrolyzation of bound GTP, thereby driving the protein in the inactive, GDP bound 
state (Alberts et al., 2015). At the opposite site, GEFs promote the release of bound GDP. As the 
empty nucleotide-binding site immediately binds a free GTP molecule, GEFs indirectly activate 
the GTPase. Active Rho GTPases need to be membrane-associated. They reside and function 
mainly at the plasma membrane, but a part of Rho GTPase proteins is localized to intracellular 
endomembranes (Phuyal & Farhan, 2019). GDIs do not only inhibit activation of GTPases by 
preventing the dissociation of GDP from the GTPase, but also by preventing the GTPases from 
membrane-association (Figure 1.7) (Biro et al., 2014).  
 
Figure 1.7: Regulation of Rho GTPases by GEFs, GAPs and GDIs. Inactive GDP-bound Rho GTPases 
are activated by GEFs through catalyzation of GDP to GTP exchange. GAPs in turn catalyze hydrolysis of 
GTP bound to Rho GTPase resulting in its inactivation. Binding of GDIs to Rho GTPases prevents 
dissociation of GDI and thus Rho GTPase activation. Modified from Kim et al. (2019).  
Many GEFs and GAPs are known that are involved in the regulation of Rho GTPase-mediated 
migration (Lawson & Ridley, 2018). In general, there are two subtypes of GEFs activating Rho 
GTPases (RhoGEFs): the DOCK and the Dbl family. All 11 human DOCK GEFs contain a DOCK 
homology region 2 (DHR2), that catalyzes guanine nucleotide exchange, and a DOCK homology 
region 1 (DHR1), that binds to plasma membrane-associated phospholipids. The human Dbl 
family is composed of about 70 GEFs, that all share a catalytically active Dbl homology (DH) 




involved in GEF activation and localization (A. Schmidt & Hall, 2002). The well-characterized GEF 
β-PIX belongs to the Dbl family of Rho GEFs and is able to activate Rac1 and Cdc42, depending 
on the bound co-factor. When bound to Rac1, β-PIX triggers focal adhesion turnover, while its 
activation of Cdc42 induces leading edge polarization. In complex with diverse co-factors, the Dbl 
family GEF TIAM1 (T-lymphoma invasion and metastasis inducing protein 1) activates Rac1, 
thereby promoting multiple cell type and context dependent changes in the actin cytoskeleton: on 
the one hand, TIAM1 was shown to inhibit cell migration by enhancing cell-cell adhesion. On the 
other hand, TIAM1 is involved in lamellipodium extension, thereby stimulating migration (Figure 
1.9). Another Dbl family Rho GEF that is involved in the regulation of migratory processes is the 
triple functional domain protein (TRIO) (S. Schmidt & Debant, 2014). Together with its paralog 
Kalirin, TRIO is the only Dbl family member that contains two GEF domains responsible for the 
activation of distinct Rho GEFs. The GEF-D1 domain activates the two GTPases Rac1 and RhoG, 
while the GEF-D2 domain specifically activates RhoA. Additionally, TRIO harbors a serine kinase 
domain, so that the name of TRIO refers to the fact that is possesses three catalytic domains 
(Figure 1.8). The PH domain of TRIO GEF-D1 is not only positively involved in the catalytic 
reaction, but also binds to the actin filament crosslinker filamin A, thereby targeting TRIO to the 
actin cytoskeleton (Bellanger et al., 2000). In contrast, the RhoA-activating PH domain of TRIO 
GEF-D2 has an inhibitory effect on the GEF-D2 catalytic reaction, so that it requires activating 
factors, from which Gαq is one (Rojas et al., 2007). Interestingly, upon activation by Gαq, TRIO 
GEF-D1 activated Rac1 as well as TRIO GEF-D2 activated RhoA were shown to stimulate mitosis-
inducing (mitogenic) signaling via the MAPK family members (mitogen-activated protein kinase) 
JNK (Jun N-terminal kinase) and p38 (Vaqué et al., 2013). Consequently, overexpression of TRIO 
was found to result in sustained activation of mitogenic signaling resulting in aberrant cell 
proliferation. Moreover, increased mitogenic signaling, such as induced by JNK, was found to 
promote genomic instability as it promotes unscheduled activation of replication and transcription 
(Chen et al., 2010; Tubbs & Nussenzweig, 2017). This causes replication and transcription stress, 
resulting in the generation of DNA double strand breaks and ssDNA and thereby structural 
chromosome aberrations. 
In addition to its well-studied function as regulator of axon guidance in neuronal development, the 
ubiquitously expressed TRIO was also shown to regulate cell migration by stimulating Rac1-
dependent lamellipodia formation (van Rijssel et al., 2012), as well as the formation of integrin-
mediated cell-ECM adhesions, but it also participated in the generation of cadherin-mediated cell-
cell adhesions (Figure 1.9) (S. Schmidt & Debant, 2014). To enable cell migration, cadherin-




with the F-actin binding protein Tara (TRIO-associated repeat on actin). TRIO is not only located 
at the actin cytoskeleton via binding of filamin A, but also at the plasma membrane by binding to 
the transmembrane tyrosine phosphatase LAR (van Rijssel & van Buul, 2012). Additionally, TRIO 
was found to localize to microtubule +TIPs by interacting with the EB1-binding protein Nav1 
(Navigator 1) and by direct binding of TRIO to EB1 via one of its two SXIP motifs (van Haren et 
al., 2014). Reducing the amount of TRIO bound to +TIPs by Nav1 knock down resulted in 
decreased Rac1 activity, thereby proposing a +TIP dependent role for TRIO-mediated Rac1 
activation.  
Due to their strong impact on cell migratory processes, high levels of Rho GTPases, especially 
RhoA, Rac1 and Cdc42, and of GEFs, such as TIAM1 and TRIO, are associated with tumor 
progression and metastasis in different human tumors, including melanoma, liver cancer, breast 
cancer, testicular cancer and ovarian cancer (Ellenbroek & Collard, 2007; Haga & Ridley, 2016; 
Lane et al., 2008; Wang et al., 2015).  
Although it is known for long, that the actin cytoskeleton plays a major role in cell migration, the 
microtubule cytoskeleton is also of particular importance for this process (Garcin & Straube, 2019; 
Kaverina & Straube, 2011). Consequently, deregulation of microtubule dependent processes 
during cell migration induces cancer progression and metastasis. Microtubules provide an 
 
 
Figure 1.8: The multidomain protein TRIO and its functional domains. TRIO contains two GEF 
domains, GEF-D1 for the activation of RhoG and Rac1 and GEF-D2 for RhoA activation. The third 
catalytically active domain is a serine/threonine kinase domain at the C-terminus. Due to various interaction 
partners, TRIO localizes to the F-actin cytoskeleton via Tara and filamin A, to microtubule plus-ends by 
binding to NAV1 and EB1, and to the plasma membrane by interacting with LAR and Gαq. Moreover, TRIO 
harbors a N-terminal Sec14 motif, several spectrin-like repeats, two SH3 domains and an Immunoglobulin 




intracellular transport network, that allows rapid and directed transport of membrane vesicles 
containing cytoskeletal components, signaling molecules and mRNAs resulting in the required 
front/back polarity between the leading edge and the rear of a migrating cell. Not only the directed, 
microtubule-associated transport of membrane vesicles generates cell polarity, but also 
microtubule +TIP protein complexes that assemble at growing microtubule plus-ends and that 
carry signaling molecules acting as regulators for microtubule and actin dynamics. Additionally, 
microtubules are involved in the formation of membrane protrusions due to their physical 
properties, that make them stable against compressive forces and at the same time enable them 
to generate pushing forces. Moreover, microtubules exhibit pulling forces that facilitate movement 
of the nucleus and the centrosome during cell migration. Due to all these functions, microtubule 
dynamics mediate cell migration by regulating actin dynamics and Rho GTPase signaling, as well 
as focal adhesion turnover.    
In order to generate cell polarity in a migrating cell, spatially different modulation of actin and 
microtubule dynamics is required. Microtubules are selectively destabilized at the cell rear, 
whereas activities at the lamellipodial leading edge promote microtubule stabilization and growth 
(Kaverina & Straube, 2011; Torsten Wittmann et al., 2003). While the microtubule depolymerase 
MCAK triggers microtubule disassembly mainly at the cell rear (Braun et al., 2014), microtubule 
stability is increased at the leading edge by +TIP complex proteins, such as CLIP170, CLASPs, 
APC and EBs, which link microtubule plus-ends to the cell cortex (Akhmanova & Steinmetz, 2008; 
Henty-Ridilla et al., 2016). Rho GTPase activated mDia formins have also been shown to be 
involved in +TIP protein-induced microtubule stability, due to their interaction with EB1, APC and 
CLIP170 (Henty-Ridilla et al., 2016; Wen et al., 2004). Moreover, Rac1 and Cdc42 activated 
IQGAP1 was reported to interact with the +TIPs CLIP170, CLASPs and APC, resulting in the 
induction of Arp2/3 and formin dependent formation of actin filaments at the leading edge 
(Kaverina & Straube, 2011). Rac1 and Cdc42 were also shown to have an effect on microtubule 
dynamics by inducing microtubule growth via their effector PAK, that phosphorylates and thereby 
inactivates the tubulin polymerization preventing protein stathmin (Daub et al., 2001; Torsten 
Wittmann et al., 2003). Interestingly, microtubule plus-end growth was shown to vice versa induce 
Rac1 activity, resulting in actin polymerization in lamellipodial protrusions of migrating cells 
(Waterman-Storer et al., 1999). Looking for the link between microtubule plus-end growth and 
Rac1 activity in migrating cells, the GEF STEF (Sif and TIAM1-like exchange factor) was identified. 






Figure 1.9: Involvement of GEFs and their Rho GTPases in cell migration and proliferation. The GEFs 
STEF and β-PIX activate Rac1 to promote focal adhesion turnover, thereby inducing cell migration. β-PIX 
also activates Cdc42, that triggers polarization of the cell´s leading edge. The GEFs TIAM1 and TRIO 
activate Rac1 to induce actin polymerization at the lamellipodium, but also cell-cell adhesion. For cell 
migration, Rac1-mediated cell-cell adhesion is decreased by local TIAM1 and TRIO inhibition. TRIO also 
controls cell-ECM adhesion by activating Rac1 and RhoG and promotes mitogenic signaling through 
activation of Rac1 and RhoA. Modified from S. Schmidt and Debant (2014) and Lawson and Ridley (2018). 
 
focal adhesion turnover (Rooney et al., 2010). The GEF TRIO, that is known to also localize to 
microtubule plus-ends via EB1 and Nav1, induces cell migration especially by triggering Rac1-
dependent actin polymerization in lamellipodial protrusions (Figure 1.9) (S. Schmidt & Debant, 
2014; van Rijssel et al., 2012). However, although it was reported that neuronal axon outgrowth 
is induced by TRIO-mediated Rac1 activation in a microtubule plus-end binding dependent 
manner, it seems that this binding is not required for TRIOs effect on cell migration (van Haren et 
al., 2014). 
1.2.4 Structure and function of the actin cytoskeleton in mitosis  
At the onset of mitosis, cells need to round up to generate an appropriate geometry for proper 
mitotic spindle alignment and function as well as cleavage furrow positioning required for error-
free chromosome segregation and cell division (Cadart et al., 2014; Lancaster et al., 2013; Théry 
& Bornens, 2006). In order to facilitate mitotic rounding, the actin cytoskeleton undergoes profound 
reorganization (Théry & Bornens, 2008). This especially includes disassembly of stress fibers, 




cell adhesions via adherens junctions and of cell-ECM adhesions via focal adhesions (Tojkander 
et al., 2012). Following disassembly of stress fibers and adhesion sites, only actin- and myosin II-
rich retraction fibers keep the mitotic cell attached and in correct spatial arrangement required for 
proper mitotic spindle positioning (Fink et al., 2011; Mitchison, 1992; Théry et al., 2005). Rounding 
of the cell is mediated by increasing the intracellular, hydrostatic pressure as well as the tension 
of the mitotic cortex by actomyosin-driven contractility (Cadart et al., 2014; Lancaster & Baum, 
2014; Stewart et al., 2011). While the intracellular, hydrostatic pressure is regulated by plasma 
membrane transporters, cortical tension depends on myosin II, which creates contractile forces 
by pulling actin filaments relative to one another, but also on the cortical actin network architecture 
(Figure 1.10) (Chugh et al., 2017; Ramanathan et al., 2015). To generate an increase in cortex 
tension detected in mitotic cells, myosin II accumulates at the cortex and is activated via the RhoA-
ROCK pathway (Maddox & Burridge, 2003; Théry & Bornens, 2008). Interestingly, activation of 
RhoA was shown to be driven by Cdk1 via its downstream target and Rho GEF Ect2 (Matthews 
et al., 2012; Ramanathan et al., 2015). In addition, the cortical actin network of mitotic cells 
involves the actin nucleators Arp2/3 and mDia1 (Bovellan et al., 2014), as well as the actin 
crosslinkers α-actinin and fascin (Toyoda et al., 2017). Moreover, F-actin capping protein as well 
as cofilin participate in the regulation of mitotic cortex architecture (Chugh et al., 2017). 
Deregulation of the actin cortex structure was shown to result in decreased cortex tension. On the 
one hand, cortical tension is modulated by the thickness of the actin cortex, which is determined 
by actin filament length regulators, such as mDia, capping protein and cofilin: Depletion of the 
actin filament elongator mDia1 results in short actin filaments and a reduced cortex thickness, that 
is missing enough actin filament connections required for increased cortex tension. However, 
depletion of capping protein and cofilin leading to the formation of long actin filaments and a thick, 
overly rigid actin cortex also causes decreased cortex tension. Consequently, proper mitotic cortex 
tension requires the actin cortex to contain actin filaments of intermediate length, resulting in a 
defined cortex thickness. On the other hand, cortex tension is also modulated by the cortical actin 
network connectivity, that is determined by actin filament crosslinkers, such as Arp2/3 and α-
actinin (Ennomani et al., 2016). A highly connected actin network exhibits only low contractility, 
that can be increased by debranching. Debranching of an actin network with optimal connectivity, 
however, reduces contractile forces. Summed up, the composition and organization of the mitotic 
actomyosin cortex need to be tightly balanced for the generation of sufficient contractile forces 
required for an increase in cortical tension. However, mechanisms that contribute to a tension-






Figure 1.10: The role of the actin and microtubule cytoskeleton in mitotic spindle positioning. Astral 
microtubules link the spindle pole to the cortex via bound dynein, that interacts with the plasma membrane 
anchored NuMA-LGN-Gαi complex. LGN also generates a connection to the actin cortex by interacting with 
the actin binding protein Afadin. In addition, astral microtubules transmit the force, which is generated by 
retraction fibers, to centrosomes via myosin 10-mediated interaction with subcortical actin clouds.  
Moreover, a proper spindle positioning requires an ERM-mediated connection between the plasma 
membrane and the actin cortex. Additionally, mitotic cell rounding, that is essential for correct spindle 
positioning, is generated by an increase in cortical tension, which in turn requires myosin II dependent cortex 
contractility and a proper actin cortex architecture. Modified from Di Pietro et al. (2016).  
 
Cortex tension seems to be important not only for mitotic cell rounding, but also for migration and 
invasion, as clinical studies revealed a decreased stiffness for metastatic cancer cells of different 
types and cell lines when compared to benign cells (Cross et al., 2007; Remmerbach et al., 2009; 
Swaminathan et al., 2011).  
In addition to the role of the actin cytoskeleton within the process of cell rounding, it was also found 
to form dynamic, subcortical clusters of Arp2/3-dependent actin filaments, so-called actin clouds, 
during mitosis (Mitsushima et al., 2010). These have further been shown to mediate mitotic spindle 
orientation by forwarding pulling forces generated from retraction fibers to centrosomes via 
myosin 10 (Myo10)-mediated binding to astral microtubules (Kwon et al., 2015). Ablation of 
retraction fibers impairs subcortical actin cloud dynamics and results in spindle alignment defects 
(Fink et al., 2011). Since spindle positioning defects have been associated with chromosome mis-
segregation, deregulation of the structure or dynamics of mitotic, subcortical actin clouds might 




1.3 The mitotic spindle  
During mitosis, not only tight regulation of the actin cytoskeleton is essential for proper spindle 
positioning and chromosome segregation, but in particular also the assembly of a bipolar 
microtubule-based mitotic spindle (Prosser & Pelletier, 2017). The trigger for mitotic spindle 
assembly is given by the formation and activation of the cyclin B/ CDK1 complex at the end of G2 
phase. In general, a mitotic spindle consists of an antiparallel array of microtubules being 
anchored at the two spindle poles by their minus ends and radiating outwards from the poles with 
their plus ends (T. Wittmann et al., 2001). Microtubules within this array, whose plus ends are 
attached to the kinetochores from sister chromatids, are called kinetochore microtubules, whereas 
the plus ends of so-called interpolar microtubules overlap with plus ends from microtubules 
emanating from the other pole. For a correct positioning of the spindle within the round mitotic cell, 
astral microtubules connect the spindle poles with the cell cortex, that is defined as a layer of an 
actomyosin network bound to the inner surface of the plasma membrane. In mitotic vertebrate 
cells, the two spindle poles are associated with the centrosomes, that are each composed of two 
centrioles surrounded by amorphous pericentriolar material (PCM), and that drive spindle 
assembly by their function as main microtubule organization center (MTOC). The MTOC is 
important for γ-tubulin-driven microtubule nucleation, but also for microtubule anchorage and 
arrangement. However, higher plant cells as well as meiotic cells lack centrosomes, so that bipolar 
spindle assembly is mediated acentrosomally. Centrosome containing cells were also shown to 
still form bipolar mitotic spindles after centrosome disassembly by ablation or removal of 
centrioles, thereby proving centrosome independent spindle assembly pathways to exist not only 
in centrosome-lacking cells (Khodjakov et al., 2000).  
1.3.1 Chromosome dependent and independent assembly of the mitotic spindle 
By today, spindle assembly has been shown to be mediated by one centrosome dependent and 
several centrosome independent pathways. In cells containing centrosomes, these are duplicated 
at about the time of DNA replication (T. Wittmann et al., 2001). The resulting centrosome pair is 
connected by centrosomal linker proteins and remains at the outer side of the nuclear envelope 
until mitotic entry. When cells enter mitosis, the amount of γ-TurC complexes at the centrosomes 
increases, thereby promoting massive microtubule nucleation. Additionally, microtubule dynamics 
increase greatly, resulting in microtubule plus ends rapidly changing between growth and 
shrinkage. Moreover, the centrosomal linker is dissolved and the centrosomes are separated by 






Figure 1.11: Assembly of the mitotic spindle. Upon entry into mitosis, centrosome dependent and 
independent (not shown) pathways induce massive microtubule nucleation. Centrosomes are pushed apart 
via activity of plus-end directed Eg5 kinesin on microtubules emanating from opposing spindle poles. 
Additionally, nuclear envelope-associated dynein (before NEBD, not shown) and cortex-associated dynein 
pull microtubules and thus the centrosomes towards opposing poles. Microtubules that connect the spindle 
poles with the cortex are called astral microtubules, while interpolar microtubules overlap with plus ends 
from microtubules emanating from the other pole and kinetochore microtubules are attached to kinetochores 
with their plus end. Modified from Prosser and Pelletier (2017). 
 
activity, and the minus-end directed motor protein dynein (Agircan et al., 2014; Tanenbaum & 
Medema, 2010; van Heesbeen et al., 2013). Eg5 crosslinks and moves apart antiparallel 
microtubules emanating from opposing centrosomes, resulting in centrosome separation along 
the nucleus. Nuclear envelope-associated dynein pulls the centrosomes further apart. 
Microtubules that grow towards the periphery are captured and linked to the cell cortex by cortical 
dynein, which pulls the centrosomes to opposing poles of the cell (Figure 1.11). Following nuclear 
envelope breakdown (NEBD), further centrosome separation and spindle positioning is driven by 
astral microtubules that are connected to and move along the cortex via localized cortical 
actomyosin contractions (Rosenblatt et al., 2004). Again, dynein was shown to generate the 
required link between astral microtubules and the actomyosin cortex (Simone et al., 2016). 
When centrosomes are present in a cell, they provide the dominant microtubule nucleation and 
organization site (Heald et al., 1997). However, there is also a chromosome-based self-
organization process going on in a mitotic cell, that acts as major driver for spindle assembly in 




nucleocytoplasmic transport by binding to nuclear transport receptors (NTR). Ran activity is 
controlled by its locally separated regulators, the chromatin-bound GEF RCC1 (regulator of 
chromatin condensation 1) and the cytoplasmic GAP RanGAP (Kalab & Heald, 2008). Due to the 
different localization of its regulators, RanGTP is formed at a higher rate around chromosomes 
and is rather converted to RanGDP in the cytoplasm. Even after NEBD, there are still high 
RanGTP concentrations around the chromosomes decreasing with increasing distance from the 
chromosomes. This RanGTP gradient goes along with a gradient of RanGTP-bound NTRs and 
their cargo proteins. These cargo proteins especially include spindle assembly factors, that recruit 
microtubule nucleating γ-TurC complexes to the proximity of chromosomes or stabilize 
microtubules, such as the cyclin L/CDK11 complex (Forbes et al., 2015; Yokoyama et al., 2008). 
Further stabilization of microtubules, that have been nucleated by γ-TurC complexes, takes place 
at kinetochores and depends the chromosomal passenger complex (CPC) and its component 
Aurora B kinase, which both are localized at centromeres during mitosis (Meunier & Vernos, 
2016). Aurora B phosphorylates and thus inactivates the microtubule depolymerase MCAK and 
the protein stathmin, which is known to prevent tubulin polymerization.  
Acentrosomal spindle assembly is not only triggered by chromosomes via the RanGTP gradient 
and the CPC, but also by an augmin dependent pathway that induces microtubule nucleation and 
amplification depending on microtubules themselves. The augmin complex recruits γ-TurC to the 
side of a pre-existing microtubules, resulting in the nucleation of a new, branched microtubule, 
that is transported along the pre-existing microtubule by dynein and Eg5 towards the spindle poles 
(Lecland & Lüders, 2014). The chromosome dependent pathway and the chromosome-
independent pathways are not mutually exclusive, but function together in the assembly of the 
mitotic spindle (Prosser & Pelletier, 2017).       
1.3.2 Orientation of the mitotic spindle 
The orientation of the mitotic spindle is not only essential for the maintenance of the tissue 
architecture within an epithelium, but also plays an important role for proper chromosome 
alignment and segregation, as spindle mis-positioning is associated with chromosome mis-
segregation and chromosomal instability (Ertych et al., 2014; Silkworth & Cimini, 2012). As 
described above, a proper spindle positioning requires not only an increase in cortex tension to 
round up (Kunda et al., 2008), but also a complex interplay between the actin and microtubule 
cytoskeleton: astral spindle microtubules have to be linked to the actomyosin cortex by dynein 
(Tanenbaum & Medema, 2010) and they have to transmit the force generated by retraction fibers 




2015). The dynein-mediated crosslink between astral microtubules and the actin cortex involves 
a complex consisting of several proteins: close to the inner cortex surface, microtubule-bound 
dynein interacts with NuMA (nuclear mitotic apparatus protein). NuMA binds to LGN (Leu-Gly-Asn 
repeat enriched protein) that in turn interacts with the plasma membrane-anchored heterotrimeric 
protein Gαi, thereby completing the connection between the microtubule and the plasma 
membrane (Figure 1.10) (Zheng et al., 2010). In interphase, NuMA resides in the nucleus and is 
not available for LGN binding. As this interaction is required for LGN to adopt an active 
conformation, it does not interact with plasma membrane-bound Gαi (Di Pietro et al., 2016). Upon 
NEBD in early mitosis, NuMA is released from the nucleus and binds to LGN that is than recruited 
to the cortex by Gαi. As the LGN-NuMA-Gαi complex is only located at the lateral and not the apical 
cell cortex during mitosis, the bipolar spindle is oriented parallel to the substratum, thus ensuring 
proper positioning of the spindle. However, the LGN-NuMA complex was not only reported to be 
linked to the plasma membrane, but also to the actin cortex via LGN interaction with the actin 
binding protein Afadin (Carminati et al., 2016). Further connection between the plasma membrane 
and the actomyosin cortex is generated by the actin-membrane crosslinking ERM (ezrin-radixin-
moesin) proteins. These have been shown to be crucial for cortical tension, as this was decreased 
in Moesin depleted cells due to myosin II mis-localization (Fehon et al., 2010). Moreover, ERM 
proteins control spindle orientation by regulating the LGN-NuMA-Gαi localization at the mitotic 
cortex (Machicoane et al., 2014).  
1.3.3 Function of the mitotic spindle in chromosome alignment and segregation 
Following assembly and positioning of the bipolar spindle, it now has to fulfil its main function: 
proper alignment and segregation of the duplicated sister chromatids. To facilitate this process, 
highly dynamic microtubules emanating from the centrosomal spindle poles undergo growth and 
shrinkage in various directions until they attach to kinetochores (Guo et al., 2013). This mechanism 
for chromosome alignment is known as “search and capture” (Kirschner & Mitchison, 1986). 
However, not only the search and capture mechanism, but also spindle assembly mediated by the 
RanGTP-gradient and the augmin complex as described above, promote microtubule-kinetochore 
attachment and stabilization (Heald & Khodjakov, 2015). Another important factor that contributes 
to a stable microtubule-kinetochore attachment is the Ndc80 complex, that resides at the outer 
kinetochore during mitosis. Subsequently after attachment, the minus-end directed motor protein 
dynein starts to pull the sister chromatid pair poleward, whereas the plus-end directed kinesin 
CENP-E promotes the opposite movement (Guo et al., 2013). When both sister chromatids are 




and other factors, move them toward the spindle equator so that finally all of them are positioned 
at the metaphase plate. Only when the SAC is satisfied, the sister chromatids become separated 
and are pulled towards the spindle poles.  
 
1.4 Chromosomal Instability 
Only an error-free progression through mitosis ending with faithful chromosome segregation will 
result in the generation of two euploid daughter cells harboring the same genetic information. 
However, defects that occur during mitotic progression have been shown to frequently cause 
chromosome mis-segregation, a process that is termed as chromosomal instability (CIN) 
(Thompson et al., 2010). Due to chromosomal instability, cells become aneuploid, a state in which 
the chromosome number of a cell deviates from the modal number of the haploid set of 
chromosomes. Although CIN was originally only used to refer to the persistent high rate of whole 
chromosome mis-segregation, soon this term was also used to describe the frequent loss of 
chromosome fragments. In order to differentiate between these two phenomena, the terms whole 
chromosome instability (W-CIN) and structural chromosome instability (S-CIN) were introduced 
(Sansregret et al., 2018). In the following, the term chromosomal instability is used for W-CIN and 
the term structural chromosome instability is used separately. Both types of chromosomal 
instability result in an aberrant genomic state, that is the most common characteristic of solid 
tumors.  Due to persistently high rates of chromosome mis-segregation, cells become aneuploid 
and acquire genetic heterogeneity (Heng et al., 2013). Although most chromosome mis-
segregation events result in two daughter cells, that undergo apoptosis or that at least do not 
inherit an advantage through the gain or loss or chromosomes, there need to be just a small 
fraction of cells obtaining selective or adaptive advantage by the new chromosome combination. 
This in turn is the main driver for the development of cancer heterogeneity, which is the major 
cause of therapy resistance and poor patient´s survival (Bach et al., 2019). Therefore, it is of 
utmost interest to investigate strategies, that suppress CIN and thus prevent therapy resistance. 
Especially colorectal cancer cells (CRC) have been found to exhibit genomic heterogeneity due 
to chromosome instability. About 80-85 % of CRCs have the CIN phenotype associated with poor 
patient´s prognosis, whereas with about 15 % most non-CIN CRCs exhibit the microsatellite 
instability (MIN/MSI) phenotype. The MIN phenotype is characterized by mutations of genes 
participating in DNA mismatch repair and is associated with good patient´s outcome (Cisyk et al., 




1.4.1 Mechanisms of whole chromosome instability 
Whole chromosome mis-segregation can appear through different mechanisms that compromise 
the SAC, sister chromatid cohesion, centrosome amplification or the stability of microtubule-
kinetochore attachments (Thompson et al., 2010). As described above, the SAC recognizes all 
kinds of erroneous attachments that are associates with the assembly of the MCC at unattached 
kinetochores and with weak kinetochore tension (Lara-Gonzalez et al., 2012). Correct 
chromosome segregation takes place when kinetochores of sister chromatids are attached to 
microtubules from opposing spindle poles in a bi-oriented (amphitelic) manner (Figure 1.12) 
(Godek et al., 2015). Then the MCC is disassembled from the kinetochore and pulling forces from 
both spindle poles generate enough kinetochore tension, thereby satisfying the SAC. Monotelic 
attachments occur when only the kinetochore of one of the sister chromatids is bound to 
microtubules from one spindle pole. Due to binding of the MCC complex to the unattached 
kinetochore, the SAC is active and allows further mitotic progression only after correction of the 
erroneous attachment. In addition, monotelic as well as syntelic attachments, in which the 
kinetochores of both sister chromatids are bound to microtubules from the same spindle pole, only 
transmit pulling forces from one spindle pole and not from opposing poles resulting in weak 
kinetochore tension. Tension-related error correction depends on several factors, of which 
Aurora B kinase is the major player (Funabiki, 2019). Aurora B accumulates at kinetochores with 
weak tension, where it phosphorylates kinetochore substrates such as Ndc80, thereby 
destabilizing the microtubule-kinetochore attachment. Afterwards, the kinetochore is free for 
binding to another microtubule. In case the microtubule emanates from the correct pole, 
kinetochore tension increases resulting in a stable microtubule-kinetochore attachment that 
satisfies the SAC. Another kind of erroneous attachments are merotelic attachments, in which one 
kinetochore of the chromatid sister pair is attached to microtubules emanating from one spindle 
pole and the other kinetochore to microtubules growing from both spindle poles (Godek et al., 
2015). Merotelic attachments cannot be detected by the SAC, as both the disassembly of the MCC 
at kinetochores as well as increased kinetochore tension take place. Consequently, this mis-
attachment can result in lagging chromosomes, which lead to the formation of two aneuploid 
daughter cells when pulled to the incorrect spindle pole. Therefore, mechanisms that cause the 
frequent occurrence of lagging chromosomes also contribute to chromosomal instability (Gregan 






Figure 1.12: Modes of kinetochore-microtubule attachments. (a) In the correct, amphitelic kinetochore-
microtubule attachment, kinetochores of sister chromatids are attached to microtubules from opposing 
spindle poles in a bi-oriented manner. Monotelic attachments are formed when only the kinetochore of one 
of the sister chromatids is bound to microtubules from one spindle pole. This results in MCC complex binding 
to the unattached kinetochore and weak kinetochore tension, thereby activating the SAC. Syntelic 
attachments, in which the kinetochores of both sister chromatids are bound to microtubules from the same 
spindle pole, only transmit pulling forces from one spindle pole and not from opposing poles resulting in 
weak kinetochore tension and SAC activation. In merotelic attachments, one kinetochore of the chromatid 
sister pair is attached to microtubules emanating from one spindle pole and the other kinetochore to 
microtubules growing from both spindle poles. (b) Merotelic attachments do not activate the SAC. In case, 
chromosome segregation starts before the attachment is corrected, the sister chromatid that is attached to 
microtubules from one spindle pole is pulled toward this pole, while the other sister chromatid remains as 
lagging chromosome near the spindle equator. Later on, it is pulled to one of the two poles, resulting in 
chromosome mis-segregation when being pulled to the incorrect pole. Modified from Godek et al. (2015). 
 
correct these attachments. In merotelic attachments, the attachment site of the incorrectly bound 
microtubule is positioned close to the region of the inner centromere, where Aurora B is highly 
enriched (Cimini et al., 2006). Due to this spatial arrangement, Aurora B preferentially causes 
destabilization of microtubules emanating from the incorrect spindle pole. However, in case of an 
increased amount of merotelic attachments, these might not all be repaired in time, so that due to 
merotely-independent satisfaction of the SAC chromosome segregation is initiated even in the 
presence of these erroneous attachments. As especially the SAC and Aurora B are essential for 
proper chromosome segregation, a deregulated activity of these key players results in 
chromosome instability and aneuploidy, which has also been observed in several cancers (Huang 
et al., 2018; Minhas et al., 2003; Schuyler et al., 2012).  
Another mechanism that has been shown to induce chromosome mis-segregation is an impaired 
sister chromatid cohesion (Thompson et al., 2010). A functional cohesion complex ensures proper 




improper cohesion, however, can also be separated upon erroneous attachments resulting in 
premature, incorrect chromosome segregation. Although only rarely observed, mutated genes 
involved in sister chromatid cohesion are associated with chromosomal instability and aneuploidy 
in cancer (Barber et al., 2008; Barbero, 2011; Sajesh et al., 2013).  
Chromosome mis-segregation can also be induced by the presence of supernumary centrosomes 
(Thompson et al., 2010). These cells form multipolar spindles, that can lead to a cell division in 
more than two daughter cells, usually resulting in cell death (Ganem et al., 2009; Milunovic-Jevtic 
et al., 2016). However, some cells that harbor supernumary centrosomes form transient multipolar 
spindles in prometaphase, followed by clustering of the centrosomes into a bipolar spindle before 
chromosome segregation (Quintyne et al., 2005). This process drastically increases the number 
of merotelic attachments and thereby the amount of lagging chromosomes.  
More recently, an increase in mitotic microtubule plus-end assembly rates was discovered as 
another mechanism for the induction of chromosomal instability (Ertych et al., 2014). Increased 
microtubule plus-end assembly rates were found to cause transient spindle positioning defects in 
prometaphase, that result in an increased rate of lagging chromosomes, chromosome mis-
segregation and thus chromosome instability (Ertych et al., 2014; Silkworth & Cimini, 2012). 
1.4.2 Mechanisms of structural chromosome instability 
Structural chromosome instability is associated with amplifications, deletions, inversions and 
translocations of chromosomal regions of various sizes (Lepage et al., 2019). It has been shown, 
that increased, unrepaired DNA double-strand breaks result in chromosomal breaks and thus in 
the formation of structural chromosome aberrations (W. F. Morgan et al., 1998; van Gent et al., 
2001). DNA double strand breaks in turn, can be generated by several mechanisms, such as 
exogenous DNA-damaging agents or radiation, but also by endogenously generated replication 
stress. The latter one can be induced by oncogenic pathways that cause alterations of replication 
timing and progression and usually result in a slowing or stalling of the replication fork (Gaillard et 
al., 2015; Rickman & Smogorzewska, 2019; Schoonen et al., 2019). The cellular response to 
replications stress contains the DNA-damage checkpoint, DNA repair or replication fork restart. If 
the cell fails to respond, the replication fork collapses followed by DNA double strand breaks 
(Cortez, 2015). The resulting chromosome fragments can undergo chromosome fusions and 
thereby form dicentric chromosomes and acentric chromosome fragments, such as so-called 
double minutes. Dicentric chromosomes are genetically unstable structures: when microtubules, 
which are bound to the two centromeres of one sister chromatid, pull to opposite poles, anaphase 




called breakage/fusion/bridge (B/F/B) cycles and is known to produce chromosomal 
rearrangements, such as double minutes (Lo et al., 2002).  
Interestingly, most tumors exhibit both whole and structural chromosome aberrations (Sansregret 
et al., 2018). Recent studies found that replication stress-induced structural chromosome 
abnormalities are drivers for whole chromosome mis-segregation in mitosis (Burrell et al., 2013). 
In turn, chromosome mis-segregation-associated lagging chromosomes have been shown to form 
micronuclei that are involved in the generation of DNA breaks (Crasta et al., 2012). These and 
other studies indicate, that there is a multidirectional correlation: key oncogenic pathways were 
identified as drivers for whole chromosome mis-segregation, that in turn is known to trigger 
structural chromosome aberrations, which can be activated by and activate itself oncogenic 
pathways (Bakhoum & Swanton, 2014; Orr & Compton, 2013). In this context, our group also 
found out, that mild replication stress is an inducer of increased mitotic microtubule plus-end 
assembly rates, thereby providing another link between structural and whole chromosome 
instability (Böhly et al., 2019).  
 
1.5 Aim of this study 
In the last decade cancer genome sequencing projects revealed a prevalence of diverse genetic 
heterogeneity in the vast majority of human cancers (Heng et al., 2013). Much of the genetic 
heterogeneity in tumors is due to chromosomal instability (CIN), which was shown to contribute to 
tumorigenesis, tumor progression and therapy resistance (Holland & Cleveland, 2012). This 
shows the importance of investigating the mechanisms leading to CIN in tumors. CIN is defined 
as an elevated rate of chromosome mis-segregation during mitosis and is, thus, resulting in the 
development of aneuploid cells (Thompson et al., 2010). The molecular mechanisms that are 
involved in causing CIN in human cancer cells are still poorly understood. However, some 
mechanisms have been proposed, such as a weakened spindle checkpoint signaling, the 
presence of supernumary centrosomes and defects in sister chromatid cohesion (Kops et al., 
2005; Ganem et al., 2009; Barber et al., 2008). Recent work from our group provided another 
mechanistic insight into the generation of CIN by finding a link between CIN and increased 
microtubule plus-end assembly rates during mitosis (Ertych et al., 2014). These were further 
shown to be associated with spindle axis misalignment in prometaphase cells resulting in 
increased amounts of lagging chromosomes and thereby chromosome mis-segregation during 




misalignment and, thus, CIN, in detail was still unknown. Recently, spindle positioning was found 
to be regulated by mitotic Arp2/3 dependent subcortical actin clouds that forward pulling forces 
generated from retraction fibers to centrosomes via binding to microtubules (Mitsushima et al., 
2010; Kwon et al., 2015). At a similar time point, TRIO, a guanine exchange factor (GEF) for Rac1, 
was found to be part of the HET70 signature of genes that are most strongly upregulated in 
cancers with karyotype heterogeneity (Sheltzer, 2013), and also to contain an EB1-binding domain 
(van Haren et al., 2014). Knowing that EB1 is located at the growing microtubule plus-ends 
(Mimori-Kiyosue et al., 2000) and that Rac1 is a well-known Arp2/3 activator (H. N. Higgs & 
Pollard, 1999) finally gave rise to a hypothetical signaling pathway between microtubule plus-end 
assembly rates and actin-regulated spindle positioning. Summed up, the putative pathway 
includes microtubule plus-tip-bound EB1, at which TRIO is bound and activates Rac1, that in turn 
acts as activator for the actin regulator Arp2/3. Recent work from our group supported the 
existence of such a pathway (Berger, 2016; Schermuly, 2019). However, the evidence for 
important links within this pathway were still missing, thereby necessitating further research. This 
especially included proof of the importance of the binding between EB1 and TRIO for this pathway 
and the microtubule plus-end assembly dependency of EB1-TRIO binding in mitotic cells. In this 
context, it was also tested whether TRIO binding to EB1 was necessary, or whether a higher TRIO 
and Rac1 activity independent from TRIO-EB1 binding was already sufficient for CIN 
development. Moreover, the actin cytoskeleton was analyzed more closely in order to figure out 
the missing link between Arp2/3 activity and spindle positioning. First results had not confirmed 
the involvement of this pathway in subcortical actin cloud formation, but rather showed an effect 
for the actin cortex, which has also been reported to affect spindle positioning through changes in 
the cortex structure and tension (Bovellan et al., 2014; Chugh et al., 2017; Kunda & Baum, 2009). 
Therefore, further experiments for investigating a possible effect of the actin cortex structure and 
tension on spindle positioning were performed.  
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2. Material and Methods 
2.1 Material 
Standard working materials including cell culture dishes, reaction tubes, pipette tips, filter tips, 
falcons and dishes for microscopy were purchased from Starlab (Hamburg, Germany), Sarstedt 
(Nümbrecht, Germany), Greiner BioOne (Frickenhausen, Germany) and ibidi (Martinsried, 
Germany). 
2.1.1 Equipment 
In Table 2.1. the equipment that was used for this study is listed. 
Table 2.1 Equipment 
Equipment Model Company 
CO2 Incubator 
HERAcell 240 CO2 
Incubator 
Thermo Fisher Scientific, Waltham, 
MA, USA 
Centrifuge, cooling Multifuge X3R 
Thermo Fisher Scientific, Waltham, 
MA, USA 
Centrifuge, tabletop Biofuge pico 
Thermo Fisher Scientific, Waltham, 
MA, USA 
Centrifuge, tabletop cooling Biofuge fresco 
Thermo Fisher Scientific, Waltham, 
MA, USA 
Chemiluminescence Imaging Fusion-SL-3500.WL Vilber Lourmat, Collégien, France 
Electroporation Device GenePulser Xcell© 




Power Supply EV231 Peqlab, Erlangen, Germany 
Flow Cytometer BD FACSCanto© II 





Eppendorf, Hamburg, Germany 
Heating Block 
TDB-120 Dry Block 
Thermostat 




Sartorius, Göttingen, Germany 
Magnetic Mixer IKAMAG© RCT 
IKA Labortechnik, Stauffen, 
Germany 
Microscope 
Delta Vision Elite© 
Applied Precision, Chalfont St. 
Giles, UK 
Leica DMI6000B Leica, Wetzlar, Germany 
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Zeiss Axioscope FS Zeiss, Oberkochen, Germany 
Microscope Camera 
sCMOS camera 
GE Healthcare, Chalfont St. Giles, 
UK 





Microscope Camera Adaptor A3474-07 
Hamamatsu Photonics, 
Hamamatsu, Japan 
Objective Olympus 60x 1.40 NA Olympus, Tokyo, Japan 
Multilabel Reader Victor© X3 PerkinElmer, Rodgau, Germany 
Nitrocellulose Membrane Protran BA 83 





Pipettor Pipetboy acu 
Integra Biosciences, Fernwald, 
Germany 
PVDF Membrane ImmobilionR-P 
Merck Millipore, Darmstadt, 
Germany 
Sterile Workbench HERAsafeM 
Thermo Fisher Scientific, Waltham, 
MA, USA 
Spectrophotometer NanoDrop 2000 




 Own Manufacturing 
Vortex Mixer VORTEX-GENIE© 2 
Scientific Industries inc., Bohemia, 
NY, USA 
Wet Blotting System 
Mini Trans-Blot® Cell 
BioRad Laboratories, München, 
Germany 
 Own Manufacturing 
 
  




In Table 2.2 the software that was used for data analysis in this study is listed. 
Table 2.2 Software 
Software Company 
Fiji Is Just ImageJ LOCI, University of Wisconsin-Madison, USA 
Graph Pad Prism 8.0 
GraphPad Software, San Diego, California, 
USA 
Hokawo Launcher 2.1 Hamamatsu Photonics, Hamamatsu, Japan 
Leica Application Suite 2.7.3.9723 Leica, Wetzlar, Germany 
softWoRx© Explorer 1.3.0 
Applied Precision Inc., Issaquah, WA, USA 
softWoRx© 6.0 Software Suite 
CortexThickness 
written and kindly provided by Prof. Dr. 
Burkhard Geil, Göttingen, Germany 
 
2.1.3 Chemicals 
All standard chemicals used in this study were purchased from Amersham Biosciences 
(Buckinghamshire, Great Britain), AppliChem (Darmstadt, Germany), Bio-techne (), BD 
Biosciences (Heidelberg, Germany), Carl Roth (Karlsruhe, Germany), Enzo Life Sciences (New 
York, NY, USA), Fermentas (St. Leon-Roth, Germany), Merck Millipore (Darmstadt, Germany), 
Promega (Madison, WI, USA), Roche Diagnostics (Mannheim, Germany), Santa Cruz (Dallas, 
Texas, USA), Sigma-Aldrich (St. Louis, Missouri, USA), Thermo Fisher Scientific (Waltham, MA, 
USA), Th. Geyer (Renningen, Germany) and VWR International (West Chester, PA, USA). 
 
In Table 2.3 further chemicals as well as specific inhibitors are listed together with their functions 
and working concentrations. 
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Blebbistatin (+/-) 30 µM 
Inhibition of the ATPase of the 




CK666 20 µM 





Dimethylenastron 2 µM Inhibition of kinesin Eg5 
Calbiochem, La 
Jolla, CA, USA 
ITX3 15-50 µM 





Jasplakinolide 100 nM 
Promotion of actin 
polymerization 
Santa Cruz, Dallas, 
Texas, USA 
Latrunculin A 0.75 µM 














Nocodazole 0.5 nM 
Promotion of increased 
microtubule plus-tip assembly 




NSC23766 40-100 µM 
Inhibition of Rac1-GEF 
interaction of TRIO and Tiam1 
Santa Cruz, Dallas, 
Texas, USA 
Calpeptin 1 µg/ml Activation of RhoA, B and C 





Fluorescent staining of F-actin 
in fixed cells 
Thermo Fisher 
Scientific, 
Waltham, MA, USA 
SMIFH2 20 µM 
Inhibitor of Formin FH2 





Taxol 0.2 - 0.5 nM 
Promotion of decreased 
microtubule plus-tip assembly 




Thymidine 2 mM 





Y-27632 5-10 µM 
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2.1.4 Primary Antibodies 
In Table 2.4 all primary antibodies, their host species, clonality and the used dilution are listed. 




Clonality Use Dilution Company 
Arp3 (FMS338) mouse monoclonal WB 1:500 
Sigma-Aldrich, St. 
Louis, Missouri, USA 
α-Tubulin (B-5-1- 2) mouse monoclonal 
IF 1:700 Santa Cruz, Dallas, 
Texas, USA WB 1:2000 
β-Actin (A5441) mouse monoclonal WB 1:2000 
Sigma-Aldrich, St. 
Louis, Missouri, USA 
ch-TOG (H-4) mouse monoclonal WB 1:500 
Santa Cruz, Dallas, 
Texas, USA 














ɣ-Tubulin (T3559) rabbit polyclonal IF 1:700 
Sigma-Aldrich, St. 
Louis, Missouri, USA 
ɣ-Tubulin (T6557) mouse monoclonal IF 1:1000 
Sigma-Aldrich, St. 
Louis, Missouri, USA 
GFP (GF28R) mouse monoclonal WB 1:3000 
Thermo Fisher 
Scientific, Waltham, MA, 
USA 
Op18 (E-3) mouse monoclonal WB 1:300 





rabbit polyclonal WB 1:1000 
Cell Signaling, 
Cambridge; UK  
Rac1 [0.T.127] mouse monoclonal WB 1:800 
Abcam, Cambridge, UK 
 




TRIO mouse polyclonal WB 1:500 
Abnova, Taipei City, 
Taiwan 
TRIO (D-20) goat polyclonal IF 1:500 
Santa Cruz, Dallas, 
Texas, USA 
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2.1.5 Secondary Antibodies 
In Table 2.5 all secondary antibodies, their host species, clonality and used dilution as well as the 
conjugated molecule are listed. 
Table 2.5 Secondary Antibodies 




































In Table 2.6 all used siRNAs, their sequences and references are listed. 
Table 2.6 siRNAs 
Target Gene Sequence Reference 
Arp3  
5´-AGGUUUAUGGAGCAAGUGA-3´ 
Steffen et al. 2006 
5´-GCCAAAACCUAUUGAUGUA-3´ 
CKAP5 5 -́GAGCCCAGAGTGGTCCAAA-3  ́ De Luca et al. 2008  
EB1 5 -́AUUCCAAGCUAAGCUAGAA-3  ́ 
Watson & Stephens 
2006  
LUCIFERASE  5 -́CUUACGCUGAGUACUUCGAUU-3  ́ Elbashir et al. 2001 
Rac1  5´-AAGGAGATTGGTGCTGTAAAA-3´ Chan et al. 2005 
TRIO 
5 -́GAUAAGAGGUACAGAGAUU-3  ́ 
Cannet et al. 2014  
5 -́GGAAGUCGCUCCUUGACAA-3 ́  





In Table 2.7 all used plasmids, their purpose and reference are listed. 
Table 2.7 Plasmids 
Vector Purpose Reference 
pBluescript KS+ 
Cloning vector, used as carrier DNA 
for calcium phosphate transfection in 
this study  
Kindly provided by Prof. Heike 
Krebber, Göttingen, Germany 
pcDNA3.1  
CMV-promotor driven expression 
vector for human cells  
Invitrogen, Carlsbad, CA, USA  
pcDNA-RFP-H2B 
CMV-promoter driven expression of 
RFP-tagged H2B in human cells 
Kindly provided by Prof. Ody 




CMV-promoter driven expression of a 
N-terminal truncated version (aa 393-
1591) of TIAM1 
Kindly provided by Prof. 




CMV-promoter driven expression of 
the GFP-tagged Calponin homology 
domain of human Utrophin (aa 1-261) 
to detect F-actin in mammalian cells 
Kindly provided by Dr. Melina 
Schuh, Göttingen, Germany 
pEGFP-C1  
CMV-promotor driven GFP-
expressing vector for human cells  
Clontech, Saint-Germain-en-
Laye, France  
pEGFP-H2B 
CMV-promoter driven expression of 
GFP-tagged H2B in human cells 
Kindly provided by Prof. Stefan 
Gaubatz, Marburg, Germany 
pEGFP-EB3  
CMV-promotor driven expression of 
GFP-tagged EB3 in human cells  
Kindly provided by Prof. Linda 
Wordeman (Seattle, WA, USA)  
pmCherry-EB3  
CMV-promotor driven expression of 
mCherry-tagged EB3 in human cells  
Kindly provided by Prof. Linda 
Wordeman (Seattle, WA, USA)  
pEGFP-Rac1 
Q61L  
CMV-promotor driven expression of 
GFP-tagged constitutively active 
Rac1 in human cells  
Kindly provided by Prof. 
Robert Grosse (Marburg, 
Germany)  
pEGFP-TRIO 
CMV-promotor driven expression of 
GFP-tagged TRIO in human cells  
Kindly provided by Anne 
Debant (Montpellier, France) 
pEGFP-TRIO-
SRNN 
CMV-promotor driven expression of 
GFP-tagged TRIO in human cells  
Kindly provided by Anne 
Debant (Montpellier, France) 
pmCherry-EB1 
CMV-promotor driven expression of 
mCherry-tagged EB1 in human cells 
Addgene, Michael Davidson 
Lab  
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2.1.8 Human Cell Lines 
In Table 2.8 all human cell lines, their origin and reference are listed. 
Table 2.8 Human Cell Lines 
Cell Line Origin Reference 
HCT116 colon carcinoma  obtained from ATCC, Manassas, Virginia, USA  
HEK293T embryonic kidney obtained from ATCC, Manassas, Virginia, USA 
HT29 colon carcinoma  obtained from ATCC, Manassas, Virginia, USA 
MCF10A mammary gland 





obtained from Horizon Discovery, Cambridge; 
UK 
SW620 colon carcinoma  obtained from ATCC, Manassas, Virginia, USA 
SW480 colon carcinoma  obtained from ATCC, Manassas, Virginia, USA 
 
In Table 2.9 human cell lines that were generated in this study are listed. 




Plasmid Selection Marker 
HCT116-GFP  HCT116  pEGFP-C1 Geneticin 
HCT116-TRIO-GFP HCT116 pEGFP-TRIO Geneticin 
HCT116-TRIO-SRNN-
GFP 
HCT116 pEGFP-TRIO-SRNN Geneticin 
 
2.2 Cell Biological Methods 
2.2.1 Cultivation of Human Cell Lines 
HCT116, HT29, SW620 and SW480 cells were cultured in RPMI1640 (PAN-Biotech GmbH, 
Aidenbach, Germany) supplemented with 10% FCS (GibcoTM by Thermo Fisher Scientific, 
Waltham, MA, USA), 100 µg/ml streptomycin and 100 units/ml penicillin (PAN-Biotech GmbH, 
Aidenbach, Germany) at 37 °C and 5 % CO2. HEK293T cells were cultured in DMEM (PAN-
Biotech GmbH, Aidenbach, Germany) containing 10% FCS, 100 µg/ml streptomycin and 
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100 units/ml penicillin. For cultivation of MCF10A and MCF10A Rac1Q61L+/- cells DMEM/F12 
(PAN-Biotech GmbH, Aidenbach, Germany) was used and had been supplemented with 5% horse 
serum (GibcoTM by Thermo Fisher Scientific, Waltham, MA, USA), 100 µg/ml streptomycin and 
100 units/ml penicillin, 20 ng/ml EGF (PeproTech, Hamburg, Germany), 0.5 µg/ml hydrocortisone 
(Sigma-Aldrich, St. Louis, Missouri, USA), 100 ng/ml Cholera toxin (Sigma-Aldrich, St. Louis, 
Missouri, USA) and 10 µg/ml insulin (Sigma-Aldrich, St. Louis, Missouri, USA). The cells were 
passaged every two to three days. For this purpose, they were washed once with PBS and 
detached by using trypsin/EDTA (Lonza Group Ltd., Basel, Switzerland). Depending on the growth 
rate of the used cell line and its confluency at the day of passage various amounts of cell 
suspension were transferred to a new cell culture dish containing fresh medium. For long-term 
storage cells were harvested and resuspended in freezing medium (cell line specific medium with 
supplements and additional 10% FCS (v/v) and 10% (v/v) DMSO). Afterwards they were cooled 
down gently to -80 °C using an isopropanol-based cryo 1°C freezing container and after at least 
24 h they were transferred to liquid nitrogen. 
2.2.2 Transfection of human cells 
2.2.2.1 siRNA transfection 
siRNA transfections were performed by using either INTERFERin (Polyplus, Illkirch, France) or 
ScreenFect (ScreenFect GmbH, Eggenstein-Leopoldshafen, Germany). Before transfection cells 
were seeded with a confluency of 70-80 % in 6-well plates and were transfected after they had 
become attached again to up to 24 h after seeding. 48 h after transfection cells were used for 
experiments and knock down efficiency was checked by performing Western blots of cell lysates. 
INTERFERin Transfection 
After 60 pmol siRNA were diluted in 188 µl serum free medium, 6 µl INTERFERin were added 
and the mixture was vortexed for 10 s. During 10 min of incubation at RT, cells that have been 
seeded for transfection were washed with PBS and 1 ml fresh medium was added to the cells. 
Then the siRNA mixture was dropped onto the cells. After incubation for 4 h at 37 °C and 5 % 
CO2, medium was changed.  
ScreenFectsiRNA Transfection 
Before use ScreenFectsiRNA transfection reagent was vortexed for 10 s. 4 µl of 
ScreenFectsiRNA transfection reagent were added to 30 µl of ScreenFect dilution buffer and 
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the mixture was vortexed for 3 s. In another tube 40 pmol siRNA were diluted in 30 µl of 
ScreenFect dilution buffer and the mixture was also vortexed for 3 s. Afterwards, the diluted 
ScreenFectsiRNA transfection reagent was transferred to the diluted siRNA and mixed by 
pipetting 10 times up and down. During an incubation of 15 min at RT, medium of cells was 
changed to 1.5 ml antibiotic free medium. The transfection mixture was added drop-wise onto the 
cells which then were incubated at 37°C at 5 % CO2. Next day, the medium was changed.  
2.2.2.2 Plasmid Transfection 
Depending on the plasmid size and the purpose, plasmid transfection was performed by the 
following transfection methods. Independent of the transfection method, cells were used for 
experiments and transfection efficiency was checked by fluorescence microscopy or by 
performing Western blots of cell lysates 48 h after transfection. 
Electroporation 
Transfection of plasmids by electroporation was performed for most of the used cell lines and 
plasmids of small to medium size (up to 8 kb). Cells were trypsinated and counted. Then they 
were centrifuged for 5 min and 1500 rpm and resuspended in fresh medium to a concentration of 
2.5 x 106 cells/ml. 10-20 µg of plasmid DNA was mixed with 400 µl of cell suspension and 
transferred to a 4 mm cuvette. HCT116, SW620, SW480 and HEK293T cells were electroporated 
using a electroporator (BioRad, Hercules, California, USA) at 300 V and 500 µF. Cells were gently 
transferred into 6-well plates containing fresh medium and incubated at 37°C and 5 % CO2. After 
4h, medium was changed. 
Plasmid transfection using Calcium Phosphate 
For transfection of HEK293T cells, they were seeded in 10 cm dishes to be 60-70 % confluent the 
next day. At the day of transfection, 10 µg target DNA and 10 µg carrier DNA, for which pBluescript 
was used, as well as 62 µl 2.5 M CaCl2 were diluted with water to a total volume of 500 µl and 
mixed by carefully pipetting up and down. By using a pipette controller with a sterile plugged 
Pasteur pipette air was blown into a 500 µl 2x HBS (280 mM NaCl, 50 nmM HEPES, 1.5 mM 
Na2HPO4, pH 7.05) containing falcon. Subsequently, the 500 µl DNA mixture was added to the 2x 
HBS solution drop-wise and air was blown into the mixture for further 30 s. Then the mixture was 
added drop-wise onto the cells an incubated overnight at 37°C and 5 % CO2. The following day, 
cells were washed twice with PBS and fresh medium was added.  
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Plasmid transfection using ScreenFectA 
Cells were seeded with a confluency of 70-80 % in 6-well plates and were transfected after they 
had become attached again to up to 24 h after seeding. Before use ScreenFectA transfection 
reagent (ScreenFect GmbH, Eggenstein-Leopoldshafen, Germany) was vortexed for 10 s. 6 µl of 
ScreenFectA transfection reagent were added to 30 µl of ScreenFect dilution buffer and the 
mixture was vortexed for 3 s. In another tube, 0.25-1.5 µg plasmid DNA were diluted in 30 µl of 
ScreenFect dilution buffer and the mixture was also vortexed for 3 s. Afterwards, the diluted 
ScreenFectsiRNA transfection reagent was transferred to the diluted plasmid DNA and mixed 
by pipetting 10 times up and down, followed by 15 min incubation at RT. In the meantime, medium 
of cells were changed to 1.5 ml fresh medium without antibiotics. The transfection mixture was 
added drop-wise onto the cells which then were incubated at 37°C at 5 % CO2. The following day, 
the medium was changed.  
Plasmid transfection using Lipofectamine 3000 Transfection Reagent 
Lipofectamine 3000 (Invitrogen™ by Thermo Fisher Scientific, Waltham, MA, USA) transfection 
was used for large plasmids. One day before transfection, cells were seeded in 6-well plates to 
yield a confluency of 70-80% at the day of transfection. For transfection, 125 µl serum-free medium 
was mixed with 6.25 µl of Lipofectamine 3000 Transfection Reagent by vortexing for 3 s. In 
another tube 2.5 µg plasmid DNA and 5 µl of P3000 Reagent was added to 125 µl serum-free 
medium and vortexed for 3 s. Afterwards, the diluted Lipofectamine 3000 Transfection Reagent 
was transferred to the plasmid DNA and P3000 Reagent containing solution and mixed by 
pipetting 10 times up and down, followed by 15 min incubation at RT. Meanwhile, medium of cells 
were changed to 2 ml fresh medium without antibiotics. The transfection mixture was added 
dropwise onto the cells which then were incubated at 37°C at 5 % CO2. The following day, the 
medium was changed.  
2.2.3 Generation of stable cell lines 
To generate HCT116 cell lines stably expressing EGFP, TRIO-WT-GFP or TRIO-SRNN-GFP, 
cells were transfected using LipofectamineTM 3000 as described above. For selection of stably 
transfected cells, medium was changed to medium containing 300 µg/ml G418 (Sigma-Aldrich, 
St. Louis, Missouri, USA) one day after transfection. After three more days, serially diluted cell 
suspensions were seeded in 10 cm dishes and GFP-positive single cell clones were isolated for 
further cultivation and analysis 7-10 days later.  
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2.2.4 Karyotype Analysis via Chromosome Spreading 
To accumulate cells in mitosis, cells that have been seeded in 6-well plates were treated with 2 µM 
DME for 4-5 h. Afterwards, supernatant medium was spun down at 2000 rpm for 5 min together 
with residual cells that have been detached by treatment with 0.5 mM EDTA/PBS. Cells were 
resuspended in 750 µl hypotonic solution (10 % cell line specific medium without supplements, 
e.g. RPMI, DMEM, DMEM/F12, 60 % aqua dest.) and incubated for 15 min at RT. Afterwards, 
250 µl ice-cold Carnoy´s fixative (75 % methanol, 25 % glacial acetic acid) was added and cells 
were centrifuged at 2000 rpm for 5 min. Cells were resuspended in 1 ml ice-cold Carnoy´s fixative 
and centrifuged again. Having repeated the last fixation step one more time, the cell suspension 
was incubated for at least 15 min on ice or stored at -20°C until further procedure. For spreading, 
cells were resuspended in 300-500 µl glacial acetic acid and dropped from approximate 50 cm 
height onto an ethanol-washed, pre-cooled, wet object slide. After 5 min incubation on a 42°C 
heat block wrapped with wet paper towels, slides were air-dried. For staining, slides were 
transferred into a 8 % Giemsa solution (Sigma-Aldrich, St. Louis, Missouri, USA) for 15 min. 
Afterwards, slides were washed with water and air-dried at RT, followed by being embedded in 
Euparal (Carl Roth, Karlsruhe, Germany). For analysis of chromosome spreads, Zeiss Axioscope 
FS microscope equipped with a Hamamatsu C4742-95-12ER camera and the Hokawo Launcher 
2.1 software was used.  
2.2.3 Synchronization of human cells 
Synchronization of cells via double thymidine block 
To synchronize cell cycle progression of human cell lines, a double thymidine block which arrests 
cells at G1/S phase was performed. For this purpose, cells were grown in 2 mM thymidine 
containing cell culture medium for 16 h and subsequently washed six times for 5 min with fresh 
medium. After washing, cells were grown in cell culture medium for further 7.5 h and then seeded 
onto glass coverslips in 2 mM thymidine containing medium for another 16 h. Afterwards, cells 
were washed and released in fresh medium as described above. In order to analyze lagging 
chromosomes, cells accumulated at anaphase stage were fixed. The highest accumulation of 
anaphase cells was 8.0 h after washing for HCT116 cells and 10.5 h after washing for MCF10A 
cells. 
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2.2.4 Immunofluorescence microscopy 
Method-specific immunofluorescence staining is described in the method-related chapters 
following below. 
For immunofluorescence staining of EB1 and TRIO, cells grown on glass coverslips were fixed 
with ice-cold methanol for 6 min at -20°C, followed by washing twice with PBS and blocking with 
5 % FCS/PBS for 30 min. Staining was carried out by incubating cells with goat anti-TRIO (1:500) 
and mouse anti-EB1 (1:100) antibodies diluted in 2 % FCS/PBS for 90 min at RT. Afterwards, cells 
were washed three times with PBS, followed by an incubation with host-specific fluorescence-
labeled secondary antibodies (1:1000 dilution in 2 % FCS/PBS) for 90 min at RT. DNA was stained 
with Hoechst33342 (1:15,000 in PBS; Sigma-Aldrich, St. Louis, Missouri, USA) for 5 min at RT. 
Afterwards, cells were washed four times with PBS and one time with Millipore water. Coverslips 
were air-dried and embedded using VectaShield (Vector Laboratories, Burlingame, CA, USA). 
To analyze fixed and stained cells, a Delta Vision Elite© microscope equipped with a PCO Edge 
sCMOS camera and an Olympus 60x 1.40 NA objective was used. Images were acquired with a 
z-optical spacing of 0.2 µm and deconvolved using the softWoRx® 6.0 software. 
2.2.5 Analysis of spindle axis alignment of prometaphase cells 
For the analysis of spindle axis alignment of cells in prometaphase, asynchronously growing cells 
were seeded on fibronectin-coated coverslips. Next day, cells were and fixed with ice-cold 
methanol for 6 min at -20°C. Subsequently, cells were washed twice with PBS and blocked with 
10 % FCS/PBS for 30 min at RT. For staining of centrosomes and microtubules, cells were 
incubated with rabbit anti-ɣ-Tubulin (1:1000) and mouse anti-α-Tubulin (1:700) diluted in 2 % 
FCS/PBS for 90 min at RT. Cells were washed three times with PBS and incubated with host-
specific fluorescence-labeled secondary antibodies (1:1000 dilution in 2 % FCS/PBS) for 90 min 
at RT. DNA staining was carried out using Hoechst33342 (1:15,000 in PBS) for 5 min at RT. After 
washing the cells four times with PBS and once with Millipore water, coverslips were air-dried and 
embedded using VectaShield. Fixed and stained cells were analyzed using a Delta Vision Elite© 
microscope equipped with a PCO Edge sCMOS camera and an Olympus 60x 1.40 NA objective. 
Images were acquired with a z-optical spacing of 0.2 µm and deconvolved using the softWoRx® 
6.0 software. The angle of spindle axis alignment was determined by using the softWoRx® 
Explorer 1.3.0 and the following formula: 
α (spindle axis angle)  =  arcsin(
 number of z-stacks between centrosomes x 0.4 µm
distance between centrosomes [µm]









Figure 2.1: Schematic illustration for the calculation of the spindle axis angle.  
 
2.2.6 Analysis of lagging chromosomes  
In order to stain centromeres and microtubules for the analysis of lagging chromosomes, cells 
grown on glass coverslips have been synchronized by a double thymidine block and were fixed 
with 2 % PFA for 5 min at RT when accumulated in anaphase. Subsequently, cells underwent 
further fixation with ice-cold methanol for 5 min at -20°C. Afterwards, cells were washed twice with 
PBS and blocked with 5 % FCS/PBS for 30 min. Staining of centromeres and microtubules was 
performed by incubating cells with guinea pig anti-CENP-C (1:1000) and mouse anti-α-Tubulin 
(1:700) antibodies diluted in 2 % FCS/PBS for 90 min at RT. After washing the cells three times 
with PBS, they were incubated with host-specific fluorescence-labeled secondary antibodies 
(1:1000 dilution in 2 % FCS/PBS) for 90 min at RT. DNA was stained with Hoechst33342 
(1:15,000 in PBS) for 5 min at RT. Afterwards, cells were washed four times with PBS and one 
time with Millipore water. Coverslips were air-dried and embedded using VectaShield. 
Microscopy of fixed and stained cells was performed using a Leica DM600B fluorescence 
microscope and an ORCA-ER camera or a Delta Vision Elite© microscope equipped with a PCO 
Edge sCMOS camera. Image acquirement was carried out with a z-optical spacing of 0.4 µm, 
followed by deconvolution using the softWoRx® 6.0 software. Lagging chromosomes were defined 
as Hoechst-positive and CENP-C-positive chromosomes located clearly separated in between the 
two pole-oriented chromosome masses in anaphase cells. Per experiment, the amount of lagging 
chromosomes of 100 anaphase cells was counted. 
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2.2.7 Analysis of microtubule plus-end assembly rates 
For the analysis of microtubule plus-end assembly rates, cells were transfected with 10 µg 
pEGFP-EB3 or 10 µg pmCherry-EB3 plasmid DNA via electroporation. Next day, cells were 
seeded into µ-Slide 8 well chambers (ibidi, Martinsried, Germany). 48 h after transfection, cells 
were washed once with PBS and phenol red-free cell culture medium containing 2 µM DME to 
arrest cells in mitosis was added. After incubation for 1-2 h, live cell microscopy of microtubule 
plus-end assembly rates was carried out at 37°C and 5 % CO2 using a Delta Vision Elite© 
microscope equipped with a PCO Edge sCMOS camera and an environmental chamber for 
temperature control and CO2 injection. Images of 4 z-stacks with a z-optical spacing of 0.4 µm 
were acquired every two seconds for a duration of 30 s. Afterwards, images were deconvolved 
and the 4 z-stack images converted to 2D by using the softWoRx® 6.0 software. Microtubule plus-
end assembly rates were determined by measuring the growth of microtubule plus-ends between 
two frames using the softWoRx® Explorer 1.3.0. Per experiment, microtubule plus-end assembly 
rates of 20 microtubules per cell and a total of 10 cells were measured. 
2.2.8 In vitro migration assay 
For the analysis of the migrative behavior of cells, in vitro migration assays were performed. 
Therefore, cells were starved for 16 h in cell culture medium with a reduced FCS content of 0.5 %. 
Afterwards, cells were trypsinized, counted and resuspended in medium containing 0.5 % FCS to 
a final concentration of 1000 cells/µl. 200 µl of the cell suspension were transferred into ThinCert© 
cell culture inserts with a pore size of 8 µm (Greiner BioOne, Frickenhausen, Germany), which 
have been placed into a 24-well plate provided with 600 µl cell culture medium containing 10 % 
FCS. After incubation for 24 h at 37°C and 5 % CO2, migrated cells at the outside bottom of the 
cell culture insert were detached by Trypsin/EDTA. Collected cells were centrifuged for 5 min at 
2000 rpm, resuspended in 100 µl PBS and counted. 
2.2.9 Rac1 activation assay 
To determine the Rac1 activation of cells, the RhoA/Rac1/Cdc42 Activation Combo Biochem KitTM 
(Cytoskeleton Inc., Denver, Colorado, USA) was used. For the analysis of mitotic cells, 2 µM DME 
was added to the cell culture medium 16 h before cell lysis. Cell culture plates were washed once 
with 37°C warm PBS and were immediately placed on ice and lysed by scraping the cells after 
adding 1 ml ice-cold lysis buffer (25 mM HEPES pH 7.5, 1 % NP-40, 10 mM MgCl2, 100 mM NaCl, 
5 % glycerol, freshly supplemented with 1 mM PMSF, 1x protease inhibitor cocktail (Roche, Basel, 
Switzerland), as described in Briançon-Marjollet et al., 2008) per 10 cm dish. Subsequently, 
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lysates were subjected to centrifugation at 14,800 rpm for 1 min at 4°C to remove insoluble 
materials. Active Rac1 was pulled down by incubating the supernatant with 10 µg GST-PAK-PBD 
beads for 30 min at 4°C and head-over-tail rotation. GST-PAK-PBD beads were washed two times 
with wash buffer (25 mM HEPES, pH 7.5, 1% NP-40, 30 mM MgCl, 40 mM NaCl, 1 mM 
dithiothreitol, as described in Briançon-Marjollet et al., 2008), resuspended in 15 µl 5x SDS sample 
buffer and boiled for 5 min at 95°C. Active Rac1 bound to PAK-PBD beads was detected on 
Western blots using mouse anti-Rac1 antibodies (1:800 in 3 % BSA/TBS).   
2.2.10 GEF assay 
For determination of the Rac-GEF activity of cells, pull down assays with Rac1 G15A Agarose 
Beads (Cell Biolabs Inc., San Diego, California, USA) were performed. For the analysis of mitotic 
cells, 2 µM DME was added to the cell culture medium 16 h before cell lysis. Cell culture plates 
were washed once with 37°C warm PBS and were immediately placed on ice and lysed by 
scraping the cells after adding 1 ml ice-cold lysis buffer (20 mM TRIS-HCl pH 7.4, 100 mM NaCl, 
0.1% NP-40, 5 mM MgCl2, 1 mM EDTA, freshly supplemented with 1 mM DTT, 0.1% sodium 
desoxycholate, 20 mM Na3VO4, 25 mM β-Glycerophosphate, 50 mM NaF, 5 mM Na2MoO4 and 1x 
protease inhibitor cocktail) per 10 cm dish. Immediately, lysates were centrifuged at 14,800 rpm 
for 1 min at 4°C to remove debris. Active Rac-GEFs were pulled down by incubating lysate 
containing 5 mg protein with 20 µg Rac1 G15A Agarose Beads for 2 h at 4°C and head-over-tail 
rotation. Rac1 G15A Agarose Beads were washed twice with lysis buffer, resuspended in 5x SDS 
sample buffer and boiled for 5 min at 95°C. Active TIAM1 or TRIO bound to Rac1 G15A Agarose 
Beads were detected on Western blots using mouse anti-TRIO (1:500 in 3 % BSA/TBS) or rabbit 
anti-TIAM1 (1:1000 in 3 % BSA/TBS) antibodies. 
2.2.11 GFP pull down assay  
To investigate the binding of TRIO-WT and TRIO-SRNN to EB1, GFP pull down assays were 
carried out. For this purpose, HEK293T cells were transfected with TRIO-WT-GFP, TRIO-SRNN-
GFP or GFP expressing plasmids via calcium phosphate transfection and HCT116 clones stably 
expressing TRIO-WT-GFP, TRIO-SRNN-GFP or GFP were generated. 16 h before lysis, 2 µM 
DME were added to accumulate mitotic cells. For cell lysis, cells were placed on ice and 1 ml or 
1.5 ml ice-cold lysis buffer (20 mM TRIS-HCl pH 7.4, 100 mM NaCl, 0.1% NP-40, 5 mM MgCl2, 1 
mM EDTA, freshly supplemented with 1 mM DTT, 0.1% sodium desoxycholate, 20 mM Na3VO4, 
25 mM β-Glycerophosphate, 50 mM NaF, 5 mM Na2MoO4 and 1x protease inhibitor cocktail) were 
added per 10 cm dish of HEK293T or 15 cm dish of HCT116 cells, respectively. 2 mg lysate 
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(HEK293T cells) or 10 mg lysate (HCT116 cells) were mixed with 20 µl or 40 µl equilibrated GFP 
selector resin (NanoTag Biotechnologies, Göttingen, Germany) slurry and incubated for 1 h at 4°C 
with head-over-tail rotation. After washing three times with lysis buffer, GFP selector resin was 
resuspended in 5x SDS sample buffer and boiled for 5 min at 95°C. TRIO-WT-GFP, TRIO-SRNN-
GFP and GFP as well as co-immunoprecipitated EB1 were detected on Western blots using 
mouse anti-GFP (1:3000 in 3 % BSA/TBS) or mouse anti-EB1 (1:500 in 3 % BSA/TBS) antibodies. 
2.2.12 Detection and quantification of actin cytoskeleton intensities 
Live cell analysis 
For live cell analysis of actin cytoskeleton intensities, separated in the intensity of the F-actin 
cortex and the F-actin within the cell, hereafter referred to as actin clouds (Mitsushima et al., 2010), 
cells were transfected with 10 µg pCS2-EGFP-hUtrophinCH and 10 µg pcDNA-RFP-H2B via 
electroporation. Next day, cells were seeded into µ-Slide 8 well chambers. 48 h after transfection, 
cells were washed once with PBS and phenol red-free cell culture medium was added. Live cell 
microscopy of metaphase cells was performed at 37°C and 5 % CO2 using a Delta Vision Elite© 
microscope equipped with a PCO Edge sCMOS camera and an environmental chamber for 
temperature control and CO2 injection. Images were acquired with a z-optical spacing of 0.2 µm. 
Line scans of metaphase cells were set via softWoRx® Explorer 1.3.0 software. For calculation, 
background was defined as the mean pixel intensity of the 50 line scan pixels with the lowest 
intensity at one end of the line scan. Background was subtracted from overall mean pixel intensity. 
Actin cortex intensity was calculated as mean of the two cortex peak pixel intensities. Actin cloud 
intensity was calculated as mean of the pixel intensities in between the first low point after the first 
cortex peak and the last low point before the second cortex peak. To take different expression 
levels of EGFP-Utrophin into account, actin cortex intensity – initially assumed to stay unaffected 
by the given treatments - was used for normalization of actin cloud intensities. Per experiment at 
least 10 metaphase cells were evaluated.  
Analysis of fixed and stained cells 
For the analysis of actin cytoskeleton intensities of fixed cells, cells were seeded in µ-Slide 8 wells 
and fixed with 4 % PFA/PBS prewarmed to 37°C for 10 min. After washing two times with PBS, 
cells were permeabilized with 0.1% Triton X-100/PBS for 5 min at RT, followed by two more 
washing steps with PBS and blocking with 1% BSA/PBS for 30 min. For staining of F-actin, cells 
were incubated with 100 nM Alexa FluorTM 594 Phalloidin (Thermo Fisher Scientific, Waltham, 
MA, USA) for 1.5 h in the dark at RT. Afterwards DNA was stained with Hoechst33342 (1:15,000 
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in PBS) for 5 min at RT. After washing the cells three times with PBS, cells were left in PBS at 4°C 
until microscopy. Fixed and stained cells were analyzed using a Delta Vision Elite© microscope 
equipped with a PCO Edge sCMOS camera and an Olympus 60x 1.40 NA objective. Images were 
acquired with a z-optical spacing of 0.2 µm. Line scans of metaphase cells were set via softWoRx® 
Explorer 1.3.0 software. For evaluation, background, actin cortex and cloud intensities were 
calculated as described in `Live cell analysis´. Normalization of cortex as well as cloud intensities 
was done by setting each control group as 1. Per experiment at least 20 metaphase cells were 
evaluated.  
2.2.13 Analysis of F-actin structures using STED microscopy 
In order to visualize extremely fine structures of the F-actin cytoskeleton, STED microscopy was 
carried out. For this purpose, cells grown on glass coverslips were fixed with 4 % PFA/PBS 
prewarmed to 37°C for 10 min. Afterwards, cells were washed two times with PBS, followed by 
permeabilization with 0.1% Triton X-100/PBS for 5 min at RT. Subsequently, cells were washed 
twice with PBS and blocked with 1% BSA/PBS for 30 min. For staining of microtubules, cells were 
incubated with mouse anti-α-Tubulin (1:700) antibody diluted in 1% BSA/PBS for 90 min at RT. 
Afterwards, cells were washed three times with PBS, followed by an incubation with anti-mouse 
Abberior® STAR 580 secondary antibody (1:200, Abberior, Göttingen, Germany) and Abberior® 
STAR RED Phalloidin (1:200, Abberior, Göttingen, Germany) diluted in 1% BSA/PBS for 90 min 
at RT. DNA was stained with Hoechst33342 (1:15,000 in PBS) for 5 min at RT. Finally, cells were 
washed three times with PBS and one time with Millipore water. Coverslips were air-dried and 
embedded using 10 µl Abberior Mount Solid Antifade Medium (Abberior, Göttingen, Germany), 
preheated to 50°C, per coverslip. While I was responsible for fixation and staining as well as the 
detection and identification of prometaphase and metaphase cells by fluorescence microscopy, 
Florian Grimm (Abberior GmbH, Göttingen, Germany) acquired images of those cells using an 
Abberior Instruments Expert Line STED microscope (Abberior Instruments, Göttingen, Germany), 
equipped with a continues wave (CW) excitation laser (405 nm), two pulsed excitation lasers (561 
nm and 640 nm) as well as an pulsed STED laser (775 nm), with an Olympus IX83 microscope 
body (Olympus, Tokyo, Japan) and an Olympus UPLSAPO 100xO/1.4 objective (Olympus, Tokyo, 
Japan). Top surface images of 15 z-stacks (pixel size 20 nm, dwell time 10 µs) with a z-optical 
spacing of 0.2 µm were acquired and maximum projection was chosen to convert the z-stacks into 
2D images using the Imspector 16.1 software (Abberior Instruments, Göttingen, Germany).  
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2.2.14 AFM mechanical measurements 
For the analysis of the cortical tension of prometaphase cells, AFM indentation experiments were 
performed. To enable the identification of prometaphase cells, cells were transfected with 10 µg 
pEGFP-H2B by electroporation. Next day, 2.5 x 105 cells were seeded into μ-Dishes (35 mm, low 
Grid-500, ibidi, Martinsried, Germany) and 48 h after transfection medium was supplemented with 
15 mM HEPES. Live cell analysis was carried out by Dr. Bastian Rouven Brückner (Institute for 
Biophysical Chemistry, Group of Prof. Janshoff, Georg August University Göttingen), Nadine 
Schermuly (Institute for Molecular Onkology, Group of Prof. Bastians, University Medical Center 
Göttingen) and me, whereby in alternate order Nadine Schermuly and I were responsible for the 
detection and identification of prometaphase cells by fluorescence microscopy and Dr. Bastian 
Rouven Brückner carried out the preparation of pyramidal AFM probes (MLCT, Bruker AFM 
Probes, Camarillo, USA), AFM measurements and the analysis of force-indentation curves for the 
calculation of cortical tension T0 and membrane tension Tt. For probe preparation, probes were 
rinsed three times with isopropanol and PBS--, followed by an incubation with concanavalin A-
FITC conjugate (2.5 mg/ml in PBS--, Sigma-Aldrich, Steinheim, Germany) for 1.5 h at RT. This 
procedure allowed for a strong binding between the cell’s membrane and the probe required for 
pulling out plasma membrane tethers and, thus, for the determination of membrane tension. By 
using the thermal noise method (Hutter & Bechhoefer, 1993), the exact spring constant of each 
cantilever was determined. For recording force-indentation cycles, the cantilever tip was placed at 
the center of a prometaphase cell. Every force-indentation cycle started with an indentation up to 
a maximum force of Fmax = 1 nN, at which position the cantilever was kept for a dwell time of 0.5 s, 
followed by retraction of the probe using a pulling velocity of 2 µm/s. Per experiment, about 
10 force-indentation cycles per cell and a total of 20 cells per treatment in at least three 
independent experiments were measured.  
Force-indentation curves were analyzed by Dr. Bastian Rouven Brückner by fitting indentation 
data that starts at the contact point between the cell and the probe using following formula with F 
is the force and  is the indentation depth: 
    
To calculate the cortical tension T0 of a cell, prefactor a was used as well as  to take 
the geometrical properties of the indenter with the half-opening angle  into account: 
  

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2.2.15 Actin cortex thickness measurements 
For the determination of actin cortex thickness, cells were prepared and images were acquired as 
described for fixed cells in 2.2.12 ”Detection and quantification of actin cytoskeleton intensities”. 
The software for actin cortex thickness analysis was written and kindly provided by Prof. Dr. 
Burkhard Geil (Institute for Biophysical Chemistry, Georg August University Göttingen). Tiff-files 
of images only showing the phalloidin staining of single metaphase cells were loaded into the 
software. In order to avoid a possible impact of the F-actin signal intensity, this was normalized by 
setting the minimal pixel intensity of every image to 0 and the maximal pixel intensity of every 
image to 1. The image was adapted by using a Gaussian function with σ = 2. To take the high 
variation in the background intensity into account, adaptive thresholding was used with a block 
size of 21 and an offset of 0.025. In order to take the square size of a pixel into account for the 
calculation of the diameter at every point of the cortex the Euclidian distance was determined, 
followed by skeletonization. Finally, the pixel size was converted into µm (1 pixel = 0.108 µm) and 
the mean diameter of all calculated cortex skeleton points was determined. 
 
2.3 Statistics 
For statistical analysis of data from Rac1 activation assays, phospho-PAK1/2 levels, GEF assays 
and GFP pull down assays, differences in protein loading were corrected using the data that 
represented the expression level of housekeeping genes (α-tubulin, β-actin) or the input level 
(EB1, Rac1, TRIO). Normalization of biological replicates was performed by sum of all data points 
in a replicate (Degasperi et al., 2014). An unpaired t-test was applied to all graphs with p-values 
indicated as: ns (not significant): p > 0.05, *: p ≤ 0.05, **: p ≤ 0.01, ***: p ≤ 0.001, ****: p ≤ 0.0001.    
 
2.4 Protein Biochemistry 
2.4.1 Preparation of protein lysates 
For lysing proteins, cells were washed one time with PBS, followed by detachment using 0.5 mM 
PBS/EDTA. Alternately, cells were placed on ice and detachment was performed by using a cell 
scraper. Detached cells were centrifuged for 5 min at 2000 rpm and cell pellet was resuspended 
in 50-100 µl lysis buffer (50 mM TRIS-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1 % 
(v/v) Igepal©, 0.1 % (w/v) SDS, freshly supplemented with 0.1% sodium desoxycholate, 20 mM 
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Na3VO4, 25 mM β-Glycerophosphate, 50 mM NaF, 5 mM Na2MoO4,1x protease inhibitor cocktail 
and 0.5 µM microcystin-LR (Enzo Life Science, Lörrach, Germany)) per amount of cells grown in 
a 6-well. After 15 min incubation on ice, cell lysates were subjected to centrifugation for 15 min at 
14,800 rpm at 4°C. The supernatant was transferred into a new reaction tube and used for protein 
determination and/or stored at -20°C until further use. For checking the transfection efficiency, 
lysate containing 50 µg of protein was supplemented with 5x SDS sample buffer (50 % glycerol, 
15 % (v/v) β-mercaptoethanol, 15 % (w/v) SDS, 0.25 % (w/v) bromophenol blue). Denaturation of 
proteins was achieved by boiling the samples for 5 min at 95°C. Samples were stored at -20°C 
until further use. 
2.4.2 Protein determination 
The protein concentration of cell lysates was determined by using the Bio-Rad DCTM Protein Assay 
(BioRad, Hercules, California, USA) according to the manufacturer´s protocol. Photometric 
measurements were carried out at a VICTOR© X3 microplate reader. 
For all experiments, protein determination of cell lysates was performed and equal amounts of 
proteins were used for detection via Western blots, including IPs, Rac1 and GEF assays. 
2.4.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
In order to separate denatured proteins from cell lysates by their molecular weights, a 
discontinuous SDS-PAGE was used. The SDS gel was composed of 5 % stacking gel (300 nM 
TRIS-HCl, pH 6.8, 0.1 % (w/v) SDS, 5 % (v/v) Rotiphorese Gel 30© (Carl Roth, Karlsruhe, 
Germany)) and 7-13 % resolving gel (500 nM TRIS-HCl, pH 8.8, 0.1 % (w/v) SDS, 7-13 % (v/v) 
Rotiphorese Gel 30©). The percentage of the resolving gel was dependent on the molecular weight 
of the proteins to be detected. Gradient gels consisting of a two-part resolving gel with different 
percentages were used for the detection of proteins with strongly diverging molecular weights. 
Prepared protein lysates and 5 µl of PageRuler Prestained Protein Ladder (Fermentas, St. Leon-
Rot, Germany) for proteins up to 180 kDa, PageRuler Plus Prestained Protein Ladder (Fermentas, 
St. Leon-Rot, Germany) for proteins up to 245 kDa or ProSieveTM QuadColorTM Protein Marker 
(Lonza Group Ltd., Basel, Switzerland) for proteins up to 300 kDa or were loaded onto the SDS 
gel. Protein separation was carried out in SDS running buffer (25 mM TRIS-HCl, pH 6.8, 192 mM 
glycine, 0.15 % (w/v) SDS) for 1 h at 27 mA and 2-3 h at 37 mA. 
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2.4.4 Western blot  
Semi-dry blot 
In order to transfer proteins smaller than 100 kDa, a semi-dry blot was mostly used. For protein 
transfer, the SDS gel was placed onto a nitrocellulose membrane and wetted with transfer buffer 
(24.8 mM TRIS-HCl pH 8.0, 170 mM (v/v) glycine, 0.0025 % (w/v) SDS, 20 % methanol). Blotting 
was performed at 200 mA for 1.5 h. 
Tank blot 
For electrophoretical transfer especially of proteins larger than 100 kDa, a tank blot system was 
used. Protein transfer from the SDS gel to a nitrocellulose or PVDF (protein transfer and 
immobilization on a polyvinylidene fluoride) membrane, with the latter one being activated by an 
incubation in methanol followed by intensive washing with water, took place in a tank-blot 
chamber. Blotting was performed in transfer buffer (24.8 mM TRIS-HCl pH 8.0, 170 mM (v/v) 
glycine, 0.0025 % (w/v) SDS, 15 % methanol) at 450 mA for 3 h. 
After protein transfer, the membrane was blocked with 5 % milk powder/TBS (50mM TRIS-HCl, 
pH 7.2, 160 mM NaCl) for 30 min at RT. Proteins of interest were labelled by overnight incubation 
with specific primary antibodies diluted in 3 % BSA/TBS at 4°C shaker. Then the membrane was 
rinsed 2 times with 0.1% TBS-T (0.1 % Tween in TBS) and then washed 3 time for 10 min each 
with 0.1% TBS-T on a shaker. Afterwards, the membrane was incubated with the appropriate 
horseradish peroxidise (HRP) conjugated secondary antibody diluted in 3 % milk powder/TBS for 
1.5 h, followed by washing as described above. For protein detection, the membrane was treated 
with freshly prepared enhanced chemiluminescence (ECL) solution (0.1 mM TRIS-HCl, pH 8.5, 
2.5 mM luminol, 0.4 mM β-coumaric acid, 0.03 % (v/v) H2O2) or with Amersham ECL Western 
Blotting Detection Reagent (GE Healthcare, Chalfont St. Giles, UK). Finally, chemiluminescence 
was measured using a Fusion-SL 3500-WL chemiluminescence imaging system (Peqlab, 
Erlangen, Germany). A digital image was taken of the protein marker. 
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2.5 Molecular Biological Methods 
2.5.1 Escherichia coli (E. coli) cells 
For transformation of plasmid DNA, the following E. coli stain was used: 
DH5αF-80lacZ△M15 △(lacZYA-argF) U169 deoR recA1 hsdR17(rk
- , mk
+) phoA supE44 thi-1 
gyrA96 relA1λ-. 
2.5.2 Preparation of competent E. coli 
To prepare chemically competent E. coli cells, 5 ml Luria Bertani (LB) medium were inoculated 
with E. coli DH5α and incubated overnight at 37°C shaking at 110 rpm. The next morning the 
overnight culture was added to 400 ml LB medium and incubated shaking at 37°C until OD600 was 
approximately 0.5. After 5 min incubation on ice, cells were centrifuged for 5 min at 2000 rpm. The 
cell pellet was resuspended in 40 ml TfbI buffer (30 mM potassium acetate, 100 mM RbCl, 10 mM 
CaCl2, 15 % (v/v) glycerol, pH 6.0) and incubated on ice for 5 min, followed by centrifugation at 
2000 rpm for 5 min. This time, cells were resuspended in 4 ml TfbII buffer (10 mM MOPS, 75 mM 
CaCl2, 10 mM RbCl, 15 % glycerol, pH 6.5) and incubated on ice for 15 min. Aliquots of 100 µl 
were snap frozen in liquid nitrogen and stored at -80 °C. 
2.5.3 Transformation of E. coli cells 
To transfer plasmids into competent of E. coli DH5α cells, 1-2 µg of plasmid DNA was added to 
50 µl competent cells and gently mixed by pipetting up and down. After 20 min incubation on ice, 
cells were subjected to a heat shock at 42°C for 1 min. Subsequently, 600 µl LB medium was 
added and cells were incubated for 45-60 min at 37°C and 650 rpm shaking. Afterwards, the cell 
suspension was transferred to 400 ml LB medium supplemented with the appropriate selective 
antibiotic (100 mg/ml ampicillin or 50 mg/l kanamycin) and incubated overnight at 37°C in an 
incubation shaker at 110 rpm. Cells were harvested by centrifugation for 20 min at 4000 rpm and 
cell pellets were stored at -20°C until further processing.  
2.5.4 Plasmid Isolation 
Plasmid DNA purification was carried out using the NucleoBond© PC 100 X-TRA Midi Kit 
(Macherey-Nagel GmbH & Co. KG, Düren, Germany) according to the manufacturer´s protocol. 






3.1 TRIO binds to EB1 at microtubule plus ends in a microtubule dynamic dependent 
manner  
Recent studies as well as work from our group gave rise to a putative pathway, that connects  
microtubule dynamics to the mitotic actin cortex and that seems to be involved in the generation 
of spindle mis-positioning, chromosome mis-segregation and thus chromosomal instability when 
being hyperactivated. This pathway includes microtubule plus-end bound EB1, the GEF TRIO and 
its Rho GTPase Rac1, as well as the actin cytoskeleton remodeling Arp2/3 complex. So far it has 
been shown that microtubule plus-end assembly rates and EB1 are associated with TRIO activity 
(Berger, 2016), but not whether this is due to a direct interaction or whether further interaction 
partners are involved. In order to figure this out, EB1-TRIO interaction studies were performed, 
including looking for co-localization via immunofluorescence and performing pull down assays.  
Since van Haren et al. (2014) only showed co-localization of EB1 and overexpressed TRIO 
together with overexpressed Navigator 1 (NAV1), a microtubule plus-tip binding TRIO-interaction 
partner, evidence for co-localization of endogenously expressed EB1 and TRIO at microtubule 
plus-tips was still lacking. Unpublished immunofluorescence data from our group shows that TRIO 
is indeed microtubule-associated in chromosomally unstable SW620 in mitosis, and that this 
localization is EB1 dependent as it is abolished after EB1 knock down. Further 
immunofluorescence staining and microscopy using anti-EB1 and anti-TRIO antibodies in 
chromosomally stable HCT116 and chromosomally unstable SW620 colorectal cancer cells 
proved the co-localization of EB1 and TRIO and it was observed in interphase cells as well as in 
different mitotic phases (Figure 3.1a). Although the images are not sufficient to visualize a clear 
microtubule plus-tip localization of TRIO, the co-localization with EB1 as well-known microtubule-
end binding protein strongly suggests TRIOs microtubule plus-tip localization. In both cell lines in 
interphase and mitosis, the microtubule-associated localization of TRIO was strongly reduced 
after siRNA-mediated depletion of EB1, thereby demonstrating the EB1 dependence and further 
confirming the unpublished data from our group (Figure 3.1b). However, there was not only less 
microtubule-associated TRIO, but also an overall reduction of TRIO observed in EB1-depleted 
cells. This might be explained by a reduced stability of unbound TRIO when EB1 is not present or 
by washout of unbound TRIO during the methanol-fixation step of the staining procedure. 
Due to uncovering the role of microtubule plus-end assembly rates for CIN development, 
chromosomally stable HCT116 cells were treated with low dose of the microtubule-affecting drug 




used in subnanomolar concentrations (Ertych et al., 2014). In contrast, chromosomally unstable 
SW620 cells were treated with low dose of the microtubule-affecting drug Taxol, which in turn has 
a microtubule plus-end assembly increasing effect when used in subnanomolar concentrations. 
However, neither Nocodazole treatment of HCT116 cells showed an increasing, nor Taxol 
treatment of SW620 cells showed a reducing effect on the amount of EB1 or TRIO located at 
microtubule plus-tips (Figure 3.1b). This result indicates that there is no effect of microtubule plus-







Figure 3.1: TRIO co-localizes with EB1 at microtubules in an EB1 dependent manner. Representative 
immunofluorescence images of chromosomally stable HCT116 and chromosomally unstable SW620 cells 
showing localization of endogenous EB1 and TRIO in (a) interphase and several mitotic phases and (b) 
after treatment with microtubule plus-end assembly rate-affecting drugs (0.2 nM Taxol or 0.5 nM 
Nocodazole for 16 h) or siRNA against Luciferase (LUC) or EB1 in metaphase cells. Cells were stained for 
TRIO (green), EB1 (red) and Hoechst33342 (DNA; blue). Scale bar 10 µm.  
However, a co-localization does not automatically mean that there is also an interaction between 
EB1 and TRIO, which might be still be affected by microtubule dynamics. In order to confirm the 
EB1-TRIO interaction, postulated by van Haren et al. (2014), and to look for a possible impact of 
microtubule dynamics on this interaction, pull down assays were performed. Since EB1-TRIO co-
immunoprecipitation assays with endogenously expressed EB1 and TRIO did not prove EB1-
TRIO binding, an overexpression system was chosen to ensure that enough binding partners were 
available to be detected in pull down experiments. Due to the much higher endogenous expression 
of EB1 compared to TRIO, TRIO-GFP was used for overexpression and pull down via GFP 
selector beads. The large size of TRIO-GFP – the sequence of TRIO-GFP consists of about 10 
kb – required an overexpression system that was easy transfectable with large plasmids. For this 
reason, HEK293T cells were chosen and transfected with plasmids expressing TRIO-WT-GFP or 
TRIO-SRNN-GFP, with the latter one having a mutated SXIP sequence motif which is critical for 
EB1-binding (van Haren et al., 2014). 16 h before pull downs, cells were treated with low dose 
Taxol or Nocodazole as well as with the Eg5 inhibitor dimethylenastrone (DME) for the induction 
of mitotic arrest. Pull downs of TRIO-WT-GFP and TRIO-SRNN-GFP via GFP sector beads were 
analyzed by Western blots together with bound endogenous EB1 (Figure 3.2a). Levels of bound 
EB1 were quantified and the results not only confirmed the requirement of the SXIP motif of TRIO 
for EB1 binding, but also showed that low dose Taxol treatment led to a reduction of EB1 bound 
to TRIO-WT-GFP (Figure 3.2b). This strongly suggests an impact of microtubule plus-end 
assembly rates on the EB1-TRIO interaction. However, only low dose Taxol treatment, but not low 
dose Nocodazole treatment caused a significant change in bound EB1 levels. Ertych et al. (2014) 
has shown, that CIN cells have increased microtubule plus-end assembly rates that can be 
decreased by low dose Taxol and that non-CIN cells exhibit normal microtubule plus-end 
assembly rates that can be increased by low dose Nocodazole. Consequently, GFP pull down 
results suggested HEK293T cells to be chromosomally unstable. Chromosomal instability of 
HEK293T cells was already reported by Stepanenko and Dmitrenko (2015), but the microtubule 
plus-end assembly rate of mitotic HEK293T cells was still unknown. For this purpose, HEK293T 
cells were transfected with a plasmid for expression of the GFP-tagged microtubule plus-end-





Figure 3.2: Interaction between TRIO and EB1 can be diminished by a decrease in microtubule plus-
end assembly rates in chromosomally unstable HEK293T cells. (a) Representative Western blot of GFP 
pull down from mitotic HEK293T cells overexpressing TRIO-WT-GFP or EB1 binding deficient TRIO-SRNN-
GFP showing a reduced amount of EB1 bound to TRIO-WT-GFP in cells with decreased microtubule plus-
end assembly rates induced by low dose Taxol treatment. Treatment with low dose Nocodazole did not 
show a significant effect. HEK293T cells were transfected with TRIO-WT-GFP or TRIO-SRNN-GFP 
expressing plasmids and treated with DMSO (control), 0.2 nM Taxol or 0.5 nM Nocodazole together with 
2 µM DME for mitotic arrest for 16 h. GFP selector beads were used for pull down of TRIO-WT-GFP or 
TRIO-SRNN-GFP and bound endogenous EB1 was detected on Western blots. For detection, anti-GFP 
and anti-EB1 antibodies were used. (b) Quantification of EB1 levels from three independent GFP pull down 
experiments (mean ± SEM, t-test). (c) HEK293T cells show slightly increased microtubule plus-end 
assembly rates that are reduced to normal by treatment with low dose Taxol. 48 h before measurement of 
microtubule plus-end assembly rates, HEK293T cells were transfected with an EB3-GFP expressing 
plasmid. 2 h prior to measurement, 0.2 nM Taxol and 2 µM DME were added. Scatter dot plots show mean 
values ± SEM of 20 microtubules analyzed per cell with a total of 10 cells per experiment (n = 3, t-test). 
used for the calculation of microtubule plus-end assembly rates. As presumed, mitotic HEK293T 
cells showed an increased microtubule plus-end assembly rate of 18 µm/min, that could be 
decreased to 15.8 µm/min meaning to a non-CIN level by low dose Taxol treatment (Figure 3.2c). 
This rescue by low dose Taxol treatment goes along with the result from the GFP pull down 
experiments. Together, these results show that there is a SXIP motif dependent and microtubule 
dynamic dependent EB1-TRIO interaction in mitotic chromosomally unstable cells, that is 
diminished after rescue of microtubule plus-end assembly rates. From this it can be suggested 
that a rescue of chromosomal instability due to a rescue of microtubule plus-end assembly rates 
in chromosomally unstable cells might be the consequence of a reduced EB1-TRIO interaction 
downstream of microtubule dynamics. 
Vice versa, the abovementioned results would suggest a lower EB1-TRIO interaction in 




this assumption, HCT116 cell clones stably expressing EGFP, TRIO-WT-GFP or TRIO-SRNN-
GFP were generated, which due to the vast size of full-length TRIO has proven to be particularly 
difficult in the past not only in our group (Seipel et al., 1999). Expression of TRIO-WT-GFP and 
TRIO-SRNN-GFP of three independent cell clones was verified by Western blots (Figure 3.3a). 
Live cell images of generated HCT116 cell clones transiently co-expressing EB1-mCherry were 
difficult to interpret in terms of EB1-TRIO co-localization due to the high cytoplasmic background 
signal of transfected cells (Figure 3.3b). However, in contrast to GFP, both TRIO-WT-GFP and 
TRIO-SRNN-GFP showed clear localization at lamellipodia-like structures of interphase cells, 
which underlines the function of TRIO in lamellipodia formation that has already been described 
by Seipel et al. (1999). According to findings from van Rijssel et al. (2012), this function of TRIO 
in lamellipodia formation is also associated with cell migration. Localization of TRIO-SRNN-GFP 
at lamellipodia-like structures showed to be even more pronounced than that of TRIO-WT-GFP. 
Both, TRIO-WT-GFP and TRIO-SRNN-GFP expressing cells also seemed to have larger 
lamellipodia than GFP expressing cells, suggesting a possible effect on the migrative behavior. 
To confirm the observed structures as lamellipodia, an additional staining of lamellipodial markers 
and/or the F-actin cytoskeleton would be useful. Before being further analyzed, microtubule plus-
end assembly rates of the generated HCT116 clones were determined to exclude an effect of 
TRIO itself on microtubule dynamics. Both, TRIO-WT-GFP and TRIO-SRNN-GFP overexpression 
did not have any effect on microtubule plus-end assembly rates, thereby verifying TRIO to be 
downstream of microtubule dynamics (Figure 3.3c).  
Now knowing that HCT116 clones stably expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP 
exhibit normal microtubule plus-end assembly rates, these cells were used for GFP pull down 
experiments. In order to test, whether an increase of microtubule plus-end assembly rates would 
alter the level of EB1-TRIO interaction in mitotic HCT116 clones, these cells were treated with low 
dose Nocodazole and DME 16 h before GFP pull down. Quantification of bound endogenous EB1 
on Western blots again confirmed the requirement of the SXIP motif of TRIO for EB1 binding, but 
did not show an effect of low dose Nocodazole treatment on the amount of EB1 bound to TRIO-
WT-GFP (Figure 3.4). Whether the small band representing bound EB1 in TRIO-SRNN-GFP 
expressing HCT116 cells is due to unspecific binding or experimental reasons needs to be further 
tested by additionally performing pull downs of GFP expressing HCT116 control clones.  
Summed up, the overall GFP pull down results demonstrate that there is a SXIP motif dependent 
EB1-TRIO interaction that can be reduced by Taxol-induced decrease but not enhanced by 
Nocodazole-induced increase of upstream microtubule plus-end assembly rates. Further research 




TRIO interaction. This includes, inter alia, testing whether the microtubule-affecting impact of 






Figure 3.3: Generation of HCT116 cell clones stably expressing GFP, TRIO-WT-GFP or TRIO-SRNN-
GFP. (a) Representative Western blot of three independent HCT116 cell clones stably expressing GFP, 
TRIO-WT-GFP or TRIO-SRNN-GFP respectively. HCT116 cells have been transfected with corresponding 
plasmids using LipofectamineTM 3000 and stably transfected cells have been selected using G418. GFP-
positive single cell clones were picked and used for further analysis. Expression levels were detected on 
Western blots via an anti-TRIO antibody. Anti-α-tubulin antibody was used to test for equal protein loading. 
(b) Representative live cell images of interphase and mitotic HCT116 cell clones stably expressing GFP, 
TRIO-WT-GFP or TRIO-SRNN-GFP together with transiently expressed EB1-mCherry. HCT116 clones 
have been subjected to electroporation with pmCherry-EB1 plasmid 48 h before microscopy. Scale bar 
10 µm. (c) Stable expression of TRIO-WT-GFP or TRIO-SRNN-GFP does not affect microtubule plus-end 
assembly rates. HCT116 clones were transfected with pmCherry-EB3 plasmid 48 h before and 2 µM DME 
were added 2 h before measurements. Scatter dot plots show average microtubule growth rates from 




Figure 3.4: EB1-TRIO binding is not affected by a Nocodazole-induced increase of microtubule plus-
end assembly rates in HCT116 cells. (a) Representative Western blot of GFP pull down from mitotic 
HCT116 cell clones stably expressing TRIO-WT-GFP or EB1 binding deficient TRIO-SRNN-GFP reveal no 
impact of low dose Nocodazole treatment on the amount of EB1 bound to TRIO-WT-GFP. HCT116 clones 
have been generated as described before and treated with DMSO (control) or 0.5 nM Nocodazole together 
with 2 µM DME to induce mitotic arrest for 16 h. Pull down of TRIO-WT-GFP or TRIO-SRNN-GFP was 
carried out using GFP selector beads and bound endogenous EB1 was detected on Western blots. Anti-
GFP and anti-EB1 antibodies were used for detection. (b) Quantification of EB1 levels from three 
independent GFP pull down experiments (mean ± SEM, t-test).  




3.2 The TRIO GEF-D1 activity is independent of EB1 binding  
EB1-TRIO interaction studies described in the previous chapter confirmed this binding to be SXIP 
motif dependent and revealed a newly identified role of microtubule dynamics in this interaction. 
Further experiments should now show what effect differences in mitotic EB1-TRIO binding would 
have downstream of this interaction, especially regarding possible actin-regulated spindle 
positioning. As TRIO is a well-known multidomain protein with two GEF domains, GEF-D1 for 
GDP/GTP exchange on Rac1 and RhoG and GEF-D2 being specific for RhoA, it plays an 
important role in the regulation of F-actin cytoskeleton rearrangements (Debant et al., 1996; 
Blangy et al., 2000). Due to the importance of the GEF function of TRIO in cytoskeletal regulation, 
GEF assays should reveal whether microtubule dynamics would have an effect on TRIOs GEF-
D1 activity via disturbance of the EB1-TRIO interaction. In order to test this, GEF assays of 
interphase and mitotic SW620 and HCT116 cells treated with or without low dose Taxol were 
performed. In this assay, the active form of Rac-GEFs was selectively pulled down from cell 
lysates via Rac1 G15A Agarose beads. Since this GEF assay has been shown to work out well 
for the GEF TIAM1 (García-Mata et al., 2006), detection of active TIAM1 was used as a control. 
However, while active TIAM1 was clearly detectable on Western blots of GEF assays of SW620 
and HCT116 cells, TRIO was not (Figure 3.5a). Looking at the input fraction at least gave some 
insight into differences in expression levels between chromosomally stable HCT116 and 
chromosomally unstable SW620 cells as well as between mitotic and interphase cells. While 
HCT116 cells showed higher TIAM1 levels as well as TIAM1 GEF activity, SW620 cells showed 
higher TRIO expression levels. For both cell lines TIAM1 expression was higher in interphase 
cells, while TRIO expression levels were only higher in interphase of SW620 but not HCT116 cells 
when compared to mitosis. Looking at TIAM1 expression levels and TIAM1 GEF activity, these 
results seem to show a more important role for interphase and for chromosomally stable HCT116 
cells when compared to chromosomally unstable SW620 cells. The role of TIAM1 in interphase 
has already been demonstrated by revealing the regulatory effect of this GEF on migration, 
invasion and adhesion (Minard et al., 2004). Though not having detected TRIO GEF activity levels, 
the observed differences in TRIO expression levels might at least serve as a hint for its higher 
importance for chromosomally unstable SW620 cells when compared to chromosomally stable 
HCT116 cells. However, its higher expression in interphase SW620 cells when compared to 
mitotic SW620 cells would first of all suggest a role in signaling pathways involved in interphase, 
which has already been verified by demonstrating the role of TRIO in migration and invasion (van 
Rijssel et al., 2012; Hou et al., 2018). In order to generate meaningful results, the determination 




In this context, Maier et al. (2018) demonstrated TRIO to be only able to bind to wildtype Rac1, 
but not to Rac1 G15A, that was used for binding active GEFs within the used GEF assay due to 
the higher stability of this mutant compared to wildtype Rac1 (García-Mata et al., 2006). However, 
another group successfully showed TRIO GEF-D1 activity using Rac1 G15A coupled beads, but 
 
 
Figure 3.5: The GEF-D1 activity of TRIO is independent of EB1 binding. (a) Representative Western 
blot of a GEF assay from interphase and mitotic HCT116 and SW620 cells treated with or without low dose 
Taxol showing active endogenous TIAM1 to be detectable, but not active endogenous TRIO. For 
accumulating mitotic cells, 2 µM DME and for low dose Taxol treatment 0.2 nM Taxol were added 16 h 
before cell lysis. Rac1 G15A Agarose beads were used to selectively pull down the active form of Rac1-
GEFs from cell lysates. For detection, anti-TRIO and anti-TIAM1 antibodies were used. As loading control 
α-tubulin was detected. (b) Western blot of a GEF assay from mitotic HEK293T cells expressing TRIO-WT-
GFP, TRIO-SRNN-GFP, TIAM1-C1199 (pos. control) or an empty vector (neg. control) revealing no 
difference in TRIO GEF-D1 activity. HEK293T cells were transfected with indicated plasmids and treated 
with 2 µM DME for mitotic arrest for 16 h. GEF assay was carried out as described above. Anti-GFP and 





only after overexpression of TRIO GEF-D1 in HeLa cells (van Rijssel et al., 2012) or in a clearly 
detectable manner only after increasing TRIO expression and activity by inducing inflammatory 
conditions via TNF-α treatment in endothelial HUVEC cells (van Rijssel et al., 2013). Due to these 
findings, further GEF assays were carried out with overexpressed TRIO, again using HEK293T 
cells as overexpression system. HEK293T cells were transfected with plasmids coding for TRIO-
WT-GFP, TRIO-SRNN-GFP, the positive control TIAM1-C1199 that is a more stable N-terminal 
truncated version appeared to have a higher Rac1-GEF activity than full-length TIAM1 (Michiels 
et al., 1995; van Leeuwen et al., 1995), or an empty vector as negative control. Using these 
conditions in GEF assays now allowed for detection of active TRIO in Western blots (Figure 3.5b). 
Quantification and comparison of active TRIO levels in TRIO-WT-GFP expressing and TRIO-
SRNN-GFP expressing HEK293T cells revealed no difference between the wildtype and the EB1 
binding deficient mutant of TRIO in two out of four experiments. Due to a lower expression level 
of TRIO-SRNN-GFP than of TRIO-WT-GFP in the other two experiments, this result needs to be 
confirmed by repeating this experiment. However, cautiously considered this result suggests that 
the EB1-TRIO interaction does not affect the overall GEF-D1 activity of TRIO. This finding 
corresponds with work done by van Haren et al. (2014), who also observed no difference in GEF-
D1 activity of TRIO-WT-GFP and TRIO-SRNN-GFP by performing fluorescence-based in vitro 
guanine nucleotide exchange assays measuring Mant-GTP loading onto GDP-preloaded RhoG. 
But even if they have the same GEF activity, this does not mean that TRIO-WT-GFP and TRIO-
SRNN-GFP have the same effect downstream in the signaling pathway. Especially the difference 
in localization could alter downstream effects, as TRIO-WT-GFP but not TRIO-SRNN-GFP is able 
to bind to EB1 and might, thus, be rather involved in activating Rho GTPases at locations only 
reached by microtubule plus-tip-bound EB1. 
 
3.3 An increase in Rac1 activity requires EB1 binding of TRIO in mitotic cells 
Previous chapters already dealt with the impact of microtubule dynamics on the EB1-TRIO 
interaction and with the independency of EB1 binding on overall TRIO GEF-D1 activity. In the 
following, it is now important to investigate whether microtubule dynamics, EB1-TRIO binding and 
TRIO GEF-D1 activity affect Rac1 activity in mitotic cells. First, this was tried to be analyzed by 
determining endogenous Rac1 levels via pull down with PAK-PBD coated beads. Therefore, 
mitotic SW620 cells were treated with or without low dose Taxol, the TRIO inhibitor ITX3 or the 
Rac1 inhibitor NSC23766. The Rac1 activity level of mitotic HCT116 cells was also determined in 




GEF TIAM1-C1199 was overexpressed. However, while Tiam1-C1199 overexpression worked 
out well as positive control and showed the expected increase in Rac1 activity, treatments with 
low dose Taxol, different concentrations of the TRIO inhibitor ITX3 or with the Rac1 inhibitor 
NSC23766 did not show a decrease in Rac1 activity (Figure 3.6a). Maybe, this is due to the fact 
that Rac1 activity decreases rapidly on entry into mitosis (Yoshizaki et al., 2003), which does not 
allow to make a further reduction visible. Abovementioned results from GEF assays affirm a low 
mitotic Rac1 activity, as they show a lower amount of active TIAM1 in mitotic cells when compared 
to interphase cells and this is even lower for SW620 than for HCT116 cells (Figure 3.5a). 
Additionally, there was a lower amount of TRIO expressed in mitosis. Mitotic HCT116 cells, 
however, showed a higher Rac1 activity than mitotic SW620 cells (Figure 3.6a), which also goes 
along with the higher detected TIAM1 expression and activity in HCT116 cells (Figure 3.5a). But 
a higher Rac1 activity in mitotic HCT116 than in mitotic SW620 cells does not directly mean that 
there is no microtubule dynamic, EB1, and TRIO dependent activation of Rac1 existing in 
chromosomally unstable cells. It becomes clear once again, that the localization of activation of 
components of this pathway might be the crucial difference and not the overall activation. Thus, 
there might be still a part of Rac1 being activated by TRIO located at microtubule plus-tip bound 
EB1 that cannot be visualized under these conditions. 
However, besides the low Rac1 activity in mitotic SW620 cells, the low affinity that the used PAK-
PBD beads also have for inactive Rac1-GDP might hide differences in active Rac1-GTP levels at 
these low concentrations. In order to exclude a possible effect of the Rac1 activity assay itself, 
activity of the Rac1 target PAK1/2 was determined as readout for Rac1 activity. PAK1/2 activity is 
regulated by phosphorylation at various sites, whereby binding of Rac1 or Cdc42 to the PAK-PBD 
domain causes autophosphorylation and conformational changes activating PAK1/2 (Knaus & 
Bokoch, 1998; G. A. Martin et al., 1995). Therefore, a phospho-PAK1 (Ser199/204)/ PAK2 
(Ser192/197) antibody, that has previously been used to demonstrate Rac1 dependent PAK1/2 
activation (May et al., 2014; Whalley et al., 2015), was used to detect active PAK1/2. Again, mitotic 
SW620 were treated with DMSO, low dose Taxol, the TRIO inhibitor ITX3 or the Rac1 inhibitor 
NSC23766 and compared with DMSO treated mitotic HCT116 cells. This time, there was a 
significant and concentration dependent reduction of phospho-PAK1/2 levels visible after 
treatment of SW620 cells with ITX3 or NSC23766 indicating a reduced Rac1 activity (Figure 3.6b). 
This is not surprising, as TRIO is a well-known GEF for Rac1 and, thus, TRIO inhibition is expected 
to reduce Rac1 activity. However, when having a look at the effect of low dose Taxol treatment, 
there is no change in phospho-PAK1/2 levels of mitotic SW620 cells. This result demonstrates for 





Figure 3.6: Rac1 activity is reduced by TRIO inhibition, but not by a Taxol-induced decrease of 
microtubule plus-end assembly rates. (a) Representative Western blot of a Rac1 activity assay from 
mitotic SW620 and HCT116 cells treated with or without low dose Taxol, ITX3 (TRIO inhibitor) or NSC23766 
(Rac1 inhibitor). SW620 cells were transfected with a TIAM1-C1199 expressing plasmid (pos. control) or an 
empty vector or treated with DMSO (control), 0.2 nM Taxol, 15 µM, 30 µM or 50 µM ITX3 or 40 µM 
NSC23766 for 16 h. To induce mitotic arrest, 2 µM DME was added 16 h before cell lysis. Rac1 activity 
assays were performed using PAK-PBD beads for pull down of active Rac1 from cell lysates. For detection, 
an anti-Rac1 antibody was used. Bar graphs show quantification of active Rac1 from three or two (15 and 
30 µM ITX3) independent Rac1 activity assays (mean ± SEM, t-test). (b) Representative Western blots of 
phospho-PAK1/2 levels from mitotic SW620 and HCT116 cells after treatment with or without low dose 
Taxol, TRIO inhibitor or Rac1 inhibitor. Cells have been treated with DMSO (control), 0.2 nM Taxol, 15 µM 
or 50 µM ITX3, 40 µM or 100 µM NSC23766 together with 2 µM DME for 16 h. Active PAK1/2 as readout 
for active Rac1 was detected on Western blots by a phospho-PAK1 (Ser199/204)/ PAK2 (Ser192/197) 
antibody and detection of β-actin served as loading control. Data was normalized to DMSO treated SW620 
cells. Bar graphs show quantification of phospho-PAK1/2 levels from two to three independent experiments 
(mean ± SEM, t-test). 
 
not have an impact on overall Rac1 activity. However, this again might be explained by the 
importance of a microtubule plus-tip, EB1, TRIO dependent localization of activation of maybe 
only a small part of Rac1. While inhibitors as ITX3 for TRIO and NSC23766 for Rac1 affect the 
whole pool of active Rac1 within a cell, microtubule dynamic changes by low dose Taxol would 




might not be detectable within the performed assays. But maybe it is exactly that part of Rac1 that 
is involved in actin dependent cytoskeletal changes important for the regulation of spindle 
positioning. 
Since the detection of phospho-PAK1/2 levels could not reveal whether there is a part of Rac1 
being activated via a microtubule plus-tip, EB1, TRIO dependent pathway, again HEK293T cells 
were used for expressing TRIO-WT-GFP or TRIO-SRNN-GFP in order to look for a possible 
difference in Rac1 activation. Although TRIO-WT-GFP and TRIO-SRNN-GFP has been shown to 
have the same GEF-D1 activity (chapter 3.2), there might nevertheless be differences in their 
activation of downstream targets caused by differences in their localization and, thus, site of 
action. Therefore, Rac1 activity assays were performed with mitotic HEK293T cells transfected 
with plasmids encoding TRIO-WT-GFP, TRIO-SRNN-GFP, TIAM1-C1199 as positive control or 
an empty vector. While cells expressing the Rac1-GEF TIAM1-C1199 showed an almost 3-fold 
increase in Rac1 activity, the TRIO variants increased Rac1 activity to a lesser extend (Figure 
3.7a). However, TRIO-WT-GFP expression resulted in a 39 % increase in Rac1 activity, whereas 
the EB1 binding deficient TRIO-SRNN-GFP only lead to a small increase in Rac1 activity of about 
18 %. These results reveal the importance of EB1-TRIO binding for the downstream activation of 
Rac1. To prove these results, Rac1 assays were repeated with HCT116 cells that have been 
transfected with plasmids coding for GFP, TRIO-WT-GFP or TRIO-SRNN-GFP. While TRIO-WT-
GFP expression increased Rac1 activity by almost 2-fold, TRIO-SRNN-GFP led only to a Rac1 
activity increase of about 63 % (Figure 3.7b). Taken together, the results show that transient 
overexpression of both TRIO-SRNN-GFP and TRIO-WT-GFP causes increased Rac1 activity, but 
that this increase is higher for TRIO that still allows for EB1 binding. Thus, there seems to be a 
Rac1-activating pathway dependent on TRIO bound to EB1 at microtubule plus-tips.  
As the generation of HCT116 cell clones stably expressing EGFP, TRIO-WT-GFP or TRIO-SRNN-
GFP was finally successful, they were used for further Rac1 activity assays in order to test, 
whether an ongoing overexpression of TRIO-WT-GFP or TRIO-SRNN-GFP would have an 
additional impact on the cells Rac1 activity. Surprisingly, the EB1 binding deficient mutant of TRIO 
did not show any increase in Rac1 activity any more, while the EB1 binding wildtype of TRIO still 
exhibited approximately 2- to 3-fold activation of Rac1 dependent on the clone tested (Figure 3.8a-
b). Looking for an explanation for this difference between transiently and stably overexpressed 
TRIO-SRNN-GFP, consequences due to differences in the expression levels of individual cells 






Figure 3.7: EB1 binding of TRIO is needed for a stronger increase in Rac1 activity of mitotic cells. 
Representative Western blots of Rac1 activity assays from mitotic (a) HEK293T or (b) HCT116 cells 
showing a higher increase in Rac1 activity when expressing the wildtype of TRIO compared to the EB1 
binding deficient mutant of TRIO. HEK293T cells were transfected with TRIO-WT-GFP, TRIO-SRNN-GFP, 
TIAM-C1199 encoding plasmids or an empty vector and HCT116 cells were transfected with plasmids 
expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP. Both cell lines were treated with 2 µM DME 16 h 
before cell lysis. Rac1 activity assays were carried out as described above. Anti-Rac1, anti-GFP and anti-
TIAM1 antibodies were used for detection. Bar graphs show quantification of three independent Rac1 
activity assays (mean ± SEM, t-test).  
some cells have not been transfected, others express the protein in a low to moderate manner 
and still others show a huge overexpression, mainly due to a different copy number of the 
transfected plasmid. In contrast, the generated cell clones consist of a cell population with rather 
equal and moderate protein expression, although TRIO levels were still much higher than in GFP-
expressing control clones (Figure 3.3). As consequence, an increase in Rac1 activity in transiently 




overexpression of TRIO-SRNN-GFP, thereby hiding that a moderate overexpression is not 
sufficient to increase Rac1 activity. Consequently, this would also mean that the wildtype of TRIO 
leads to increased Rac1 activity not only when strongly but also when moderately overexpressed.  
Summed up, the abovementioned results clearly show that EB1 binding of TRIO is crucial for Rac1 
activation in mitotic cells by that supporting the hypothesis of a mitotic microtubule plus-tip, EB1, 
TRIO dependent pathway for Rac1 activation.  
 
Figure 3.8: EB1-TRIO binding is crucial for activating Rac1 in mitotic cells with moderate, long-term 
TRIO overexpression. (a) Representative Western blot of a Rac1 assay from mitotic HCT116 cell clones 
stably expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP demonstrating that EB1 binding of TRIO is 
needed for Rac1 activation in mitotic cells. HCT116 clones were generated and Rac1 activity assays were 
performed as described before. Cells were treated with 2 µM DME for 16 h. Rac1 was detected using an 
anti-Rac1 antibody and for detection of TRIO-WT-GFP, TRIO-SRNN-GFP as well as GFP an anti-GFP 
antibody was used. (b) Quantification of active Rac1 levels from three independent Rac1 activity assays 




3.4 TRIO overexpression increases cell migration to a higher extend when EB1 binding is 
disturbed 
Live cell imaging of HCT116 cell clones showed a clear localization of TRIO-WT-GFP and TRIO-
SRNN-GFP at lamellipodia-like structures of interphase cells with lamellipodia being even larger 
than in control cells (Figure 3.3), which confirms TRIOs function in lamellipodia formation and 
migration described by van Rijssel et al. (2012). This finding, together with the observation that 
TRIO-SRNN-GFP localization at lamellipodia was even more pronounced than TRIO-WT-GFP 
localization (Figure 3.3), is in contradiction with the lack of Rac1 activation seen for TRIO-SRNN-
GFP in the Rac1 activity assays described above. In order to prove the actual impact of 
overexpressed TRIO-WT-GFP and TRIO-SRNN-GFP on the migrative behavior of cells, HCT116 
cell clones were used for migration assays. In these assays, FCS-starved cells were seeded into 
cell culture inserts with 8 µm wide pores surrounded by FCS-containing medium. Cells that have 
been migrated through the pores within 24 h were detached and counted. As expected, 
overexpression of TRIO leads to an increase in cell migration (Figure 3.9a). TRIO-SRNN-GFP cell 
clones even showed a higher migration rate than TRIO-WT-GFP cell clones, thereby supporting 
the observation of a more pronounced localization of TRIO-SRNN-GFP at lamellipodia. This result 
again contradicts the Rac1 activity assay results, since Rac1 has been reported as important 
factor for lamellipodium-driven cell migration (Steffen et al., 2013). However, Rac1 activity assays 
have only been carried out for mitotic HCT116 cell clones so far and needed to be repeated with 
interphase cells in order to actually prove the role of both TRIO variants in interphase-related cell 
migration. This time, Rac1 activity assays revealed an increase in Rac1 activity for both TRIO-
WT-GFP and TRIO-SRNN-GFP overexpressing cells (Figure 3.9b-c). Although it was only a slight 
increase of 20 % to 55 % for TRIO-SRNN-GFP cell clones, it was a clear difference when 
compared to mitotic cells. Interphase TRIO-WT-GFP overexpressing cell clones showed a 
stronger increase in Rac1 activity of 58 % to 124 %, even if it was not as pronounced as for mitotic 
cells (77 % - 211 %; Figure 3.8a-b). This result suggests that EB1 binding of TRIO is more 
important for local Rac1 activation in mitotic cells than in interphase cells, where Rac1 also 








Figure 3.9: Overexpressed TRIO induces increased cell migration to a greater extend with EB1 
binding deficiency. (a) Transwell migration assays of HCT116 cell clones expressing GFP, TRIO-WT-GFP 
or TRIO-SRNN-GFP showing a stronger increase in cell migration for EB1 binding deficient TRIO. HCT116 
were generated as described previously. 200,000 FCS-starved cells were seeded into 8 µm pore-containing 
cell culture inserts surrounded by FCS-containing medium for 24 h. Migrated cells were detached and 
counted. Bar graphs show the proportion of migrated cells from four independent migration assays (mean 
± SEM, t-test). (b) Representative Western blot of a Rac1 assay from interphase HCT116 cell clones stably 
expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP showing that also EB1 binding deficient TRIO induces 
Rac1 activation in interphase cells. Rac1 activity assays were performed as described before. For detection 
of Rac1, an anti-Rac1 antibody was used and TRIO-WT-GFP, TRIO-SRNN-GFP as well as GFP were 
detected using an anti-GFP antibody. (c) Quantification of active Rac1 levels from three independent Rac1 







3.5 Overexpression of TRIO induces spindle axis misalignment, chromosome mis-
segregation and chromosomal instability in an EB1 binding dependent manner 
Abovementioned results already revealed that EB1 binding of TRIO is affected by microtubule 
dynamics and that it is crucial for mitotic Rac1 activation. However, it still needed to be figured out 
whether the pathway revealed so far was actually involved in the induction of spindle axis 
misalignment and increased amounts of cells exhibiting lagging chromosomes, which has been 
shown to result in chromosomal instability (Ertych et al., 2014). In order to investigate possible 
effects on spindle positioning, the spindle axis angles of the generated HCT116 cell clones 
expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP were determined. In fact, HCT116 cell 
clones expressing wildtype TRIO showed a significant increase of the spindle axis angle (between 
15.44° and 16.51°) when comparted to GFP (between 10.11° and 11.05°) or TRIO-SRNN-GFP 
(between 8.96° and 9.29°) expressing cells (Figure 3.10 a and b). This finding confirms the results 
from Schermuly (2019), showing transient expression of TRIO-WT-GFP, but not TRIO-SRNN-
GFP to induce spindle axis misalignment in HCT116 cells. Furthermore, this result is in line with 
the observed differences in mitotic Rac1 activation of these clones (Figure 3.8), thereby proving 
the importance of EB1 binding of TRIO and of the resulting increase in Rac1 activity for the 
induction of spindle axis misalignment.  
Previous work from our group showed that an increase in prometaphase spindle axis misalignment 
results in an increase in chromosome mis-segregation determined by a larger proportion of cells 
exhibiting lagging chromosomes (Ertych et al., 2014). In order to prove whether the increased 
spindle axis misalignment in HCT116 cell clones would also have an impact on chromosome 
segregation, the amount of cells with lagging chromosomes was determined. Therefore, HCT116 
cell clones underwent a double thymidine block in order to synchronize cells at G1/S phase. 8.5 h 
after the second release cells were fixed, as then a large part of cells was in anaphase. 
Microtubules, centromeres and DNA was stained with antibodies against α-tubulin, CENP-C and 
Hoechst, respectively. Only chromosomes positive for CENP-C and Hoechst that were located 
clearly separated in between two pole-oriented chromosome masses were counted as lagging 
chromosomes. Again, only HCT116 cell clones expressing wildtype TRIO showed an effect by 
increasing the amount of cells with lagging chromosomes to up to 10%, while GFP expressing 
clones had at most 3.67% and TRIO-SRNN-GFP clones 4.33% of lagging chromosomes (Figure 
3.10 c and d). This effect has also been seen in HCT116 cells transiently expressing TRIO-WT-








Figure 3.10: TRIO overexpression leads to an EB1 binding dependent increase in spindle axis 
misalignment, in the amount of lagging chromosomes and in karyotype variability. (a) Representative 
immunofluorescence images of prometaphase cells showing only an increase in spindle axis angle for 
wildtype TRIO but not EB1 binding deficient TRIO expressing HCT116 cell clones. HCT116 cell clones 
expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP were generated as described previously, seeded 
onto fibronectin-coated glass coverslips and stained for α-tubulin (microtubules; green), γ-tubulin 
(centrosomes; red) and Hoechst33342 (DNA; blue). Scale bar 5 µm. (b) Box and whisker plots of spindle 
axis angle measurements of cells depicted in (a) showing median, quartile and range of three independent 
experiments (n = 20 cells per experiment, t-test). (c) Representative immunofluorescence images of 
anaphase HCT116 cells with (normal) and without (abnormal) the occurrence of a lagging chromosome 
(LC). Cells were synchronized by a double thymidine block and fixed after release for 8.5 h to obtain an 
increased amount of anaphase cells. Cells were stained for α-tubulin, CENP-C (centromeres; red) and 
Hoechst33342. Scale bar 5 µm. (d) The amount of lagging chromosomes is increased in HCT116 cell clones 
expressing wildtype TRIO, but not EB1 binding deficient TRIO. HCT116 cell clones were synchronized and 
stained as described in (c). For determination of lagging chromosomes in anaphase cells, only 
chromosomes positive for Hoechst and CENP-C that were located clearly separated in between two pole-
oriented chromosome masses were counted. Bar graphs show the proportion of cells with lagging 
chromosomes from three independent experiments (n = 100 analyzed anaphase cells per experiment, mean 
± SEM, t-test). (e) Karyotype analysis of HCT116 cell clones showing chromosomal instability for TRIO-WT-
GFP, but not for TRIO-SRNN-GFP expressing cell clones. HCT116 cell clones have been cultivated for 
approximately 30 generations after single cell isolation and used for preparing metaphase chromosome 
spreads. Bar graphs show the proportion of cells with a chromosome number deviating from the modal 
number (n = 50 metaphase spreads for each clone were counted). 
 
increased rate of chromosome mis-segregation (Thompson et al., 2010), these results claimed 
the wildtype TRIO expressing HCT116 cell clones to be chromosomally unstable. To prove this, 
chromosomes of metaphase spreads of HCT116 cell clones, which have been cultivated for about 
30 generations after single cell isolation, were counted for karyotype analysis. In fact, in HCT116 
cell clones expressing TRIO-WT-GFP 32 % to up to 46 % of cells exhibited a chromosome number 
that deviated from the modal number (Figure 3.10 e). In contrast, GFP expressing clones showed 
with 6 % to 8 % and TRIO-SRNN-GFP expressing clones with 10 % to 12 % quite a stable 
karyotype. These findings further confirmed the role of the hypothesized microtubule plus-tip, EB1, 








3.6 Chromosomal instability induced by overexpression of TRIO is rescuable by inhibition 
of TRIO GEF-D1, Rac1 or Arp2/3 
So far it could be shown that overexpression of wildtype TRIO increases mitotic Rac1 activity in 
an EB1 binding dependent manner and triggers chromosomal instability via the induction of 
spindle axis misalignment. Further work should show whether Rac1 is the only target of TRIO 
responsible for the generation of chromosomal instability. As TRIO has not only GEF function for 
Rac1, but also for RhoG and RhoA, which activity changes due to TRIO overexpression had not 
been analyzed, it was important to clarify the components downstream of TRIO in the suggested 
pathway. This also included proof of the hypothesized link between a TRIO-induced increased 
mitotic Rac1 activity and the activation of the actin cytoskeleton regulator Arp2/3 within this 
pathway, as spindle positioning has been shown to be regulated by mitotic Arp2/3 dependent 
subcortical actin clouds (Mitsushima et al., 2010; Kwon et al., 2015). For this purpose, generated 
HCT116 cell clones expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP were treated with low 
dose Taxol, low dose Nocodazole, the TRIO inhibitor ITX3, the Rac1 inhibitor NSC23766 or the 
Arp2/3 inhibitor CK666, followed by analyzing their effect on chromosome mis-segregation by 
counting lagging chromosomes. Additionally, single cell subclones were isolated from HCT116 
cell clones and treated with the abovementioned drugs for further 30 generations, followed by 
preparing and counting metaphase chromosome spreads for karyotype analysis. Low dose Taxol 
treatment was initially performed as negative control, since HCT116 cell clones have been shown 
to exhibit normal microtubule plus-end assembly rates that were hardy affected by subnanomolar 
concentrations of Taxol (Ertych et al., 2014). Therefore, an interference within this pathway 
upstream of TRIO was thought to have no impact on the downstream effect of a TRIO 
overexpression. Low dose Nocodazole was used to induce increased microtubule plus-end 
assembly rates, thereby generating a phenotype given in chromosomally unstable cells (Ertych et 
al., 2014). Initially, the idea was that generating an environment with increased microtubule plus-
end assembly rates and overexpressed TRIO in chromosomally stable HCT116 cells might cause 
an even greater increase in chromosomal instability than TRIO overexpression alone. However, 
as low dose Nocodazole treatment had not shown any impact on EB1-TRIO binding (Figure 3.4), 
it was uncertain what effect it would have on chromosomal instability of the analyzed clones. The 
inhibitor ITX3 only inhibits the TRIO GEF-D1 domain, but not the GEF-D2 domain (Bouquier et 
al., 2009). Using this inhibitor allowed to unravel possible effects of TRIO GEF-D2-activated RhoA 
on chromosomal instability, as these effects would continue in ITX3 treated clones. For Rac1 
inhibition, the widely used Rac1 inhibitor NSC23766 was used, thereby proving whether Rac1 was 




Arp2/3 inhibitor CK666 should help to figure out, whether the F-actin polymerization promoter 
Arp2/3 was the actual Rac1 target involved in the described chromosomal instability-inducing 
pathway. In order to investigate possible effects of the abovementioned treatments on 
chromosomal instability, chromosome mis-segregation rates were determined by counting 
anaphase lagging chromosomes of HCT116 cell clones expressing GFP, TRIO-WT-GFP or TRIO-
SRNN-GFP. The results confirmed the finding illustrated in  d, showing that only overexpression 
of wildtype TRIO increased the amount of cells with lagging chromosomes (Figure 3.11a). This 
demonstrates once more that EB1 binding is required for TRIO to induce chromosome mis-
segregation. Treatment with the abovementioned drugs did not have an impact on the generation 
of lagging chromosomes in GFP or TRIO-SRNN-GFP expressing clones (Figure 3.11b). Only 
Nocodazole treatment of GFP expressing cells induced a slight increase that has already been 
observed in previous studies from our group (Berger, 2016; Ertych et al., 2014; Schermuly, 2019). 
However, Nocodazole also did not affect the generation of lagging chromosomes in TRIO-WT-
GFP and TRIO-SRNN-GFP expressing clones. This result further indicates that the microtubule-
affecting impact of Nocodazole might be somehow restricted by TRIO overexpression in HCT116 
cells, thus, supporting the finding from EB1-TRIO binding studies (Figure 3.4). Moreover, it could 
also play a role that TRIO overexpression alone already results in a higher amount of TRIO 
interacting with EB1. This can be explained by assuming EB1-TRIO binding follows a saturation 
curve with other EB1 binding proteins acting as competitors as described by Michaelis-Menten 
kinetics (Michaelis & Menten, 1913). Consequently, a high abundancy of TRIO in the cell would 
already mean a higher amount of wildtype TRIO bound to EB1 with or without a Nocodazole-
induced increase in microtubule plus-end assembly rates. Surprisingly, low dose Taxol treatment 
of TRIO-WT-GFP clones showed a rescue of the increased generation of lagging chromosomes 
(Figure 3.11b). While TRIO overexpression was shown to have no impact on microtubule plus-
end assembly rates that could have been an explanation for this Taxol-induced rescue (Figure 
3.3c), the disturbed EB1-TRIO binding due to Taxol treatment that have been detected in GFP 
pull down assays might rather be the cause (Figure 3.2a and b). Following Michaelis-Menten 
kinetics once more, the increased amount of TRIO bound to EB1 as consequence of its high 
abundancy due to being overexpressed might be decreased again by a Taxol-induced disturbance 
of the EB1-TRIO interaction. Consequently, the pathway downstream of EB1-TRIO interaction 
would be less activated resulting in the observed rescue of lagging chromosome formation. Having 
a look at the result of the other treatments in TRIO-WT-GFP expressing clones, inhibition of TRIO 









Figure 3.11: The increase in lagging chromosome formation in TRIO overexpressing HCT116 cells 
can be rescued by low dose Taxol as well as inhibition of TRIO GEF-D1, Rac1 or Arp2/3. (a) HCT116 
cell clones expressing wildtype TRIO, but not EB1 binding deficient TRIO show an increase in the generation 
of lagging chromosomes. HCT116 cell clones expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP were 
generated as described above and synchronized by a double thymidine block with fixation 8.5 h after release 
(DMSO control in b). Cells were stained for α-tubulin, CENP-C and Hoechst33342. Lagging chromosomes 
were determined as previously described. Bar graphs show the proportion of cells with lagging 
chromosomes from three independent experiments (n = 100 analyzed anaphase cells per experiment, mean 
± SEM, t-test). (b) Increased lagging chromosome generation induced by wildtype TRIO overexpression 
can be rescued by low dose Taxol or inhibition of TRIO GEF-D1, Rac1 or Arp2/3. HCT116 cell clones were 
synchronized as described above and treated with DMSO (control), 0.5 nM Nocodazole, 0.5 nM Taxol, 
30 µM ITX3, 40 µM NSC23766 or 20 µM CK666 for 8 h. Cells were stained and examined for lagging 
chromosomes as described above. Bar graphs show the proportion of cells with lagging chromosomes from 
three independent experiments (n = 100 analyzed anaphase cells per experiment, mean ± SEM, t-test). (c) 
Representative immunofluorescence images of anaphase HCT116 cell clones from (a) showing the 
occurrence of lagging chromosomes (LC), DNA fragments (DF) or anaphase bridges (AB). Scale bar 5 µm. 
(Figure 3.11b). This confirms the introduced pathway, as it excludes other TRIO targets than Rac1 
from being involved in the induction of chromosomal instability and proves Arp2/3 as missing link 
between the upstream pathway and the F-actin cytoskeleton.  
However, during counting lagging chromosomes other structural abnormalities than lagging 
chromosomes were observed in TRIO expressing clones. These especially included anaphase 
bridges and DNA fragments located separately from the two-pole oriented chromosome masses 
of anaphase cells that had no CENP-C (centromere) signal (Figure 3.11c). While an increase in 
the amount of anaphase bridges was strong in TRIO-WT-GFP and only slight in TRIO-SRNN-GFP 
expressing clones (Figure 3.12a), the increase in the number of DNA fragments was similar for 
TRIO-WT-GFP and TRIO-SRNN-GFP clones (Figure 3.12c). Interestingly, anaphase bridges in 
TRIO-WT-GFP clones could be rescued to the level of untreated TRIO-SRNN-GFP clones by 
treatment with low dose Taxol or the inhibitors against TRIO, Rac1 and Arp2/3 (Figure 3.12b). The 
rescue was even stronger for TRIO-WT-GFP clone A2 than for clone A6 with clone A2 showing 
the lesser TRIO overexpression (Figure 3.3a). However, there was no further decrease detectable 
for TRIO-SRNN-GFP clones after inhibitor treatment, resulting in a similar slight increase of 
anaphase bridges in both TRIO-WT-GFP and TRIO-SRNN-GFP clones when compared to control 
GFP clones. This result suggests that the occurrence of anaphase bridges can only partially be 
caused by the given pathway. Instead, EB1 binding independent TRIO targets seem to play a role 
in the induction of anaphase bridge formation. When looking at the amount of DNA fragments, 
there was also a slight rescue for TRIO-WT-GFP clones after low dose Taxol treatment or 
inhibition of TRIO, Rac1 or Arp2/3 (Figure 3.12d). Again, the rescue was more pronounced in the 
TRIO-WT-GFP clone A2 expressing less TRIO than clone A6. In contrast, TRIO-SRNN-GFP 
clones did not show a significant reduction of the amount of DNA fragments. These results confirm 







Figure 3.12: TRIO overexpression causes an increase in anaphase bridges and DNA fragments 
that is only partially rescuable by low dose Taxol or inhibition of TRIO GEF-D1, Rac1 or Arp2/3. (a-
b) Anaphase bridge formation is increased in HCT116 TRIO-WT-GFP clones in a strong, but partially 
rescuable manner, whereas the increase is slight and not rescuable for TRIO-SRNN-GFP clones. Bar 
graphs show the amount of cells from Figure 3.11a-b with anaphase bridges from three independent 
experiments (n = 100 analyzed anaphase cells per experiment, mean ± SEM, t-test). (c-d) The occurrence 
of DNA fragments is similarly increased in both HCT116 TRIO-WT-GFP and TRIO-SRNN-GFP clones, 
with being rescuable in part in TRIO-WT-GFP clones. DNA fragments were defined as Hoechst positive 
fragments located separately from the two-pole oriented chromosome masses of anaphase cells without 
CENP-C signal. Bar graphs show the proportion of cells from Figure 3.11a-b with anaphase DNA 
fragments from three independent experiments (n = 100 analyzed anaphase cells per experiment, mean ± 
SEM, t-test). 
TRIO GEF-D1 activity that is involved in the generation of the observed structural abnormalities. 
Further research would need to be done to figure out whether the other TRIO target is GEF-D2 
activated RhoA or whether it is another TRIO interaction partner independent of its GEF function. 
In order to finally prove the effect of the abovementioned treatments on karyotype variability, single 
cell subclones were isolated from HCT116 cell clones expressing GFP, TRIO-WT-GFP or TRIO-
SRNN-GFP and treated with low dose Taxol, low dose Nocodazole, the TRIO inhibitor ITX3, the 
Rac1 inhibitor NSC23766 or the Arp2/3 inhibitor CK666 for further 30 generations. Counting of 
metaphase chromosome spreads affirmed the results illustrated in  e, as they also showed a 
strong increase in cells with a varying chromosome number only for wildtype TRIO expressing 
subclones (Figure 3.13a). Treatments with the abovementioned drugs did not affect the karyotype 
stability of GFP or TRIO-SRNN-GFP expressing subclones, except from low dose Nocodazole 
treatment that led to an increase of cells with a chromosome number deviating from modal to up 
to 26.7 % (Figure 3.13b). This chromosomal instability inducing effect of subnanomolar 
concentrations of Nocodazole has also been described before from our group (Ertych et al., 2014). 
Being in line with the abovementioned lagging chromosome counts, there was no further increase 
in karyotype variability in Nocodazole treated, but a rescue in Taxol treated wildtype TRIO 
expressing subclones (Figure 3.13b). This supports the suggestion, that cells with proper 
microtubule dynamics but TRIO overexpression already exhibit an increased amount of EB1-
bound TRIO when compared to control cells, thereby also being prone to Taxol-induced disruption 
of the EB1-TRIO interaction. When looking at the result of the other treatments in TRIO- WT-GFP 
expressing clones, inhibition of Rac1 and Arp2/3 showed a strong rescue of karyotype variability, 
while inhibition of TRIO GEF-D1 by ITX3 caused a mild rescue (Figure 3.13b). Taken as a whole, 
this again supports the pathway introduced at the beginning of the study being composed of 









Figure 3.13: TRIO overexpression induced karyotype variability in HCT116 cells is rescuable by low 
dose Taxol or by inhibition of TRIO GEF-D1, Rac1 or Arp2/3. (a) HCT116 cell clones expressing wildtype 
TRIO, but not EB1 binding deficient TRIO exhibit an increase in karyotype variability. HCT116 cell clones 
expressing GFP, TRIO-WT-GFP or TRIO-SRNN-GFP were generated as previously described and used 
for further isolation of single cell subclones that have been cultivated for about 30 generations (DMSO 
control in b). Metaphase chromosome spreads were prepared for karyotype analysis. Bar graphs show the 
proportion of cells with a chromosome number deviating from the modal number (n = 50 metaphase spreads 
for three subclones per originated clone were counted, mean ± SEM, t-test). (b) Karyotype variability 
induced by wildtype TRIO overexpression is rescuable by low dose Taxol as well as inhibition of TRIO GEF-
D1, Rac1 or Arp2/3. Abovementioned HCT116 cell clones were used for further isolation of single cell 
subclones that have been cultivated for approximately 30 generations in the presence of DMSO (control), 
0.5 nM Nocodazole, 0.5 nM Taxol, 30 µM ITX3, 40 µM NSC23766 or 20 µM CK666 and were used for the 
preparation of metaphase chromosome spreads. Bar graphs show the proportion of cells with a 
chromosome number deviating from the modal number (n = 50 metaphase spreads for three subclones per 
originated clone were counted, mean ± SEM, t-test). (c) Representative light microscopy images of 
metaphase spreads from HCT116 cell clones from (a) with or without the occurrence of a dicentric 
chromosome or a double minute. Scale bar 10 µm. 
 
Rac1 activation, which in turn activates the F-actin polymerization-promoting Arp2/3 complex. 
However, the reason why the rescue of karyotype variability after treatment with the TRIO GEF-
D1 inhibitor ITX3 was not as pronounced as after inhibition of Rac1 or Arp2/3 remained unknown 
for now.  
Parallel to the finding of structural abnormalities during lagging chromosome counts, metaphase 
chromosome spreads of the analyzed subclones revealed in addition to whole chromosomal 
instability (W-CIN) also signs of structural chromosomal instability (S-CIN), from which many can 
be also analyzed via Giemsa chromosome staining (Abe et al., 2015; Lepage et al., 2019; Ryu et 
al., 2016). This was demonstrated by the occurrence of dicentric chromosomes and acentric 
chromosomes, with the latter one appearing in pairs as so-called double minutes (Bao et al., 2016) 
(Figure 3.13c). Dicentric chromosomes are genetically unstable structures, as when microtubules 
bound to the two centromeres of one sister chromatid pull to opposite poles, anaphase bridges 
are formed, followed by DNA breakage (Lopez et al., 2015). This process is part of so called 
breakage/fusion/bridge (B/F/B) cycles and is known to produce rearrangements, such as the 
observed double minutes that are probably visible as DNA fragments during anaphase as 
illustrated in Figure 3.11c (Lo et al., 2002). While the induction of dicentric chromosome and 
double minute formation was strong in wildtype TRIO expressing subclones, it was slight to 
mediate in subclones expressing EB1 binding deficient TRIO (Figure 3.14a and c). Similar to the 
results from lagging chromosome counts, the formation of dicentric chromosomes could only 








Figure 3.14: Overexpressed TRIO induces the formation of dicentric chromosomes and double 
minutes that are only partially or not rescuable by low dose Taxol or inhibition of Rac1 or Arp2/3. (a-
b) Dicentric chromosome formation is strongly induced, but partially rescuable in HCT116 TRIO-WT-GFP 
subclones and slightly induced in TRIO-SRNN-GFP subclones. Bar graphs show the proportion of cells from 
Figure 3.13a-Figure 3.11b with dicentric chromosomes (n = 50 metaphase spreads for three subclones per 
originated clone were counted, mean ± SEM, t-test). (c-d) The generation of double minutes is strongly 
induced by wildtype TRIO and slightly induced by EB1 binding deficient TRIO expression in HCT116 cell 
clones and cannot be rescued by the given treatments. Bar graphs show the amount of cells from Figure 
3.13a-b with double minutes (n = 50 metaphase spreads for three subclones per originated clone were 
counted, mean ± SEM, t-test). 
 
against Rac1 or Arp2/3, but there was no further decrease detected for TRIO-SRNN-GFP 
subclones (Figure 3.14b). Surprisingly, treatment with the TRIO GEF-D1 inhibitor ITX3 even 
caused a significant increase in dicentric chromosome formation, but only in wildtype TRIO 
expressing subclones. This probably explains the only mild rescue of karyotype variability seen 
for ITX3 in TRIO-WT-GFP subclones, as a dicentric chromosome is counted as one chromosome 
in metaphase chromosome spreads, thereby resulting in a chromosome number that is reduced 
by one. Due to the finding that ITX3 shows this effect only in wildtype TRIO expressing subclones, 
it might require EB1 binding of TRIO. However, the actual mechanism by which ITX3 enhances 
the generation of dicentric chromosomes in these cells remained unknown. When looking at 
double minute formation, TRIO-WT-GFP subclones showed a high and TRIO-SRNN-GFP 
subclones a mediate inductive effect (Figure 3.14d). This induction could slightly be rescued in 
wildtype TRIO expressing subclones by low dose Taxol treatment and to a very mild, but 
statistically not significant extend by inhibition of TRIO, Rac1 or Arp2/3. Again, the mediate 
induction observed for EB1 binding deficient TRIO expressing subclones was not rescuable by 
the given treatments.  
Taken together, these results support the suggestion established on the base of anaphase bridge 
and DNA fragment counts, that proposes the existence of a S-CIN-inducing pathway independent 
of the binding of TRIO to EB1 and its GEF-D1 activity. In this context, further research would be 








3.7 Increased mitotic Rac1 activity induces spindle axis misalignment, chromosome mis-
segregation and chromosomal instability 
The results described above already indicate the existence of a mitotic microtubule plus-tip, EB1, 
TRIO, Rac1, Arp2/3 dependent pathway for the induction of chromosomal instability. However, 
finding out Rac1 as target of TRIO within this pathway has only been shown by inhibition of TRIO 
GEF-D1 and Rac1. In order to further confirm Rac1 as component of the pathway, the effect of an 
increased activation of the given pathway downstream of TRIO on chromosomal instability was 
investigated by analyzing mitotic cells with a high Rac1 activity. So far, Rac1 activity was described 
to be downregulated upon entry into mitosis and only present at cell poles, but excluded at the 
cleavage furrow during cytokinesis (Yoshizaki et al., 2003). The expression of constitutively active 
Rac1 was shown to inhibit cytokinesis and thereby induced the generation of multinucleated cells 
(Yoshizaki et al., 2004). However, the effect of a high Rac1 activity during earlier mitotic phases 
has not been investigated, yet. In order to do so, wildtype MCF10A cells and genome-edited 
MCF10A cells, in which one RAC1 allele encodes the constitutively active Q61L mutation, were 
examined for possible differences in prometaphase spindle axis alignment and chromosome 
segregation defects in anaphase. Microtubule plus-end assembly rates were determined 
beforehand and revealed no difference between MCF10A cells expressing wildtype or 
constitutively active Rac1 (Rac1-CA), thereby excluding a possible impact of constitutively active 
Rac1 on microtubule dynamics acting upstream in the introduced pathway (Figure 3.15a). In order 
to investigate whether a high mitotic Rac1 activity, that could arise by the suggested microtubule 
plus-tip, EB1, TRIO dependent pathway, had an actual impact on spindle positioning, the spindle 
axis angle was determined in MCF10A cells with or without expressing constitutively active Rac1. 
In fact, there was a slight, but significant increase in the spindle axis angle of MCF10A cells 
expressing constitutively active Rac1 (13.88°) when compared to wildtype cells (8.25°; Figure 
3.15b). However, this increase was not as pronounced as known for chromosomally unstable 
cells, that usually showed a spindle axis angle of about 20° or higher (Ertych et al., 2014; Berger, 
2016; Schermuly, 2019). This smaller increase determined for MCF10A Rac1-CA cells might be 
explained by the additionally observed greater diameter and, thus, centrosome to centrosome 
distance of these cells in prometaphase when compared to the wildtype cells (Figure 3.15c). Due 
to taking the distance between centrosomes into account for calculating the spindle axis angle, a 
large centrosome to centrosome distance resulted in a smaller spindle axis angle (Figure 3.15e 






Figure 3.15: Expression of constitutively active Rac1 leads to a slight increase in spindle axis 
misalignment and chromosome mis-segregation. (a) Mitotic microtubule plus-end assembly rates are 
not affected by the expression of constitutively active Rac1. MCF10A wildtype and Rac1-CA cells were 
transfected with an EB3-GFP expressing plasmid and treated with 2 µM DME 2 h before measurements. 
Scatter dot plots show average microtubule growth rates from 30 cells from three independent experiments 
(mean ± SEM, t-test). (b) Spindle axis alignment is slightly increased in MCF10A Rac1-CA cells. MCF10A 
wildtype and Rac1-CA cells were seeded onto fibronectin-coated glass coverslips and stained for α-tubulin 
(microtubules), γ-tubulin (centrosomes) and Hoechst33342 (DNA). The box and whisker plots show median, 
quartile and range of three independent spindle axis angle measurements (n = 20 cells per experiment, t-
test). Further analyzed data from (b) show that MCF10A Rac1-CA cells exhibit a greater (c) centrosome to 
centrosome distance and (d) height in between centrosomes than wildtype cells and the (e-f) correlation of 
the distance between centrosomes and the spindle axis angle. (g) The amount of lagging chromosomes is 
increased in MCF10A cells with constitutively active Rac1 expression. MCF10A wildtype and Rac1-CA cells 
were synchronized by a double thymidine block and fixed 11 h after release to obtain an increased 
proportion of anaphase cells. Cells were stained for α-tubulin (microtubules), CENP-C (centromeres) and 
Hoechst33342 (DNA). Chromosomes positive for Hoechst and CENP-C and located clearly separated from 
two pole-oriented chromosome masses in anaphase cells were counted as lagging chromosomes. Bar 
graphs show the proportion of cells with lagging chromosomes from three independent experiments (n = 





centrosome distance of about 6-7 µm (Schermuly, 2019). When taking such a centrosome to 
centrosome distance into account but using the height in between centrosomes observed for 
MCF10A wildtype and Rac1-CA cells for calculation (Figure 3.15d), MCF10A wildtype would 
exhibit a spindle axis angle of about 10°, whereas MCF10A Rac1-CA cells had an angle of about 
20°. This would reflect the difference between chromosomally stable and unstable cells reported 
 
  
Figure 3.16: Expression of constitutively active Rac1 not only induces the generation of 
multinucleated cells, but also chromosomal instability. (a-b) Karyotype analysis of MCF10A cell clones 
demonstrating chromosomal instability for constitutively active Rac1 expressing cells. Single cell clones of 
MCF10A wildtype and Rac1-CA cells were isolated and cultivated for about 30 generations. Chromosomes 
of metaphase spreads were counted. Bar graphs in (a) show the proportion of cells with certain chromosome 
numbers between 45 and 48 and in (b) illustrate the proportion of cells with a chromosome number that is 
deviating from the modal number of 47 (n = 50 metaphase spreads for each clone). (c) Expression of 
constitutively active Rac1 induces polyploidy. Metaphase chromosome spreads of MCF10A wildtype and 





previously in our group (Schermuly, 2019). Consequently, the used calculation for the spindle axis 
angle might usually work out but is limited to cells with about the same centrosome to centrosome 
distance within a specific range. In order to prove whether the increased spindle axis misalignment 
in MCF10A Rac1-CA cells has an impact on chromosome segregation, the amount of cells with 
lagging chromosomes was determined. Again, the difference between MCF10A wildtype and 
Rac1-CA cells was not as pronounced, but significant. While MCF10A wildtype cells only exhibited 
4 % lagging chromosomes, this proportion was increased to 6 % for MCF10A Rac1-CA cells 
(Figure 3.15g). As final proof, chromosomes of metaphase spreads were counted for karyotype 
analysis. Therefore, single cell clones were isolated from MCF10A wildtype and Rac1-CA cells 
and cultivated for about 30 generations. In fact, MCF10A wildtype cell clones showed a stable 
karyotype with only 4-6 % cells having a chromosome number deviating from the modal number 
of 47, whereas this was 20-30 % for the MCF10A Rac1-CA cell clones (Figure 3.16a and b). 
Additionally, the occurrence of polyploidy was observed, but only for MCF10A Rac1-CA cells 
(Figure 3.16c). Polyploid cells were not taken into account for the abovementioned chromosome 
counting of metaphase spreads. The finding of polyploidy in MCF10A Rac1-CA cells confirms the 
previously described generation of multinucleated cells due to inhibition of cytokinesis by 
expression of constitutively active Rac1 (Yoshizaki et al., 2004). 
Summed up, a high mitotic Rac1 activity was shown to act downstream of microtubule dynamics, 
where it induces increased spindle axis misalignment, chromosome mis-segregation and 
chromosome instability. In addition, these results further confirmed Rac1 as the sought-after TRIO 
target that links microtubule plus-tip bound EB1 with the induction of chromosome instability. 
 
3.8 The mitotic F-actin cytoskeleton is regulated by a pathway containing microtubule plus-
tip bound EB1, TRIO, Rac1 and Arp2/3 
So far, this study has contributed important evidence for the introduced pathway and has revealed 
missing links within this pathway. But there was still a missing link between the by now most 
downstream component Arp2/3 and spindle axis misalignment. In this context, Kwon et al. (2015) 
found out that a mitotic Arp2/3 dependent actin cloud structure is involved in spindle positioning 
by forwarding pulling forces generated from retraction fibers to centrosomes via binding to astral 
microtubules. Whether these subcortical actin clouds were also regulated by the analyzed 
pathway should be figured out by looking for changes in the cloud structure after inhibition of 




transfected with plasmids expressing UtrophinCH-GFP for the detection of F-actin and H2B-RFP 
for DNA visualization. During live cell imaging, metaphase cells were chosen for the analysis of 
actin clouds, as described elsewhere (Kwon et al., 2015; Mitsushima et al., 2010). Differences in 
the actin cytoskeleton were determined by calculating the fluorescence intensity of the F-actin 
signal within a metaphase cell. Therefore, the pixel intensity derived from a generated line scan 
of a metaphase cell was used (Figure 3.17a). To differentiate between the signal intensity of the  
 
 
Figure 3.17: Mitotic actin cloud structures are regulated by a fraction of Arp2/3  that does not seem 
to be involved in the EB1, TRIO, Rac1, Arp2/3 dependent pathway. (a) Mitotic SW620 cells exhibit 
subcortical actin clouds that are decreased after Arp2/3 inhibitor treatment. SW620 cells were transfected 
with plasmids encoding UtrophinCH-GFP (F-actin, green) and H2B-RFP (DNA, red) and treated with DMSO 
(control) or 20 µM of the Arp2/3 inhibitor CK666 for 16 h. Cell were analyzed by live cell microscopy and 
line scans of pixel intensity values from metaphase cells were used to calculate the actin cloud and actin 
cortex signal intensity. Scale bar 5 µm. Actin cloud signal intensities in (b) SW620 and (c) HT29 cells are 
decreased after Arp2/3 inhibition, but they show only a slight (SW620) or no (HT29) reduction after low dose 
Taxol or Rac1 inhibitor treatment. SW620 and HT29 cells were transfected as described in (a) and treated 
with DMSO, 0.2-0.5 nM Taxol, 40 µM NSC23766 or 20 µM CK666 16 h before live cell microscopy. Box and 
whisker plots showing the median, quartile and range of the mean actin cloud signal intensities (normalized 
to the corresponding actin cortex signal intensity) calculated from line scans of three independent 




actin cortex and the clouds, pixel intensities representing these regions were used for the 
calculation. As inhibition of Arp2/3 was described to only inhibit the formation of the mitotic actin 
cloud structure, but not the actin cortex (Mitsushima et al., 2010), and in order to take the effect of 
different expression levels into account, the actin cortex intensity was used to normalize actin 
cloud intensity values. This was done under the assumption that the level of UtrophinCH-GFP 
expression did not affect its distribution in the actin structures of the cell, meaning the ratio 
between UtophinCH-GFP in the actin cortex and the actin clouds would stay the same in cells with 
different expression levels. When comparing the actin cloud signal intensity of metaphase SW620 
cells with or without treatment with the Arp2/3 inhibitor CK666, there was a clear reduction 
detectable for inhibitor treated cells, that has also been shown by Mitsushima et al. (2010) (Figure 
3.17a-b). This decrease in actin cloud signal intensity was also shown for Arp2/3 inhibitor treated 
HT29 cells (Figure 3.17c). However, when interfering with the introduced pathway by low dose 
Taxol-induced disruption of EB1 and TRIO or by inhibition of Rac1 using the inhibitor NSC23766, 
there was only a slight reduction of actin cloud signal intensity detected for SW620 cells (Figure 
3.17b) and no reduction for HT29 cells (Figure 3.17c). These results suggest that the fraction of 
Arp2/3 involved in actin cloud regulation is not constituting the fraction of Arp2/3 that is part of the 
EB1, TRIO, Rac1 dependent pathway. At this point it should be noted that the performed 
procedure for the determination of actin cloud intensity was done under the assumption that the 
given treatments did not affect the actin cortex but only the actin clouds, as described for CK666-
mediated Arp2/3 inhibition by Mitsushima et al. (2010). However, Bovellan et al. (2014) showed 
that Arp2/3 was also important for the mitotic actin cortex (Bovellan et al., 2014), which in turn was 
reported to be involved in spindle positioning (Kunda & Baum, 2009). In order to prove an 
involvement of the actin cortex in the introduced pathway, actin cortex signal intensities were 
determined in addition to actin cloud intensities using fixed cells stained with fluorescently-labeled 
phalloidin for F-actin visualization. This procedure allowed for a uniform F-actin staining, thereby 
avoiding the need for normalization as given in case of different UtrophinCH-GFP expression 
levels. In order to figure out, whether the actin cytoskeleton structure in chromosomally stable and 
unstable cells is affected differently after interfering with the introduced pathway, HCT116 
(chromosomally stable) as well as SW620 and SW480 (chromosomally unstable) cells were 
analyzed. To manipulate the pathway at different parts, the cells were treated with low dose Taxol, 
the TRIO inhibitor ITX3, the Rac1 inhibitor NSC23766 or the Arp2/3 inhibitor CK666. Interestingly, 









Figure 3.18: The mitotic F-actin cytoskeleton is regulated by a microtubule dynamic dependent 
pathway in chromosomally unstable cells. (a) Representative immunofluorescence images of the F-actin 
cytoskeleton of HCT116 (non-CIN), SW620 (CIN) and SW480 (CIN) cells with or without low dose Taxol 
treatment showing a Taxol-induced decrease in the actin signal intensity only in CIN cells. Cells were treated 
with DMSO (control) or 0.2-0.5 nM Taxol for 16 h and stained for F-actin (AlexaFluorTM 594 Phalloidin; red) 
and DNA (Hoechst33342; blue). Scale bar 5 µm. Quantification of actin cortex and cloud signal intensities 
showing a decrease in (b) HCT116, (c) SW620 and (d) SW480 cells after inhibition of TRIO, Rac1 or Arp2/3, 
but only a decrease for SW620 and SW480 cells after low dose Taxol treatment. Cells were treated with 
DMSO, 0.2-0.5 nM Taxol, 15 µM ITX3, 40 µM NSC23766 or 20 µM CK666 for 16 h and stained as described 
in (a). Box and whisker plots showing the median, quartile and range of the mean actin cortex and cloud 
intensity calculated from metaphase line scans of three independent experiments (n = 20-36 cells per 
experiment, t-test).  
 
actin cortex as well as the actin cloud signal intensity after low dose Taxol treatment while 
chromosomally stable HCT116 cells stayed unaffected (Figure 3.18a-d). Consequently, an 
increased microtubule plus-end assembly rate in chromosomally unstable cells seems to induce 
increased cytoskeletal F-actin polymerization that is rescuable by restoring proper microtubule 
plus-end assembly rates using low dose Taxol. In contrast, the actin cytoskeleton of 
chromosomally stable cells is not affected as they exhibit normal microtubule plus-end assembly 
rates that do hardly decrease after treatment with low dose Taxol (Ertych et al., 2014). These 
results indicate that microtubule dynamics are involved in the regulation of mitotic actin 
cytoskeleton structures, that in turn play an important role for spindle axis alignment. Having a 
look at the effect of the other inhibitor treatments, it was striking that both chromosomally unstable 
(SW620 and SW480) and chromosomally stable (HCT116) cells showed a clear decrease in actin 
cortex and cloud signal intensities (Figure 3.18c-d). However, it is of note that the decrease was 
more pronounced in SW620 (up to 29% decrease in cortex and 31% in cloud signal intensity) and 
SW480 (up to 28% decrease in cortex and 30% in cloud signal intensity) than in HCT116 cells (up 
to 16% decrease in cortex signal and 20% in cloud signal intensity). This again suggests that the 
introduced pathway might be stronger activated in chromosomally unstable cells as an inhibition 
of pathway components has a stronger impact on the actin cytoskeleton downstream of the 
pathway. Besides, it is not surprising that the actin cytoskeleton of chromosomally stable HCT116 
cells is also affected by inhibition of the overall pool of TRIO, Rac1 or Arp2/3, as these are 
important actin cytoskeleton regulators in general.  
In order to exclude possible off-target effects of the used drugs, siRNA-mediated knock downs 
were performed, followed by actin cytoskeleton signal intensity measurements. First, proteins 
involved in upstream parts of the pathway were knocked down in SW620 and SW480 cells. 




ch-TOG whose knockdown was shown to cause a decrease in microtubule plus-end assembly 
rates (Ertych et al., 2014), with siRNA for EB1 or for TRIO. The knock down efficiency was verified 
by Western blots (Figure 3.19a). Both SW620 and SW480 cells showed a clear reduction in actin 
cortex and cloud signal intensities after knockdown of CKAP5, EB1 or TRIO, thereby confirming 




Figure 3.19: Knock down of CKAP5, EB1 or TRIO decreases the F-actin signal intensity in 
chromosomally unstable cells. (a) Representative Western blots verify the depletion of CKAP5, EB1 and 
TRIO after siRNA-mediated knock downs. α-tubulin was detected to serve as loading control. Quantification 
of actin cortex and cloud signal intensities of (b) SW620 (CIN) and (c) SW480 (CIN) cells demonstrating a 
decrease in actin signal intensity after knock down of CKAP5, EB1 or TRIO. Knock downs were archived 
by transfection with siRNA against indicated target genes. 48 h after transfection, cells were stained for F-
actin (AlexaFluorTM 594 Phalloidin) and DNA (Hoechst33342). Box and whisker plots showing the median, 
quartile and range of the mean actin cortex and cloud intensity calculated from metaphase line scans of 






For the knock down of more downstream parts of the pathway, SW620, SW480 and HCT116 cells 
were transfected with siRNA for Rac1 and Arp3 and the knock down efficiency was proved by 
Western blots (Figure 3.20a). Again, SW620, SW480 and HCT116 cells showed a decrease in 
actin cortex and cloud signal intensity, whereby SW620 and SW480 cells showed a stronger 
overall reduction (up to 23% or 35% decrease in cortex signal and 26% or 37% in cloud signal 
intensity respectively) than HCT116 cells (up to 19% decrease in cortex and cloud signal intensity) 
(Figure 3.20b-d). These results confirm the findings from inhibitor treated cells described above, 
thereby further supporting the involvement of the introduced microtubule dynamic, EB1, TRIO, 
Rac1, Arp2/3 dependent pathway in the organization of the actin cytoskeleton. 
 
 
Figure 3.20: Knock down of Rac1 or Arp3 leads to a decrease in the F-actin signal intensity of 
chromosomally unstable and chromosomally stable cells. (a) Representative Western blots detecting 
Rac1 and Arp3 show the efficiency of siRNA-mediated knock downs of corresponding target genes. 
Detection of α-tubulin served as loading control. Actin cortex and cloud signal intensities of (b) SW620 (CIN), 
(c) SW480 (CIN) and (d) HCT116 (non-CIN) cells transfected with siRNA for Rac1 or Arp3 were quantified 
showing a more pronounced overall reduction for CIN cells. 48 h after siRNA-transfection, cells were stained 
for F-actin (AlexaFluorTM 594 Phalloidin) and DNA (Hoechst33342). Box and whisker plots showing the 
median, quartile and range of the mean actin cortex and cloud intensity calculated from metaphase line 




Having shown that inhibition or downregulation of components of the given pathway causes a 
strong decrease in the F-actin signal intensity of chromosomally unstable cells, further 
experiments should now prove whether hyperactivation of pathway components would in turn lead 
to an increase in the F-actin signal intensity of chromosomally stable cells. Figuring out possible 
inductive conditions, treatment with low dose Nocodazole was chosen to induce increased 
microtubule plus-end assembly rates and overexpression of constitutively active Rac1 (Rac1-CA) 
was carried out for hyperactivation of the pathway further downstream (Figure 3.21a). However, 
neither low dose Nocodazole treatment, nor Rac1-CA overexpression resulted in an increase of 
actin cortex or cloud signal intensities (Figure 3.21b). A possible explanation for this result could 
be that increasing the activity of only one component of the pathway might not be enough to cause 
an hyperactivation of the whole pathway due to the still limited amount of downstream 
components. This is supported by the finding that TRIO is part of the HET70 signature of genes 
that are most strongly upregulated in cancers with karyotype heterogeneity (Sheltzer, 2013), which 
corresponds with Western blot results showing that TRIO expression was stronger in 
chromosomally unstable SW620 cells than in chromosomally stable HCT116 cells (Figure 3.5a).  
 
 
Figure 3.21: The F-actin signal intensity of chromosomally stable HCT116 cells is not affected by 
solely increasing microtubule plus-end assembly rates or by overexpression of constitutively active 
Rac1. (a) Representative Western blot showing overexpressed constitutively active Rac1 (Rac1-CA-GFP) 
in HCT116 cells. α-tubulin was detected to serve as loading control. (b) Quantification of actin cortex and 
cloud signal intensities showing no impact of low dose Nocodazole or overexpression of Rac1-CA-GFP in 
HCT116 cells. Cells were transfected with a plasmid encoding Rac1-CA-GFP or GFP as control 48 h before 
fixation or treated with DMSO (control) or 0.5 nM Nocodazole 16 h before fixation, followed by staining for 
F-actin (AlexaFluorTM 594 Phalloidin) and DNA (Hoechst33342). Box and whisker plots showing the median, 
quartile and range of the mean actin cortex and cloud intensity calculated from metaphase line scans of five 




These findings indicate that an hyperactivation of the given pathway requires not only an increase 
in microtubule plus-end assembly rates, but also a higher expression of TRIO. However, this might 
not serve as possible explanation for the observed result from constitutively active Rac1 
overexpressing HCT116 cells, since Rac1 is downstream of TRIO. Here, the correct localization 
of activated Rac1 might again be the crux of the matter, meaning that only overexpressing one 
pathway component does not automatically result in this component being localized at the required 
site of action. Consequently, for a successful hyperactivation of the introduced pathway it seems 
to be necessary that all components involved are active at the correct location. This would need 
to be proved in further experiments.   
The results so far indicate that the F-actin cytoskeleton is indeed regulated by the introduced 
pathway in chromosomally unstable cells. However, regulation of the mitotic F-actin cytoskeleton 
was mainly described to be dependent on other pathways, whereby RhoA dependent pathways 
need to be particularly mentioned (Maddox & Burridge, 2003). RhoA activity increases at the onset 
of mitosis and leads to activation of its effectors, especially the Rho-associated kinase ROCK and 
the formin mDia. ROCK activates myosin II via phosphorylation of the myosin light chain (MLC), 
thereby increasing actin binding of myosin II which results in enhanced contractility (Amano et al., 
1996). The formin mDia is a well-known actin nucleator, but instead of branched F-actin that is 
generated by Arp2/3 dependent actin nucleation mDia promotes nucleation of unbranched F-actin 
(Goode & Eck, 2007). The RhoA effectors ROCK and mDia were both reported to be involved in 
mitotic cortex contractility and cytokinesis (Bovellan et al., 2014; Kosako et al., 2000; Maddox & 
Burridge, 2003). Since RhoA and its effectors play an important role in the regulation of the mitotic 
F-actin cytoskeleton, it was of interest whether such other actin regulating pathways would also 
be involved in spindle axis alignment, chromosome segregation and the development of 
chromosomal instability. In order to investigate this question, SW620 and HCT116 cells were 
treated with different inhibitors and activators for RhoA and its effectors, followed by determining 
their effect on F-actin signal intensities. To inhibit RhoA, the C3 toxin was used, whereas calpeptin 
treatment was chosen for RhoA activation. Further downstream, formins were inhibited by 
SMIFH2. However, only very low concentrations of calpeptin and SMIFH2 were used, as work 
from our group has been shown that these already affect spindle positioning and the generation 
of lagging chromosomes (Schermuly, 2019). Additionally, Latrunculin A was used for general 
promotion and Jasplakinolide for general inhibition of F-actin assembly. While inhibition of RhoA 
by C3 resulted in disruption of a functional mitotic F-actin cortex that was even more pronounced 
In SW620 cells than in HCT116 cells (Figure 3.22a), an activation of RhoA by calpeptin treatment 




b). Inhibition of formins by SMIFH2 treatment did also not cause visible changes in the F-actin 
cytoskeleton and in its signal intensity (Figure 3.22a-b). Cells treated with the F-actin assembly 
promoting drug Jasplakinolide seemed to have an intact actin cortex but showed the formation of 







Figure 3.22: The F-actin signal intensity of chromosomally unstable SW620 cells is not affected by 
mild activation of RhoA or mild inhibition of formins, but by inhibition of RhoA or myosin II. (a) 
Representative immunofluorescence images of SW260 and HCT116 cells after treatment with drugs 
affecting RhoA or its downstream effectors or drugs directly affecting F-actin assembly. Cells were treated 
with DMSO (control), 3 µg/ml C3 toxin (RhoA inhibitor) for 6 h, 1 µg/ml calpeptin (RhoA activator) for 2 h, 
20 µM SMIFH2 (formin inhibitor) for 2 h, 0.1 µM Jasplakinolide (inducer of F-actin assembly) for 16 h or 
0.75 µM Latrunculin A (inhibitor of F-actin assembly) for 2 h and stained for F-actin (AlexaFluorTM 594 
Phalloidin; red) and DNA (Hoechst33342; blue). Scale bar 5 µm. (b) Quantification of actin cortex and cloud 
signal intensities of SW620 cells showing no effect after RhoA activation or formin inhibition. Cell were 
treated with calpeptin or SMIFH2 and stained as described in (a). Box and whisker plots showing the 
median, quartile and range of the mean actin cortex and cloud intensity calculated from metaphase line 
scans of three independent experiments (n = 20-24 cells per experiment, t-test). (c) Representative 
immunofluorescence images of SW260 cells treated with the myosin II inhibitor blebbistatin showing a clear 
decrease in F-actin signal intensity. Cells were treated with DMSO or 30 µM blebbistatin for 1 h and stained 
as described in (a). Scale bar 5 µm. (d) Actin cloud and cortex signal intensities from SW620 cells treated 
with DMSO or with 25, 20, 35 or 40 µM blebbistatin for 1 h were quantified and show a concentration 
dependent decrease. Cells were stained as described in (a). Box and whisker plots showing the median, 
quartile and range of the mean actin cortex and cloud intensity calculated from metaphase line scans of one 
blebbistatin titration experiment (n = 27-32 cells per different concentration, t-test). 
assembly inhibiting drug Latrunculin A lead to a strong disruption of the F-actin cortex in mitotic 
SW620 cells, but caused almost no visible effects in mitotic HCT116 cells (Figure 3.22a). When 
trying to figure out the meaning of these results, the cortical F-actin disrupting (SW620) or 
diminishing (HCT116) effect of RhoA inhibition is not surprising, as Nishimura et al. (2019) also 
detected a decreased enrichment of cortical F-actin in C3 treated metaphase Hela cells. RhoA 
inhibition results in reduced activation of its effector ROCK. Less active ROCK leads to less active 
myosin II, thereby causing a reorganization of cortical F-actin from dense bundles to a loose, 
disorganized F-actin network (Ivanov et al., 2008). This might explain the observed changes in 
the F-actin structure after C3 treatment. However, the formin mDia1, an isoform of mDia, is also 
an effector of RhoA and known to be a major contributor to nucleation of cortical actin (Bovellan 
et al., 2014), therefore raising the question why inhibition of formins by SMIFH2 did not cause 
visible changes in the F-actin cortex or its signal intensity (Figure 3.22Figure 3.22a-b). 
Interestingly, while Bovellan et al. (2014) also showed a drastic reduction in F-actin cortex 
fluorescence intensity after Arp2/3 inhibition by CK666, they only detected a slight, but not 
significant reduction after mDia1 knock down. Despite this obvious difference on F-actin cortex 
intensity between Arp2/3 and mDia1 downregulation, their work revealed a more important role 
for mDia1 than for Arp2/3 in cell division. This suggests that although F-actin cortex signal 
intensities can be determined to reveal changes in cortical F-actin, it cannot be used to show all 
changes that might appear. This might also be true for changes induced by activation of RhoA by 
calpeptin treatment as it did not increase F-actin cortex signal intensities (Figure 3.22a-b). At this 
point, it should also be noted, that the used concentrations of calpeptin and SMIFH2 were quite 
low when compared to literature, thereby raising the possibility that higher concentrations might 




In order to prove whether the RhoA effector ROCK and its target myosin II are responsible for the 
observed disruption of the F-actin cytoskeleton, SW620 cells were treated with the myosin II 
inhibitor blebbistatin. F-actin signal intensity measurements clearly showed a concentration 
dependent decrease after myosin II inhibition (Figure 3.22c-d), thereby supporting the observed 
changes in the cortical actin structure reported by Ivanov et al. (2008). The range of the detected 
decrease was comparable with the measured F-actin signal intensities after inhibition of the EB1, 
TRIO, Rac1, Arp2/3 dependent pathway. Therefore, it would be worth investigating whether an 
inhibition of the RhoA dependent pathway and especially myosin II would also cause a rescue of 
chromosomal instability. However, the results concerning the RhoA-related pathway also 
demonstrate that only measuring the F-actin signal intensity is not sufficient to detect every 
possible change in the F-actin structure. For this reason, other experimental approaches are 
required that allow further insight into the F-actin structure and its physical properties. 
 
3.9 Chromosomally unstable cells exhibit decreased mitotic actin cortex tension that is 
rescuable by inhibition of a microtubule dynamic, EB1, TRIO, Rac1, Arp2/3 dependent 
pathway  
Although measurements of the mitotic F-actin signal intensity revealed a role for the introduced 
microtubule dynamic, EB1, TRIO, Rac1, Arp2/3 dependent pathway in the regulation of the F-actin 
cytoskeleton especially in chromosomally unstable cells, further experimental approaches were 
required to figure out what consequences the observed changes have for a mitotic cell. Recent 
studies revealed that cortical tension is higher in mitotic than in interphase cells (Fischer-Friedrich 
et al., 2014; Stewart et al., 2011), and that not myosin II activity alone but also the actin cortex 
architecture itself is involved in the generation of cortical tension (Chugh et al., 2017). Moreover, 
cortical rigidity and tension has been reported to regulate spindle positioning in mitotic cells 
(Kozlowski et al., 2007; Morin & Bellaïche, 2011). These findings led to the suggestion that the 
observed changes in F-actin structure and signal intensity due to interfering with the given pathway 
might have an impact on the mitotic cortex tension, thereby regulating mitotic spindle positioning. 
In order to test this assumption, atomic force microscopy (AFM) indentation experiments were 
performed on chromosomally stable HCT116 and chromosomally unstable SW620 cells in 
prometaphase that have been treated with drugs affecting the given pathway. Interestingly, 
HCT116 cells exhibited a generally higher cortex tension when compared to SW620 cells (Figure 
3.23a), thereby indicating that chromosomally unstable cells have a decreased mitotic cortex 




increased, and thus were rescued to HCT116 level by restoring proper microtubule plus-end 
assembly rates using low dose Taxol or by inhibiting TRIO, Rac1 or Arp2/3 (Figure 3.23). In 
contrast, treatment of HCT116 cells with low dose Taxol or with a Rac1 inhibitor did not affect 
cortex tension. Consequently, HCT116 cells seem to already have an optimal mitotic cortex 
tension that cannot be further increased by the given treatments. Interestingly, low dose 
Nocodazole treatment did almost not affect the cortex tension of mitotic HCT116 cells, thereby 
supporting the result from F-actin signal intensity measurements that also did not show an effect 
for Nocodazole (Figure 3.21b). 
 
Figure 3.23: Chromosomally unstable SW620 cells exhibit decreased mitotic cortex tension T0 that 
is rescuable by inhibition of the microtubule dynamic, EB1, TRIO, Rac1, Arp2/3 dependent pathway, 
but not by myosin II inhibition. (a) AFM indentation measurements of prometaphase HCT116 (non-CIN) 
and SW620 (CIN) cells showing a decreased cortex tension for CIN cells and its rescue by Taxol-induced 
restoration of proper microtubule plus-end assembly rates or inhibition of TRIO, Rac1 or Arp2/3. Cells were 
transfected with a GFP-H2B expressing plasmid to allow for identification and measurement of 
prometaphase cells and treated with DMSO (control), 0.2 nM Taxol, 0.5 nM Nocodazole, 15 µM ITX3 (TRIO 
inhibitor), 40 µM NSC23766 (Rac1 inhibitor) or 20 µM CK666 (Arp2/3 inhibitor) for about 16 h. Scatter dot 
plots show calculated values for cortical tension (n ≥ 20 cells in at least three independent experiments, 
mean ± SEM, t-test). (b) Measurements of cortex tension of prometaphase HCT116 and SW620 cells 
showing a decreasing effect for myosin II inhibition, as well as by increasing or decreasing F-actin assembly. 
Cells were transfected as described in (a) and treated with DMSO, 30 µM blebbistatin (myosin II inhibitor) 
for 1 h, 0.1 µM Jasplakinolide (inducer of F-actin assembly) for 16 h or 0.75 µM Latrunculin A (inhibitor of 
F-actin assembly) for 2 h. Scatter dot plots show calculated values for cortical tension (n ≥ 20 cells in at 
least three independent experiments, mean ± SEM, t-test). AFM indentation measurements were carried 
out in collaboration with Dr. Brückner and Prof. Dr. Janshoff (Institute for Biophysical Chemistry, Georg 
August University Göttingen) and Nadine Schermuly (Institute for Molecular Onkology, University Medical 
Center Göttingen) with distribution of tasks described in chapter 2.2.14. Nadine Schermuly already 




Inhibition of myosin II by blebbistatin treatment has shown a similar decrease in F-actin signal 
intensity as drugs affecting the given actin-regulating pathway (Figure 3.22c-d). However, 
blebbistatin is known to reduce cortical tension (Chugh et al., 2017), which has been confirmed 
by measuring the cortex tension of HCT116 and SW620 cells after blebbistatin treatment (Figure 
3.23b). These opposite effects on cortical tension suggest that although showing the same 
decreasing effect in F-actin signal intensity, inhibition of myosin II seems to induce different 
changes in the mitotic F-actin cortex structure than inhibition of the microtubule dynamic, EB1, 
TRIO, Rac1, Arp2/3 dependent pathway. In order to further investigate the effect of a general 
increase or decrease in F-actin assembly, HCT116 and SW620 cells were treated with 
Jasplakinolide or Latrunculin A. Increased F-actin assembly by Jasplakinolide treatment caused 
a clear decrease in cortex tension in HCT116 cells to approximately untreated SW620 level, 
whereas the cortex tension of SW620 did not further decrease (Figure 3.23b). In contrast, 
inhibition of F-actin assembly by treatment with Latrunculin A made it possible to reduce the cortex 
tension in SW620 cells even further. These observed decrease in cortex tension might also be 
explained by the severe changes that have been observed for the mitotic F-actin structure (Figure 
3.22a).  
Taken together, AFM indentation measurements revealed a link between the microtubule 
dynamic, EB1, TRIO, Rac1, Arp2/3 dependent pathway and the generation of mitotic cortex 
tension. It could be shown that chromosomally unstable cells exhibit a decreased mitotic cortex 
tension that is rescuable by inhibition of components of the introduced pathway, thereby probably 
enabling a proper spindle axis alignment and chromosome segregation.  
Abovementioned results show that cortical tension depends on actin cortex architecture, whereby 
measuring the F-actin signal intensity is considered to represent actin density. Interestingly,  
Chugh et al. (2017) found out, that also the actin cortex thickness plays an important role for the 
generation of mitotic cortex tension. In order to investigate whether there is a correlation between 
actin cortex thickness and actin cortex density, the actin cortex thickness of SW620 cells, in which 
the introduced microtubule plus-end-EB1-TRIO-Rac1-Arp2/3 pathway was downregulated, were 
determined. Therefore, the cells were treated with low dose Taxol, the TRIO inhibitor ITX3, the 
Rac1 inhibitor NSC23766 or the Arp2/3 inhibitor CK666. Interestingly, there was no effect on 
cortex thickness by any of the treatments (Figure 3.24a). This shows, that either a change in actin 
cortex density or in actin cortex thickness is sufficient to affect cortex tension. Moreover, this result 






Figure 3.24: The actin cortex thickness of is not affected by downregulation of components of the 
microtubule plus-end-EB1-TRIO-Rac1-Arp2/3 pathway. (a) Measurements of actin cortex thickness of 
metaphase SW620 cells (from Figure 3.18c) showing no effect for a Taxol-induced rescue of microtubule 
plus-end growth rates or inhibition of TRIO, Rac1 or Arp2/3. Cells were treated with DMSO, 0.2 nM Taxol, 
15 µM ITX3, 40 µM NSC23766 or 20 µM CK666 for 16 h and stained for F-actin (AlexaFluorTM 594 
Phalloidin) and DNA (Hoechst33342). Box and whisker plots showing the median, quartile and range of the 
mean actin cortex thickness calculated from metaphase cells of three independent experiments (n = 20-36 
cells per experiment, t-test). (b) Actin cortex thickness measurements of metaphase SW620 cells (from 
Figure 3.22b) demonstrating no effect for slightly increased RhoA activation or slightly reduced formin 
inhibition. Cells were treated with DMSO, 1 µg/ml calpeptin (RhoA activator) for 2 h or 20 µM SMIFH2 
(formin inhibitor) for 2 h and stained as described in (a). Box and whisker plots showing the median, quartile 
and range of the mean actin cortex thickness calculated from metaphase cells of three independent 
experiments (n = 20-24 cells per experiment, t-test). 
 
cortex thickness after Arp2/3 inhibition by CK666, but only after changing actin filament length 
regulators, such as mDia, capping protein or cofilin. Since mDia belongs to the family of formins 
and is also regulated by RhoA, the question was raised whether SW620 cells treated with 
calpeptin or SMIFH2, which did not alter F-actin cortex intensity, would rather show changes in 
the actin cortex thickness. However, the low concentrations used did not cause alterations in actin 
cortex thickness (Figure 3.24b).   
Due to the finding that measurement of the mitotic F-actin signal intensity is not sufficient to detect 
every change in the F-actin structure, and that in case of a change it gives no information whether 
this induces an increase or decrease of cortex tension, additional experimental approaches should 
enable visualization of extremely fine structural alterations in the F-actin cytoskeleton. Therefore, 









Figure 3.25: STED microscopy visualizes changes in the F-actin cytoskeleton of mitotic SW620 cells 
after inhibition of Rac1 and Arp2/3, but not after Taxol-induced restoration of microtubule plus-end 
assembly rates. Representative three color confocal images of DNA (blue), α-tubulin (green) and F-actin 
(red) in xy-, xz- and yz plane, respectively, as well as confocal and corresponding STED images of the top 
surface F-actin network of (a) DMSO treated HCT116 cells, and SW620 cells treated with (b) DMSO, (c) 
0.2 nM Taxol, (d) 40 µM NSC23766 (Rac1 inhibitor) or (e) 20 µM CK666 (Arp2/3 inhibitor). Cells were 
seeded on glass coverslips, treated with the indicated drugs for 16 h and stained for F-actin (Abberior® 
STAR-RED Phalloidin; red), α-tubulin (Abberior® STAR 580; green) and DNA (Hoechst33342; blue). Scale 
bars as indicated. Maximum projections of top surface images of 15 z-stacks with a z-optical spacing of 
0.2 µm are shown. STED microscopy was carried out in collaboration with Florian Grimm (Abberior GmbH, 
Göttingen). 
 
resolution images was performed. HCT116 and SW620 cells were grown on glass coverslips and 
microtubule structures were labelled with Abberior® STAR 580, whereas F-actin was stained with 
Abberior® STAR-RED Phalloidin. When comparing STED images of the top surface of mitotic 
(prometaphase or metaphase) cells, HCT116 cells clearly exhibited a more defined cortical F-
actin structure (Figure 3.25a), whereas SW620 cells showed a rather diffuse cortical F-actin 
network that seemed to strongly pervade cytoplasmic regions (Figure 3.25b). For restoration of 
proper microtubule plus-end assembly rates, SW620 cells were treated with low dose Taxol and 
for inhibition of Rac1 or Arp2/3 with NSC23766 or CK666, respectively. However, while inhibition 
of Rac1 or Arp2/3 indeed induced the formation of a rather defined F-actin cortex similar to but 
still not as defined as in HCT116 cells, low dose Taxol treatment did not lead to visible changes 
of the F-actin cytoskeleton (Figure 3.25c-e). Interestingly, Arp2/3 inhibition additionally induced 
the formation of actin-rich blebs at the cortex, which was detected especially in metaphase SW620 
cells (Figure 3.25e) and has also been observed from Bovellan et al. (2014). These observed 
differences in the effect of the given treatments suggest that although a general inhibition of Rac1 
or Arp2/3 indeed triggers remodeling of the F-actin cytoskeleton, these visible changes might not 
be due to a downregulation restricted to the microtubule dynamic, EB1, TRIO, Rac1, Arp2/3 
pathway. There might be even more subtle changes in the F-actin cytoskeleton caused by 





Recently, evidence came up by work from our group, that there is a new pathway that provides a 
link between microtubule dynamics and the mitotic actin cortex. When hyperactivated, this 
pathway seems to induce the generation of spindle mis-positioning, chromosome mis-segregation 
and thereby chromosomal instability (Berger, 2016; Schermuly, 2019). Moreover, in interphase 
cells this pathway was also shown to be involved in cell migration (Berger, 2016). From recent 
work it is known that the pathway includes the microtubule plus-end binding protein EB1, the GEF 
TRIO and its Rho GTPase Rac1, as well as the F-actin regulating Arp2/3 complex. In addition, 
increased mitotic microtubule plus-end growth rates, as exhibited by chromosomally unstable 
cancer cells, were associated with a hyperactivation of this pathway. However, many links within 
this pathway were still elusive and required further investigation.  
This study revealed a microtubule dynamic dependent EB1-TRIO interaction at microtubule plus 
ends in mitotic cells, that is required for downstream activation of Rac1 and Arp2/3, thereby 
causing cortical actin cytoskeleton reorganization. When hyperactivated, such as by increased 
microtubule plus end assembly rates found in CIN cells, this pathway triggers the formation of an 
actin cortex architecture with increased density that causes decreased cortex tension. A reduced 
cortical tension, in turn, is associated with defects in spindle positioning, as demonstrated by 
Kunda et al. (2008), and this was further shown to cause chromosome mis-segregation and thus 
CIN (Ertych et al., 2014; Silkworth & Cimini, 2012). Moreover, this study is the first to show that 
an increase in the level and thus the activity of the Rho GEF TRIO triggers EB1 binding dependent 
whole and structural chromosome instability as well as EB1 binding independent structural 
chromosome instability. Moreover, whole chromosome instability could be rescued by 
downregulation of TRIO, Rac1 or Arp2/3, thereby confirming Rac1 as the actual TRIO effector 
within this pathway. However, structural chromosome instability could only partially be rescued by 
downregulation of the TRIO-Rac1-Arp2/3 pathway. This again confirms that there is an additional 
EB1 independent pathway participating in the generation of structural chromosome instability, 
driven by another TRIO effector than Rac1. Additionally, this study revealed that the increase in 
cell migration observed for cells with enhanced TRIO levels and activity is not only EB1 binding 
independent, but there is even a stronger increase in cell migration for cells exhibiting high levels 
of active EB1 binding deficient TRIO. Summing up all unraveled TRIO functions, this protein drives 
EB1 dependent whole and structural chromosome instability, EB1 independent structural 
chromosome instability and EB1 binding independent cell migration via different effector pathways 





Figure 4.1: Model for the microtubule plus-end-EB1-TRIO-Rac1-Arp2/3 dependent pathway and its 
role in the development of CIN via decreasing actin cortex tension. An irregular increase in mitotic 
microtubule plus-end growth rates results in hyperactivation of a pathway involving EB1, TRIO, Rac1 and 
the F-actin organizing Arp2/3 complex. This leads to an increase in actin cortex connectivity and thus 
density, thereby causing a decreased cortical tension. A low cortex tension in turn results in a transient 
defect of the mitotic spindle position and thereby triggers the formation of merotelic kinetochore-microtubule 
attachments, followed by an increased amount of lagging chromosomes. Consequently, a higher rate of 
chromosome mis-segregation occurs that finally leads to whole chromosome instability. Additionally, 
upregulated TRIO also induces structural chromosome instability in an EB1 and Rac1 independent pathway. 




4.1 Why is the TRIO-EB1 interaction affected by a Taxol dependent decrease, but not by a 
Nocodazole independent decrease of microtubule plus-end assembly rates? 
Immunofluorescence images clearly demonstrated an EB1 dependent localization of TRIO to 
microtubule plus-ends. Although affecting microtubule dynamics did not visibly reduce the amount 
of TRIO localized to microtubule plus-ends, further pull down experiments revealed a decrease in 
TRIO-EB1 interaction of chromosomally unstable HEK293T cells due to a Taxol induced decrease 
of microtubule plus-end growth rates. This observed reduction of TRIO-EB1 binding is consistent 
with the finding, that EB1 preferentially binds to growing microtubule plus ends (Vaughan, 2005): 
Due to low dose Taxol treatment microtubule dynamics are especially reduced at microtubule 
plus-ends (Derry et al., 1998), that also means a decrease in microtubule plus-end growth rates 
(Ertych et al., 2014), thereby resulting in diminished EB1 binding to microtubule plus-ends. 
Consequently, EB1 recruitment and interaction with other +TIP proteins, such as TRIO, is 
diminished. While in this study, a Taxol induced decrease in microtubule plus-end dynamics was 
observed to diminish the interaction of TRIO and EB1, work from van Haren et al. (2014) 
demonstrated, that stabilization of microtubules by high doses of Taxol affects the interaction 
between TRIO and the +TIP protein Nav1 and causes depletion of the TRIO-Nav1 complex at 
neurite tips. Both low and high doses of Taxol reduce microtubule dynamics and especially plus-
end growth rates, thereby triggering the disassembly of +TIPs, such as TRIO, Nav1 and EB1, at 
microtubule plus ends.  
In order to prove, whether an increase in microtubule plus-end growth rates of chromosomally 
stable HCT116 cells would have the opposite effect, low dose Nocodazole treatment was used, 
as this has been frequently shown to increase microtubule growth rates in our group (Berger, 
2016; Ertych et al., 2014; Schermuly, 2019). However, there was no increase in TRIO-EB1 binding 
following low dose Nocodazole treatment. Interestingly, Nocodazole was found to not only bind to 
the colchicine binding site at the β-tubulin subunit of tubulin dimers, but also of microtubule 
polymers (Lee et al., 1980). Additionally, Nunez et al. (1979) found out, that binding of colchicine 
to tubulin and binding of microtubule associated proteins is competitive. Although Nunez et al. 
(1979) did not further specify the affected microtubule associated proteins, it might be possible, 
that Nocodazole competes with EB1 for tubulin binding. This would cancel out the positive effect, 
that a Nocodazole induced increase in microtubule dynamics might have on EB1 binding to 
growing microtubule plus ends. If this would be the case, another explanation than the EB1-TRIO-
Rac1-ARP2/3 dependent pathway would be required to explain the observed inducing effects of 
low dose Nocodazole treatment on spindle mis-orientation, chromosome mis-segregation and 




Nocodazole to affect mitotic spindle morphology, as microtubules were redistributed from central 
spindles to asters. This might have an impact on the generation of stable microtubule-kinetochore 
attachments, which would then serve as cause for the observed abovementioned effects. Of 
course, further research would be required to prove this idea or to figure out other reasons 
responsible for the effects observed for Nocodazole. 
4.2 The role of EB1 binding for the functions of TRIO and its effector Rac1  
While the immunofluorescence images of TRIO clearly showed an EB1 dependent microtubule 
plus-end localization, the generated HCT116 clones with TRIO overexpression did rather show a 
strong overall localization. But what is the reason for this difference in the observed localization?  
TRIO is a multidomain protein and has many other interaction partners than EB1, thereby being 
located at different compartments of the cell. Due to its interaction with filamin A and Tara it is 
strongly associated with actin filaments, while its interaction with LAR also results in plasma 
membrane localization of TRIO (S. Schmidt & Debant, 2014; van Rijssel & van Buul, 2012). For 
immunofluorescence staining, however, methanol fixation was performed, as the anti-TRIO 
antibody that was used did not detect formaldehyde-fixed TRIO antigens. However, methanol 
destroys the actin cytoskeleton and also damages the cell membrane, thereby also ruling out the 
possibility to visualize associated proteins (Hoetelmans et al., 2001; Melak et al., 2017). For this 
reason, immunofluorescence images only show +TIP localization for TRIO, while in unfixed, live 
cell images of HCT116 clones TRIO was localized at several compartments. This observation is 
confirmed by van Haren et al. (2014), who found overexpressed mCherry-TRIO also largely 
diffused in the cytoplasm. Interestingly, work from van Haren et al. (2014) and unpublished work 
from our group showed that overexpression of TRIOs +TIP interaction partner Nav1 results in an 
increased recruitment of TRIO to microtubule plus ends that becomes visible in live cell images. 
This increase in +TIP localization was also seen when only overexpressing the GEF-D2 domain 
of TRIO, that harbors the SXIP domain responsible for EB1 binding (van Haren et al., 2014). As 
most other domains required for the interaction with other proteins are missing within this strongly 
truncated TRIO variant, it cannot localize to other compartments anymore. A part of the diffuse 
TRIO signal in these cells might be also due to overexpression of this protein, as an excess protein 
concentration is also associated with protein mis-localization (Huh et al., 2003).  
GEF activity assays with HEK293T cells overexpressing the wildtype of TRIO, that has EB1 
binding capacity, and the SXIP-mutated TRIO, that is deficient of EB1 binding, revealed that the 
GEF-D1 activity does not depend on EB1 binding. This finding is consistent with the observations 




and SXIP-mutated TRIO by performing fluorescence-based in vitro guanine nucleotide exchange 
assays measuring Mant-GTP loading onto GDP-preloaded RhoG. A HEK293T cell 
overexpression system was chosen, as GEF activity assays with HCT116 and SW620 cells 
endogenously expressing TRIO did not exhibit detectable active TRIO levels, but only detectable 
active TIAM1 levels. This is consistent with the findings of García-Mata et al. (2006), who figured 
out that TRIO is only able to bind to wildtype Rac1, but not to Rac1 G15A, that was used for 
binding active GEFs within the used GEF assays due to the higher stability of this mutant 
compared to wildtype Rac1. However, van Rijssel et al. (2012) successfully performed GEF 
activity assays for TRIO by increasing TRIO levels and/or activity via TRIO overexpression or 
TNF-α-treatment. Consequently, TRIO was overexpressed in this study to successfully carry out 
GEF activity assays. Interestingly, Berger (2016) was able to detect active TRIO from GEF activity 
assays with untransfected HCT116 and SW620 cells. She could even observe a decrease in the 
GEF activity of TRIO in mitotic SW620 cells upon Taxol or TRIO inhibitor treatment. However, in 
GEF assays carried out by Berger (2016), mitotic HCT116 cells showed a level of active TRIO 
similar to SW620 cells, therefore it would also be of interest, whether Taxol or a TRIO inhibitor 
treatment might also decrease TRIO activity in these cells.  
Due to the finding in this study, that the GEF-D1 activity of TRIO does not depend on EB1 binding, 
the question was raised whether there are still differences in the activation of downstream 
effectors. Indeed, it was found a difference in Rac1 activation by the EB1 binding TRIO wildtype 
and the EB1 binding deficient TRIO mutant. Rac1 activity assays performed in this study revealed 
that the EB1 binding capacity of TRIO is essential for Rac1 activation in mitotic cells, but not in 
interphase cells. This is consistent with the work from other groups, showing that EB1 is involved 
in mitotic spindle assembly and positioning, chromosome alignment and chromosomal instability 
(Green et al., 2005; Rogers et al., 2002; Rogers et al., 2004; Tirnauer & Bierer, 2000). Especially 
Rogers et al. (2002) found out, that siRNA-mediated knock down of EB1 results in a dramatic 
decrease of microtubule dynamics, that did not affect microtubule organization in interphase, but 
resulted in severely reduced astral microtubules, a malformed mitotic spindle and spindle 
mispositioning, followed by chromosome mis-segregation. Interestingly, EB1 depletion did only 
affect the frequency of catastrophe and rescue events, but not the growth or shrinkage rate. This 
is consistent with work from Berger (2016), who also found no difference in the microtubule growth 
rate of EB1 depleted and control SW620 cells. However, she detected a slight decrease in the 
amount of lagging chromosomes after partial EB1 depletion, suggesting rather a rescue of 
chromosome mis-segregation. This observation can be probably explained by findings of more 




correlation with a poor prognosis (Gemoll et al., 2017; Stypula-Cyrus et al., 2014; Sugihara et al., 
2012). As SW620 cells are chromosomally unstable colorectal cancer cells, that are associated 
with a poor prognosis, these might inherit upregulated EB1 levels. Consequently, a partial 
depletion of EB1 would restore normal EB1 levels, resulting in the rescue observed from Berger 
(2016). Summed up, these findings demonstrate that alterations of the EB1 level in both directions 
might be involved in cancer development, thereby claiming that the EB1 level needs to be tightly 
balanced.  
So far, most effects seen for EB1 downregulation were mainly linked to its interaction partners 
APC and RhoGEF2 (Green et al., 2005; Rogers et al., 2004). The present study now introduced 
Rac1 as downstream effector of EB1 binding dependent TRIO is mitosis, thereby generating a 
putative link between the described cancer-related overexpression of EB1 and TRIO-mediated 
hyperactivation of Rac1 in mitotic cells. Interestingly, not only EB1 is frequently up-regulated in 
colorectal cancer with poor prognosis, but also TRIO was found to be strongly overexpressed in 
cancers with karyotype heterogeneity (Sheltzer, 2013) and correlates with poor prognosis of 
patients with colorectal cancer (Sonoshita et al., 2015).  
While EB1 dependent TRIO binding at microtubule plus-ends seems to be essential for Rac1 
activation in mitosis, it is not required for TRIO-mediated Rac1 activation in interphase. This could 
explain, why there is an increase in cell migration, which is known to be an essential driver of 
cancer cell metastasis, observed for both TRIO variants. This migration-inducing effect of TRIO 
has also been reported by van Rijssel et al. (2012). Interestingly, the EB1 binding deficient mutant 
of TRIO even showed a stronger increase in cell migration than wildtype TRIO. This observation 
is consistent with the stronger localization of the TRIO mutant at lamellipodia when compared to 
wildtype TRIO. Moreover, this finding goes along with a study from van Haren et al. (2014), who 
observed stronger lamellipodia formation when TRIO localization at microtubule plus-ends was 
decreased via re-expression of a microtubule plus-end binding deficient mutant of TRIOs +TIP 
interaction partner Nav1.  
Although there was a stronger increase in cell migration upon overexpression of the EB1 binding 
deficient TRIO mutant, the increase in Rac1 activation was still higher for wildtype TRIO than for 
the TRIO mutant. One possible explanation might be, that due to the differences in localization of 
these two TRIO variants, Rac1 is activated at different sites that not all contribute to cell migration. 
To be more precise, a part of TRIO-WT-GFP is probably located at microtubule plus-tip-bound 
EB1 and might thereby not be available for migration-related processes at lamellipodia. In 
contrast, TRIO-SRNN-GFP is not bound to EB1 at microtubule plus-tips and, thus, a larger amount 




In addition, it has also been reported that a high Rac1 activity alone is not always sufficient for an 
increase in cell migration and that this depends on the cell type and culturing conditions (A. J. 
Ridley, 2001). Moreover, other Rho GTPases, such as RhoA, RhoG and Cdc42, are involved in 
the dynamic and spatially tightly regulated cytoskeletal changes required for successful cell 
migration (Katoh et al., 2006; A. J. Ridley, 2001). Since TRIO is not only a GEF for Rac1, but also 
for RhoG and RhoA, activation of the latter Rho GTPases might also play an important role for the 
impact of TRIO on cell migration. Therefore, it would be of need to further analyze, how wildtype 
TRIO and the EB1 binding deficient mutant of TRIO affect RhoA and RhoG activity. 
As overexpression systems usually do not represent the physiological condition, Rac1 assays with 
endogenously expressed TRIO have also been performed within this study. However, they did not 
reveal a change in Rac1 activity in mitotic SW620 cells upon treatment with low dose Taxol or 
inhibitors against TRIO or Rac1. This might be due to the fact that Rac1 activity decreases rapidly 
when a cell enters mitosis (Yoshizaki et al., 2003), which does not allow to detect further reduction.  
GEF assays performed in this study affirm a low mitotic Rac1 activity, as they show a lower amount 
of active TIAM1 in mitotic cells when compared to interphase cells and this was even lower for 
SW620 than for HCT116 cells. Moreover, TRIO levels were also lower in mitosis than in 
interphase. However, in Rac1 activity assays carried out by Berger (2016) there was even a visible 
decrease after treatment with low dose Taxol, TRIO inhibitor or Rac1 inhibitor. This result could 
also be seen in the present study when using phospho-PAK1/2 levels as readout for Rac1 activity, 
but only after TRIO or Rac1 inhibition and not upon Taxol treatment. Moreover, Rac1 assays 
performed in this study revealed a higher Rac1 activity in mitotic HCT116 cells than in mitotic 
SW620 cells. Unpublished data showed Rac1 levels of these two cell lines to be generally higher 
in interphase than in mitosis and they also showed a higher Rac1 activity for interphase HCT116 
than for SW620 cells, which is consistent with work from Toledo et al. (2012). Surprisingly, Berger 
(2016) detected a higher mitotic Rac1 activity in SW620 than in HCT116 cells. These differences 
in the results make clear, that the Rac1 activity assay is quite error-prone when used for cells or 
cell cycle phases that intrinsically exhibit low active Rac1 levels. Consequently, this assay has to 
be further improved in order to generate meaningful results. In this context, quantification of the 
phospho-PAK1/2 level as readout for Rac1 activity might be a useful alternative. However, 
detection and quantification of the whole PAK1/2 level should be performed as an additional 
control. 
However, even in case the mitotic Rac1 activity is higher in chromosomally stable HCT116 than 
in chromosomally unstable SW620 cells, this does not directly mean that there is no microtubule 




Due to the fact, that only a small part of the whole pool of Rac1 might be involved in the given 
pathway, changes in the overall Rac1 activity only due to alterations in microtubule dynamics 
might not be easily detectable. This would mean, that there might be still a part of Rac1 being 
activated by TRIO that is located at microtubule plus-tip bound EB1, but it cannot be visualized 
under these conditions. 
4.3 The role of TRIO in the induction of whole and structural chromosomal instability 
As mentioned above, TRIO was found to be strongly upregulated in cancers with karyotype 
heterogeneity (Sheltzer, 2013) and correlates with poor prognosis of patients with colorectal 
cancer (Sonoshita et al., 2015). This is consistent with the finding in the present study, that 
chromosomally unstable SW620 cells have a higher TRIO level than chromosomally stable 
HCT116 cells. In this context, this study could show for the first time, that TRIO overexpression in 
originally chromosomally stable HCT116 cells results in whole as well as structural chromosome 
instability. Interestingly, the observed whole chromosome instability was almost completely 
dependent on the EB1 binding capacity of TRIO, as HCT116 cell clones overexpressing the EB1 
binding deficient TRIO mutant only exhibited a very slight increase in karyotype heterogeneity. 
Moreover, the observed whole chromosome instability correlated with an increase in spindle 
misorientation and in the occurrence of lagging chromosomes, thereby suggesting TRIO to induce 
whole chromosome instability via an EB1 binding dependent involvement in spindle positioning. 
The finding, that the observed whole chromosome instability could be rescued by inhibition of 
components of the introduced EB1-TRIO-Rac1-Arp2/3 pathway confirms the role of TRIO and 
especially of its Rac1-activating GEF-D1 domain within this pathway as well as the role of this 
pathway in the induction of chromosomal instability. In contrast, the observed structural 
chromosome instability in form of dicentric chromosomes and acentric double minutes was 
observed in both the TRIO wildtype with EB1 binding capacity and the TRIO mutant with EB1 
binding deficiency. However, the amount of structural chromosome aberrations was clearly higher 
in wildtype TRIO than in mutant TRIO overexpressing cells. The finding that cells overexpressing 
wildtype TRIO do not only show whole, but also structural chromosome instability is consistent 
with recent studies, who revealed a correlation between whole and structural chromosome 
instability (Sansregret et al., 2018). Crasta et al. (2012) demonstrated that a CIN-associated 
generation of lagging chromosomes results in the formation of micronuclei that are involved in the 
generation of DNA breaks and thus structural chromosome aberrations. Moreover, Burrell et al. 
(2013) found out that the generation of replication stress, which occurs due to the frequent loss of 




and thus structural chromosome aberrations, but also to whole chromosome mis-segregation. 
Interestingly, our own group further found replication stress to be associated with impaired mitotic 
microtubule dynamics, that was identified as a trigger for whole chromosomal instability (Böhly et 
al., 2019). Moreover, a correlation between W-CIN and S-CIN was reported to be multidirectional: 
oncogenic pathways can trigger S-CIN or W-CIN, with the latter one acting itself as trigger for 
S-CIN (Bakhoum & Swanton, 2014). In turn, both S-CIN and W-CIN can induce oncogenic 
pathways due to loss of tumor suppressor genes or gain of oncogenes. Furthermore, aneuploidy 
in form of a W-CIN-driven gain of chromosomes also was shown to induce replication stress 
(Passerini et al., 2016). Taken together, the results from the abovementioned studies revealed a 
complex relationship between the induction of W-CIN and S-CIN (Figure 4.2).  
 
Figure 4.2: Correlations between the induction of W-CIN and S-CIN. W-CIN and S-CIN can both be 
induced by replication stress and/or oncogenic pathways, but they can also trigger oncogenic pathways 
themselves. S-CIN can be also induced by W-CIN. Moreover, W-CIN results in aneuploid cells, from which 
those with a gain of chromosomes trigger replication stress. TRIO induces W-CIN via binding to EB1, 
followed by GEF-D1-mediated activation of downstream Rac1, that in turn activates Arp2/3, thereby 
reducing cortex tension. This results in spindle mispositioning, which triggers chromosome mis-segregation 
and thus W-CIN. TRIO also induces structural chromosome instability, but via an EB1 binding and GEF-D1 




However, while inhibition of components of the EB1-TRIO-Rac1-Arp2/3 pathway in wildtype TRIO 
overexpressing cells resulted in a strong rescue of W-CIN, it only caused a partial rescue of S-CIN. 
This suggests that the observed S-CIN is not only caused via a correlation between the induction 
of W-CIN and S-CIN, but most likely also by another TRIO-mediated mechanism. Moreover, 
inhibition of components of the EB1-TRIO-Rac1-Arp2/3 pathway did not rescue S-CIN in cells with 
overexpression of the EB1 binding deficient mutant of TRIO, thereby further affirming the 
existence of another TRIO pathway involved in S-CIN development (Figure 4.2). As neither 
inhibition of the TRIO GEF-D1 domain nor the inhibition of Rac1 results in a rescue, this pathway 
does not only seem to be EB1 binding independent but also Rac1 independent. TRIO is a 
multidomain protein, which leaves many other interaction partners left to be the possible effector 
that is responsible for the induction of S-CIN. Interestingly, recent work from Osaki et al. (2016) 
showed that both an increase and a decrease of active RhoA impairs the induction of DNA damage 
repair, thereby causing increased levels of DNA damage. This finding leads to the suggestion, 
that RhoA might be the TRIO effector responsible for the induction of S-CIN. However, further 
research would need to be done to prove this or to figure out the actual sought-for TRIO effector. 
The importance of a tightly regulated expression and activity has already been described for EB1, 
as a downregulation was shown to cause spindle mispositioning and chromosome mis-
segregation, while an upregulation correlates with colorectal cancers that exhibit a poor prognosis. 
However, a tightly balanced activity is not only relevant for EB1, but it has also been shown to be 
important for TRIO. While the present study demonstrates that an overexpression of TRIO results 
in W-CIN and S-CIN, Liskovykh et al. (2019) showed similar effects upon siRNA-mediated 
depletion of TRIO, as they also observed an induction in the formation of lagging chromosomes 
and anaphase bridges.  
 
4.4 The EB1-TRIO-Rac1-Arp2/3 dependent pathway represents the missing link between 
microtubule dynamics and spindle positioning by modulating mitotic cortex tension 
Recent studies from our group showed that an increase in microtubule plus-end growth rates 
correlates with a transient spindle mis-positioning (Ertych et al., 2014; Schermuly, 2019). Further 
work from our group as well as the present study suggest that the introduced EB1-TRIO-Rac1-
Arp2/3 pathway represents the missing link. Although Mitsushima et al. (2010) and Kwon et al. 
(2015) described the existence of mitotic subcortical actin clouds and their importance for correct 




TRIO-Rac1-Arp2/3 pathway but it is rather the actin cortex. Nevertheless, in this study the actin 
intensity of subcortical actin clouds always changed simultaneously with the intensity of the actin 
cortex. Interestingly, most results from actin intensity measurements are consistent with the results 
from AFM indentation experiments, as a downregulation of the EB1-TRIO-Rac1-Arp2/3 pathway 
in chromosomally unstable SW620 cells resulted in a decreased actin intensity together with an 
increased cortex tension. Upon downregulation of pathway components, mitotic cortex tension of 
SW620 cells could even be rescued to the level of chromosomally stable HCT116 cells. 
Downregulation of pathway components in mitotic HCT116 cells resulted in a slightly less 
pronounced decrease in the intensity of the actin cytoskeleton and also in an only slight further 
increase in cortex tension after Rac1 inhibition. These results demonstrate that chromosomally 
stable HCT116 cells but not chromosomally unstable SW620 cells generate a sufficient increase 
in cortex tension upon mitotic entry and that this tension is affected by the activity of the EB1-
TRIO-Rac1-Arp2/3 pathway rather in CIN cells than in non-CIN cells. Unpublished data confirmed 
that the measured differences in cortical tension are actually due to changes within the actomyosin 
cortex, as there was no change in plasma membrane tension. Cortex tension could also be 
reduced in both HCT116 and SW620 cells by inhibition of myosin II, that is one major driver for 
cortical contractility. However, myosin II inhibition also resulted in a decreased actin cortex 
intensity, thereby indicating that not every decrease in actin intensity results in an increase in 
cortex tension. In fact, it is not surprising that myosin II inhibition decreases actin intensity, as to 
fulfil its function as contractile force inducer myosin II acts as actin crosslinker and was also 
reported to support other actin crosslinkers (Laevsky & Knecht, 2003; Luo & Robinson, 2010). 
Similar as a reduction of Arp2/3 activity, also a reduction of myosin II activity results in decreased 
actin crosslinking and thus actin density. Recent work from Ennomani et al. (2016) demonstrated, 
that a tightly balanced level of actin crosslinking is required to increase cortex tension, as both to 
less and to strong crosslinking of actin filaments results in decreased tension. In conclusion, a 
hyperactivation of the introduced microtubule plus-end-EB1-TRIO-Rac1-Arp2/3 pathway probably 
leads to a too strong actin crosslinking and branching resulting in decreased cortical tension. This 
can be rescued by downregulation of the pathway as demonstrated for chromosomally unstable 
SW620 cells. Chromosomally stable HCT116 cells only showed a slight decrease in F-actin signal 
intensity and thus actin density upon inhibition of TRIO or Rac1, that was stronger upon Arp2/3 
inhibition. This indicates that the introduced pathway seems to play a minor role for these cells. 
When considering the model that an optimal actin crosslinking is required for the generation of 
sufficient cortex tension and that HCT116 cells exhibit this optimal crosslinking, one would expect 




even showed a slight increase in cortex tension, thereby suggesting that the small, Rac1 inhibition-
induced change within the crosslinking level of the actin cytoskeleton still contributed to the 
formation of an actin cortex architecture optimal for the generation cortical tension. As Arp2/3 
inhibition caused a much stronger decrease in actin cortex density of HCT116 cells, it would be 
the aim of future experiments to reveal whether this Arp2/3 inhibition decreases actin crosslinking 
to a level that deviates from the optimum to an extent, that then results in reduced cortical tension.  
In addition to actin filament crosslinking, Chugh et al. (2017) demonstrated that the actin cortex 
thickness also plays an important role for the generation of mitotic cortex tension. Similar to actin 
crosslinking, an optimal actin cortex thickness is required for a sufficient increase in cortical 
tension, as both a decrease and an increase in cortex thickness have been shown to reduce 
cortical tension. Chugh et al. (2017) showed that especially the level and activity of actin filament 
length regulators, such as mDia, capping protein and cofilin, are responsible for actin cortex 
thickness, but not actin crosslinking proteins like Arp2/3, α-actinin or filamin A, and also not cortex-
membrane crosslinking proteins, such as ERM proteins. This is consistent with actin cortex  
 
 
Figure 4.3: Model for the impact of actin cortex architecture and myosin II on cortical tension. Mitotic 
cell rounding depends on an increase in cortex tension (green arrow) that requires an optimal actin cortex 
thickness and density, as well as sufficient myosin II-mediated contractility. Both a deregulation of actin 
cortex thickness via actin filament length regulators, such as capping protein and mDia, and of actin cortex 
density via actin filament crosslinking proteins like Arp2/3 and α-actinin results in a decreased cortical 
tension (red arrow). Moreover, a decreased myosin II activity also results in a reduced cortex tension, 
whereas an irregular increase in myosin II activity further increases cortical tension. Every deregulation, 





thickness measurements from the present study, as a downregulation of the EB1-TRIO-Rac1-
Arp2/3 pathway did not change cortex thickness. The same effect was reported by Cartagena-
Rivera et al. (2016), who also measured no difference in cortex thickness, but an increase in 
cortical tension in Arp2/3-inhibited, nonadherent HFF cells.  
Taken all results together, this gives rise to a model, in which an optimal actin cortex thickness, 
regulated by actin filament length regulators, and an optimal actin cortex density, regulated by 
actin filament crosslinkers, is required for the generation of sufficient mitotic cortex tension (Figure 
4.3). Deviations from any optimum to any direction always results in a decreased cortical tension. 
Following this model, an increase in actin filament length would lead to an increase in actin cortex 
thickness and thus a reduced cortex tension. RhoA is a well-known activator of mDia formins, so 
that an increase in RhoA activation would be suggested to cause an increase in actin filament 
length via hyperactivated mDia, whereas inhibition of formins would reduce cortex thickness. 
However, in the present study there was no increase in actin cortex thickness measurable after 
treatment with low concentrations of the RhoA activator calpeptin and no decrease upon treatment 
with low dose of the formin inhibitor SMIFH2. At first glance, these results argue against the 
introduced model, but in this context it is of special importance to note that in a study from 
Ramanathan et al. (2015) the 50-100 fold concentration of calpeptin was used to induce slight 
changes in actin cortex thickness. Moreover, they showed that about a 2-fold concentration of 
SMIFH2 was required to induce significant changes in cortex tension. Consequently, actin cortex 
thickness can be altered by deregulation of RhoA or formin activity when using a higher drug 
concentration. Another important factor that needs to be considered is that activating RhoA via 
calpeptin does not only trigger the activation of mDia but also of the RhoA effector ROCK and 
thereby myosin II. This in turn has been shown to cause increased myosin II activity at the mitotic 
cortex (Ramanathan et al., 2015). Therefore, a strong increase in RhoA activity does not only lead 
to an increase in actin cortex thickness, but also myosin II-mediated contractility. Interestingly,  
Ramanathan et al. (2015) showed that in sum this still leads to an increase in cortical tension, 
thereby suggesting a stronger impact of myosin II than of cortex thickness following increased 
RhoA activation. This raises the question, whether cortical tension also has to be within a specific 
range to ensure correct spindle positioning in mitotic cells. Interestingly, Chaigne et al. (2015) 
revealed that this is at least the case for mouse oocytes, as both a too high or too low cortex 
tension caused defects in spindle positioning. In accordance with this study, Schermuly (2019) 
detected a defect in mitotic spindle positioning in chromosomally stable HCT116 cells upon RhoA 
inhibition by C3 toxin as well as by overexpression of a constitutively active RhoA mutant, thereby 




in spindle mispositioning. However, Schermuly (2019) measured a rescue in spindle positioning 
in chromosomally unstable SW620 cells after RhoA inhibition, which is not in line with the even 
more decreased cortex tension that these cells would exhibit after RhoA inhibition and also not 
with the heavily damaged actin cortex that especially SW620 cells showed after C3 toxin 
treatment. This observation might be explained by the strongly impaired cell rounding after C3 
toxin treatment in SW620 cells, which does not allow the mitotic spindle poles to position randomly. 
This explanation is supported by work from Lázaro-Diéguez et al. (2015), who found out that the 
positioning of the mitotic spindle is restricted in its x-z position due to constraints that are given 
when the mitotic cell is too flat. This probably also accounts as explanation for the apparent rescue 
of spindle orientation in SW620 cells, that have been treated with the actin-depolymerizing drug 
Latrunculin A, or the myosin II inhibitor blebbistatin, detected by Schermuly (2019). These 
treatments resulted in a damaged actin structure and/or a strong decrease in actin cortex tension, 
thereby probably impairing mitotic cell rounding and thus constraining the x-z position of the 
spindle. Moreover, the fact that Latrunculin A (IC50 = 0.75 µM and 0.33 µM for MKN45 and NUGC-
4 cells, 72 h) and blebbistatin (IC50 = 28.5 µM for hBMSC cells, 48 h) are known to induce cell 
death (Konishi et al., 2009; Paulamäki, 2017) and that C3 toxin has an antiproliferative effect 
(Elsner et al., 2017) rather excludes these drugs from causing an actual rescue.  
The results from F-actin signal intensity and AFM measurements indicated that the actin cortex 
organization is somehow altered by the EB1-TRIO-Rac1-Arp2/3 pathway. Interestingly, STED 
experiments actually revealed a changed morphology of the actin cortex upon Rac1 or Arp2/3 
inhibition, but not for low dose Taxol treatment in SW620 cells. However, even STED microscopy 
could still not visualize subtle changes, such as the pore size within the actin meshwork, that was 
reported to represent actin cortex density (Kronlage et al., 2015). In order to make these changes 
visible, scanning electron microscopy (SEM) (Bovellan et al., 2014; Chugh et al., 2017; Fritzsche 
et al., 2017), contact-mode AFM (Kronlage et al., 2015; Xia et al., 2019) or single molecule 
localization based super-resolution microscopy (SMLM) methods, such as STORM (Xia et al., 
2019), have proved successful. Interestingly, SEM images from Fritzsche et al. (2017) as well as 
STORM images from Xia et al. (2019) demonstrated a larger pore size within the actin meshwork 
after Arp2/3 inhibition, which confirms the decreased actin density determined by F-actin signal 
intensity measurements in the present study. Therefore, it would be of utmost interest to use these 
super-resolution microscopy methods to investigate whether these changes in pore size of the 
actin meshwork are also induced via downregulation of components upstream of Arp2/3 within the 
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